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SUMMARY 
Virology has contributed substantially to the biological revolution in the last 
century. Studying virus-host-interactions has revealed many of the fundamental 
molecular mechanisms such as the nature of genes and splicing. Adenoviruses 
have received intense attention in this regard as they are of low pathogenicity, 
easy to grow and rather well characterized. Still, biological mechanisms 
enabling adenovirus infections are not completely understood. In particular, 
processes that lead to disassembly of viral particles during entry as well as 
release of newly synthesized particles upon cell lysis at the end of the viral 
replication cycle have been difficult to address.  
Here we generated a novel human adenovirus with fluorescently tagged 
chromatin by replacing protein V by GFP-pV while keeping all the other viral 
genes intact. This virus, named Ad2-GFP-pV, completed the full replication 
cycle and therefore allowed us to study transport of incoming viral cores as well 
as viral egress from infected cells. We showed that the viral core component 
GFP-pV is released from Ad2-GFP-pV during entry and disassembly in two 
distinct steps. A fast one within 30 min where about 65% of GFP-pV is released 
and a slower up to 90 min pi leading to full dissociation of GFP-pV from viral 
particles. The full dissociation is dependent on an interaction of the incoming 
virus with the nucleus. Using this virus we were also able for the first time to 
visualize dynamics of viral egress upon cell lysis. We observed that this process 
is nonisotropic and occurs in two morphologically distinct steps, nuclear 
disintegration preceding lysis of the plasma membrane. 
Taken together we showed that this new virus is suitable to study the whole 
viral replication cycle and thus might prove useful for live analyses of viral 
infection and spreading in organisms, as well as for applications in gene 
therapy.  
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ZUSAMMENFASSUNG 
Die Untersuchung von Viren hat substanziell zur biologischen Revolution im 
letzten Jahrhundert beigetragen. Die Analyse von Virus-Wirt Interaktionen hat 
viele zelluläre Prinzipien offenbart wie zum Beispiel die Gesetzmässigkeiten 
von Genen und deren Spleissung. Ein oft benutztes Modelsystem sind 
Adenoviren. Dies, weil sie nur beschränkt krankmachend, einfach zu vermehren 
und gut charakterisiert sind. Trotzdem sind die zugrundeliegenden zellulären 
Mechanismen, welche eine Infektion ermöglichen, immer noch nicht gut 
verstanden. Insbesondere Prozesse die zum Abbau viraler Kapside während 
des Imports führen und wie Viren die Zelle verlassen, war bisher schwierig zu 
untersuchen. 
In dieser Arbeit haben wir das Chromatin eines humanen Adenovirus 
fluoreszent markiert, indem wir das Protein V gegen das fluoreszierende 
Fusionsprotein GFP-pV ausgetauscht haben, ohne dabei andere virale Gene zu 
zerstören. Dieses Virus, genannt Ad2-GFP-pV, durchlief den vollen 
Replikationszyklus und erlaubte es uns daher, viralen Transport und 
Freisetzung von Viren am Ende des Zyklus zu untersuchen. Wir konnten 
zeigen, dass während des Eintritts des Kapsids in die Zellen das GFP-pV in 
zwei Schritten dissoziiert. Innerhalb von 30 Minuten wurden 65% vom GFP-pV 
ins Zytosol abgegeben und nach 90 Minuten das restliche Protein. Der zweite 
Schritt war dabei abhängig von einer Interaktion der Viren mit dem Zellkern. Im 
Weiteren ist es uns gelungen, zum ersten Mal die Dynamik der Virenfreisetzung 
am Ende des viralen Replikationszykluses zu bestimmen. Wir konnten zeigen, 
dass dieser Prozess anisotrop ist und in zwei Schritten geschieht. Einem Zerfall 
der Kernmembran folgt die Lyse der Plasmamembran. 
Zusammenfassend konnten wir zeigen, dass dieses neue Virus ermöglicht, den 
vollständigen Replikationszyklus von Adenoviren zu untersuchen. Es hat das 
Potential, Echtzeituntersuchungen von Infektionen und deren Ausbreitung in 
Organismen zu machen oder als diagnostisches Virus in der Gentherapie 
eingesetzt zu werden. 
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INTRODUCTION 
1. Why we do virology 
1.1 Insights into cellular mechanisms through viral studies 
The field of virology contributed substantially to the biological revolution in the 
last century. This is not by chance. The reason lies in the intrinsic properties of 
viruses and the way they interact with their hosts. As obligatory parasites 
viruses depend heavily on the cells they infect. Viruses lack their own 
metabolism, and therefore have to give precise instructions to the cell to 
manipulate it for their own use. As viruses are limited in size and can carry only 
a limited amount of genes, they often directly interfere with biological key nodes 
to reach highest efficiency. This makes viruses ideal tools to study cellular 
principles. Detailed analyses of these interactions has led to the discovery of 
many of the cells basic features and mechanisms. For example, the genetic 
origin of mutations, discovery of host controlled restriction and modification, 
definition of a gene, demonstration of the triplet nature of the genetic code, RNA 
polyadenylation, arrangement of genes into introns and exons, the nuclear 
localization signal and the discovery of gene silencing by double-stranded RNA 
as antiviral response were discovered through study of viruses, to name only a 
few examples (reviewed in (Enquist, 2009)). For sure this list will continue to 
grow as new powerful techniques and methods allow a more and more detailed 
view into the cells structure and processes. One advantage of viruses is their 
size: They can be visualized by EM, and after fluorescent-tagging also by light 
microscopy. 
 
1.2 Viruses as pathogens 
Although viruses proved to be very useful for basic research, a major motivation 
to study viruses comes from the fact that they are responsible for many human 
diseases. Smallpox, for example, is known as one of humankind‟s greatest 
killers. It decimated the human population over the course of history. As an 
example, during the European conquest of the New World, imported smallpox 
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infections had a large impact on the indigenous population. The outbreak of the 
“Spanish Flu” at the end of World War I was responsible for more casualties 
then the war itself. This influenza pandemic killed an estimated 20 to 40 million 
people. Ironically but not surprising the high relevance for human health and 
associated social and economic consequences catalyzed also some of the 
largest triumphs in the history of virology and medicine. In 1796 Edward Jenner 
demonstrated that inoculation with cowpox lesions provided protection against 
the more virulent variola major virus, the causative agent of smallpox. The 
subsequent development of vaccines against many different pathogens had its 
tentative climax by the eradication of smallpox after a concerted worldwide 
vaccination campaign of the World Health Organization in 1979. Nevertheless, 
we will be confronted with new emerging viral threats, now and in the future. For 
example, the acquired immune deficiency syndrome (AIDS) caused by the 
human immunodeficiency virus (HIV) has since its discovery in 1981 (Marx, 
1982) become one of the biggest medical challenges of our time. It has a deep 
social and economical impact worldwide, but especially in Sub-Saharan Africa. 
 
1.3 Viruses as oncogenic agents 
More recently viruses gained attention because of their association with human 
cancer. Since the early demonstration of viral causation of murine leukemias by 
Gross (Gross, 1951) or the recognition of Adenovirus type 12 as first human 
virus to be oncogenic (Trentin, Yabe, & Taylor, 1962) many viruses have been 
identified to account for different cancers in mammals. Medical records indicate 
that 12-20% of the human cancer incidences worldwide are associated with 
viral infections (Parkin, 2006). Human papilloma virus, for example, is known to 
be present in 100% of all analyzed cervix cancers and vaccination efforts are 
therefore underway with the hope to reduce the amount of incidences. Other 
examples are Epstein-Barr virus (EBV) responsible for Burkitt‟s lymphoma, 
human T lymphotropic virus type 1 (HTLV-1) associated with adult T-cell 
leukemia, human herpesvirus type 8 (HHV-8) known to induce body cavity 
lymphoma or hepatitis B virus (HBV) for hepatocellular carcinoma. New viruses 
most certainly will be added to the list of cancer-causing viruses emphasizing 
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the high importance of this field and the need of detailed knowledge about the 
underlying mechanism. More information on the role of DNA-tumor viruses in 
cancer can be found in the review embedded in this thesis (DNA-tumor virus 
entry – From the plasma membrane to the nucleus (Greber & Puntener, 2009)). 
 
1.4 Viruses as tools in gene therapy 
An emerging field in virology is the use of viruses as tools in gene therapy 
(Bangari & Mittal, 2006). In particular, adenoviruses have obtained much 
attention in this regard as they are well studied, of low pathogenicity, can be 
grown easily to high titers, have a broad tropism and posses a low oncogenic 
potential as genomes are rarely integrated into the host chromosome. Gene 
therapy approaches aim to deliver genes into target cells in order to correct or 
compensate the absence or mutation of a specific gene or eliminate cancer 
cells by selective infection. Although the idea is intriguing there are still a lot of 
problems to overcome. Most importantly the efficacy of host defenses is still one 
of the major challenges in the field. Adenoviruses are highly immunogenic. Not 
only the humoral but also the cell-mediated immune responses are activated 
upon infection (Dai, et al., 1995). This dramatically reduces success rates in 
gene therapy trials because the low efficiency of gene transfer often requires 
repeated treatment with vectors. In addition there is a high prevalence of 
neutralizing antibodies against species C adenoviruses on which most vectors 
are based (Nwanegbo, et al., 2004). Although a lot of progress has been made 
in recent years and a large number of clinical trials are underway it remains to 
be seen if the substantial problems can be solved. 
Therefore, continuous basic virological research is important. Not only because 
viruses are an ongoing threat causing infections and cancer, but also because 
many of the underlying mechanisms remain to be discovered and these 
mechanisms are the basis for new virus-mediated gene therapies. 
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2. Adenoviruses 
2.1 Adenoviridae 
In this research, properties of a GFP-insertion mutant of Adenovirus type 2 
(Ad2) were studied in some detail. Ad2 belongs to the family of Adenoviridae 
which is classified into four major genera comprising Atadenovirus, 
Aviadenovirus, Mastadenovirus and Siadenovirus (Davison, Benko, & Harrach, 
2003). Recently, a fifth genus infecting fish was proposed (Benko, et al., 2002). 
The genera of Mastadenovirus comprise all Adenoviruses known to infect 
mammals, including humans. Human adenoviruses are further divided into 
species A to F including 51 serotypes. Many of them are known to cause 
respiratory infections (species B, C and E) but also gastroenteritis (species F) 
as well as keratoconjunctivitis (species B, D and E) are frequently associated 
with adenoviral infections in humans. Although adenovirus infections cause 
normally mild diseases, severe complications can occur in 
immunocompromised patients (Kojaoghlanian, Flomenberg, & Horwitz, 2003).  
 
2.2 Adenovirus structure and composition 
Adenoviruses are composed of a non-enveloped capsid of about 90 nm in 
diameter surrounding and protecting the core consisting of the 36 kbp genome 
and associated proteins (Fig.1). From the 13 known polypeptides forming the 
viral particle, hexon (pII) is the most abundant. It forms 240 homotrimeric 
capsomers that build up the icosahedral capsid together with homopentamers 
of penton base (pIII) anchoring the 37 nm long fiber (trimer of pIV) to the capsid. 
Penton base and fibers constitute the penton capsomere which is present at 
each of the 12 vertices of the icosahedral capsid. The capsid is stabilized by 
minor capsid proteins IIIa, VI, VIII and IX. The exact position of these proteins is 
still discussed. However, four trimers of pIX are assumed to be embedded in 
large cavities in the upper surface of an assembly of 9 hexons also known as 
groups-of-nine (GON) cementing this structure into a highly-stable assembly 
(Furcinitti, van Oostrum, & Burnett, 1989). pIIIa, which also lies on the outside of 
the capsid connects two neighboring GONs (Fabry, et al., 2005). The position of 
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pVI is not clear. The current model locates pVI in the internal cavity of the hexon 
trimer. Data supporting this model come from biochemical studies (Everitt, 
Lutter, & Philipson, 1975) (Matthews & Russell, 1995) and from Cryo-EM 
structural studies (Silvestry, et al., 2009; Stewart, Fuller, & Burnett, 1993). 
However, the assignment of pVI to locations inside the hexon trimer is 
problematic, as there are 360 copies of pVI per virion but only 240 capsomers. 
Interestingly, unassigned structures around the 5-fold symmetry of the vertices 
projecting towards the DNA-core have been detected in cryo-EM studies, and 
these structures have been tentatively assigned to pVI (Fabry, et al., 2005).  
While cryo-EM studies in combination with X-ray structures of individual 
component proteins resulted in a rather well defined model of the capsid 
structure (Nemerow, Pache, Reddy, & Stewart, 2009) the core is not well 
presented because it lacks symmetry (Stewart, Burnett, Cyrklaff, & Fuller, 
1991). Although structural information of the precise organization of the genome 
inside the viral particle is missing, biochemical analysis of isolated cores of 
species C human Ad2 and the closely related Ad5 revealed five DNA-
associated proteins. The basic proteins V, VII and X (pV, pVII, pX), the terminal 
protein covalently attached to the 5‟ ends of the DNA (Rekosh, Russell, Bellet, 
& Robinson, 1977), and approximately 10 copies of the viral protease loosely 
associated with the core (Weber, 2003) (Mangel, Baniecki, & McGrath, 2003). A 
schematic of the present model is shown below. (from (Russell, 2009)). 
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3. Viral chromatin 
3.1 Current model of adenovirus chromatin 
Copy numbers of VII and V were measured to be 1070 and 180, respectively, in 
virus particles (Everitt, Sundquist, Pettersson, & Philipson, 1973). Based on this 
data together with results obtained by digestion of cores with staphylococcal 
nuclease which yielded 200 base pair DNA fragments (which was later also 
confirmed by Black et al. (Black & Center, 1979)), Corden et al. suggested a 
model in which viral DNA is organized into 180 nucleosome-like units where 
200 bp DNA is condensed by hexamer of protein VII and associated with one 
copy of protein V (Corden, Engelking, & Pearson, 1976). However, micrococcal 
nuclease digestions and electron microscopy analysis of viral cores led Mirza et 
al. to conclude that the chromatin is organized into 200 nucleosome-like units 
with monomer cores of 150 bps and an average 30 bp linker region (Mirza & 
Weber, 1982). Furthermore, they could identify dimers of protein VII in 
crosslinking experiments in agreement to observations later made by Chatterjee 
et al. (Chatterjee, Vayda, & Flint, 1985) and also proposed by studies analyzing 
the binding of VII to DNA by partial proteolytic mapping of the sites of covalent-
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attachment of 32P-labelled oligonucleotides (Chatterjee, Vayda, & Flint, 1986b). 
Therefore, it was proposed that the nucleosome-like cores are composed of 
three dimers of protein VII. As pV is present in a ratio of 1 copy to 1 
nucleosome-like unit in Corden‟s model, it was speculated that protein V 
functions in bridging nucleosomes and thereby helps condensing to viral 
genome. In addition to its ability to bind DNA in a non specific manner, pV was 
also found to bind pVI and therefore a role for pV in connecting the core to the 
capsid is assumed (Matthews & Russell, 1998). It is interesting to note that a 
recombinant Ad5 in which protein V is deleted gave rise to low levels of viral 
particles, suggesting that pV was involved in the assembly of infectious virions 
(Ugai, Borovjagin, Le, Wang, & Curiel, 2007). The deletion, however, is 
compensated by mutations in mu (pX) indicating redundancy for core 
organization by molecular adaptation which is further supported by the fact that 
pV is specific for Mastadenoviruses, which exclusively infect mammals 
(http://www.vmri.hu/~harrach/ADENOSEQ.HTM). 
In Corden‟s model the copy number of VII is predicted to be 1080 while in 
Mirza‟s model it is 1200. This seems to be in conflict with biochemically 
measured copy numbers of VII and V which are 833 +/- 33 and 157 +/- 1 
respectively (van Oostrum & Burnett, 1985) or, to RP-HPLC-based estimations 
which gave, 633 +/- 59 and 170 +/- 15 for pVII and PV, respectively (Lehmberg, 
et al., 1999). However, this discrepancy could be explained by stretches in the 
viral genome lacking pVII and pV.  
 
3.2 The role of cellular histones in adenoviral infections  
The proposed model of the viral core is intriguing, especially because of its 
analogy to cellular chromatin: Eukaryotic cells package their DNA with histones 
and associated proteins into nucleosomes. Nucleosomes are octamers 
composed of two copies each of core histones H2A, H2B, H3 and H4 
condensing 146 bp of DNA (Luger & Richmond, 1998). An additional protein, 
histone H1, dynamically interconnects individual nucleosomes with a short 
residence time of a few minutes on chromatin (Janicki & Spector, 2003) (Talbert 
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& Henikoff, 2010). While nucleosomes are invariant in structure and 
composition chromatin is highly dynamic as it switches between condensed and 
decondensed states in mitosis and interphase. Flexibility is necessary in 
addition for regulating access to specific DNA sequences during transcription 
and DNA replication and is mediated by posttranslational modifications of 
specific histone residues as well as the DNA itself. These modifications include 
acetylation, phosphorylation, methylation, ubiquitination, sumoylation and ADP-
ribosylation of histones and base methylation of cytosine residues (Keppler & 
Archer, 2008; Strahl & Allis, 2000). It is worthwhile to note that several of these 
modifications are also found on the adenoviral core proteins V and VII 
suggesting a role of the cellular chromatin regulation system in viral 
transcription, replication and assembly (Dery, et al., 1986; Fedor & Daniell, 
1980; Weber & Khittoo, 1983).  
Although the viral genome is associated with virally coded proteins V, VII and X 
in the virion, it can be found condensed by cellular histones in specific phases 
of the viral life cycle. Upon nuclear entry pVII remains bound to the incoming 
DNA throughout early phase and the beginning of DNA replication (Chatterjee, 
Vayda, & Flint, 1986a) (Greber, Webster, Weber, & Helenius, 1996) (Haruki, 
Gyurcsik, Okuwaki, & Nagata, 2003) (Johnson, et al., 2004) (Xue, Johnson, 
Ornelles, Lieberman, & Engel, 2005). It is, however, released upon onset of 
transcription (J. Chen, Morral, & Engel, 2007). Besides the viral early gene 
product E1A, several cellular factors are involved in this viral chromatin 
remodeling process. The protein SET/template activating factor-Iβ (TAF-Iβ), for 
example, was found to associate with pVII (Haruki, et al., 2003) (Haruki, 
Okuwaki, Miyagishi, Taira, & Nagata, 2006) (Xue, et al., 2005) and stimulated 
transcription and DNA replication from adenovirus nucleoprotein preparations 
(Kawase, et al., 1996) (Okuwaki & Nagata, 1998). The cellular protein pp32 was 
also shown to associate with pVII in vitro (Xue, et al., 2005). Interestingly both 
proteins are components of the INHAT complex known to regulate histone 
acetylation and transcription (Seo, et al., 2001) (Seo, et al., 2002). It is tempting 
to assume that once pVII is released from the viral genome the DNA engages 
with cellular histones. Indeed newly synthesized viral DNA was found to be 
bound by cellular histones and served as template for transcription and 
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replication (Dery, et al., 1985). The use of histones in the cellular phase of the 
viral life cycle is not unique to adenoviruses. Herpesviruses, for example, 
condense the genome in viral particles with the help of polyamines but 
organizes it into regular histone-based nucleosomes during latency and 
irregularly spaced nucleosomes during productive infection (Paulus, Nitzsche, & 
Nevels, 2010). Genomes of SV40 and polyomavirus are condensed by cellular 
histones during the whole life cycle. 
 
4. Adenovirus life-cycle 
4.1 Endocytosis and transport to the nucleus 
The first step in adenovirus entry is attachment to the target cell. This is 
mediated by cellular receptors, which in case of Ad2 is the primary Coxsackie 
and Adenovirus receptor (CAR) and secondary alpha v integrin co-receptors 
which bind to a RGD motif exposed at the surface of penton base (Bergelson, et 
al., 1997) (Meier & Greber, 2004; Wickham, Mathias, Cheresh, & Nemerow, 
1993) (Burckhardt & Greber, 2009). These interactions not only induce various 
signaling events such as activation of protein kinase A (PKA) and mitogen 
activated protein kinase (MAPK) (Suomalainen, Nakano, Boucke, Keller, & 
Greber, 2001) but also leads to the shedding of fiber and therefore initiates the 
stepwise disassembly of the viral capsid during entry (Greber, Willetts, Webster, 
& Helenius, 1993; Nakano, Boucke, Suomalainen, Stidwill, & Greber, 2000). 
Adenoviruses are then internalized by clathrin-mediated endocytosis or 
macropinocytosis (Meier, et al., 2002) and accumulate in endosomes. It was 
suggested that further disassembly in this compartment results in the exposure 
of pVI which harbors an amphipathic alpha-helix with membrane lytic activity 
and therefore triggers membrane lysis and ultimately escape of viral particles 
into the cytosol (Wiethoff, Wodrich, Gerace, & Nemerow, 2005) (Maier, Galan, 
Wodrich, & Wiethoff, 2010). However, the precise mechanism is not known. The 
cytosolic Ad2 are then transported along microtubules by the dynein/dynactin 
motor complex to the microtubule organizing center (MTOC) (Suomalainen, et 
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al., 1999) (Mabit, et al., 2002) from where they reach the nuclear pore complex 
(NPC) and bind to the CAN/Nup214 receptor (Trotman, Mosberger, Fornerod, 
Stidwill, & Greber, 2001). How exactly the particles are transported from the 
MTOC to the NPC is not known. However, this process is sensitive to the 
macrolide antibiotic leptomycin B (LMB), which inhibits nuclear protein export 
and prevents the attachment of incoming virions to the NPC (Strunze, Trotman, 
Boucke, & Greber, 2005). Figure 2 depicts the described entry process. 
 
 
Figure 2. Schematic presentation of Ad2 entry. Adapted from Puntener & Greber 2009 
 
4.2 Adenovirus DNA import 
(Note: A compacted version of this chapter can be found in the review embedded in this thesis) 
Replication of adenovirus occurs in the nucleus, and therefore delivery of the 
viral DNA into this cellular compartment is a prerequisite for productive 
infection. The nucleoplasm is separated from the cytoplasm by the nuclear 
envelope, which is composed of the inner and outer nuclear membranes 
enclosing the perinuclear space, which is an extension of the ER lumen. While 
16 
the ONM is continuous with the ER and studded with ribosomes, the INM is 
characterized by a set of integral membrane proteins. Exchange of molecules 
through the two concentric lipid bilayers is maintained by multiprotein structures 
known as nuclear pore complexes at sites at which the INM and ONM are 
fused. NPCs of Saccharomyces cerevisiae contain at least 456 individual 
protein molecules and are composed of a set of ~30 distinct proteins with a total 
mass of ~50 MDa. The molecular architecture of NPCs is highly conserved 
among all eukaryotes and a detailed view of NPCs of Saccharomyces 
cerevisiae has recently been published (Alber, et al., 2007). Briefly, the NPCs 
are made up of a core scaffold that forms an interlaced network coating the 
entire curved surface of the nuclear envelope membrane. The inner face of this 
scaffold serves as the anchor site for proteins with large disordered regions 
containing characteristic repetitive sequence motifs known as FG repeats 
forming the aqueous channel and contributing to the selectivity of 
nucleocytoplasmic transport. On top of the two inner rings of the core scaffold 
are the cytoplasmic ring to which long cytoplasmic filaments are attached and 
the nuclear ring forming a basket-like structure consisting of nuclear filaments. 
The diameter of the central channel is ~39 nm, which is also the size limit for 
transported particles (Pante & Kann, 2002). The NPC has been intensively 
reviewed and for further reading the following reviews are suggested (D'Angelo 
& Hetzer, 2008) (Lim, Ullman, & Fahrenkrog, 2008) (Cook, Bono, Jinek, & Conti, 
2007). 
Kinetic studies of nuclear transport have shown that each NPC can 
accommodate up to 1000 translocation events per second, and despite the 
huge traffic, transport is highly selective and regulated (Ribbeck & Gorlich, 
2001). While small molecules such as ions or metabolites can pass the NPC by 
diffusion, cargos larger than ~40 kDa require specific transport receptors 
(Talcott & Moore, 1999). FG-proteins play an important role in the translocation 
of cargo but the biophysical properties of the pore necessary for selective 
translocation is still controversial. There are two main models discussed: 1) FG-
proteins form a gelatinous meshwork, which would allow small molecules to 
passively diffuse. Transport receptors bound to larger cargoes would locally 
interact with FG-sequences and dissolve the barrier to permit passage through 
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the pore (Frey, Richter, & Gorlich, 2006). 2) The NPC forms an entropic barrier, 
which repels non-FG-binding molecules. Binding of receptors would concentrate 
transport complexes and thereby increase the probability of transport (Lim, 
Aebi, & Stoffler, 2006). 
In both models transport receptors play a critical role. Most of the 
nucleocytoplasmic transport factors belong to the family of karyopherin-β also 
known as importin-β like proteins. Depending on its directionality they are 
grouped as importins, exportins or transportins. Karyopherins bind cargo either 
directly or via an adaptor. For example, isoforms of importin-α are often used as 
adaptors for importin-β. Translocation is driven by the guanosine triphosphatase 
(GTPase) Ran: In its GTP bound form (RanGTP), Ran binds to karyopherins 
and either triggers the dissociation of import complexes or promotes the 
assembly of export complexes. In the cytoplasm Ran GTPase-activating factor 
1 (RanGAP1) induces hydrolysis of GTP causing the dissociation of export 
complexes whereas RanGDP/GTP exchange factor (RanGEF) localized in the 
nucleoplasm stimulates exchange of GDP for GTP resulting in dissociation of 
import complexes. Ran in its GDP or GTP bound form is asymmetrically 
distributed with the first concentrated in the cytoplasm and the latter in the 
nucleoplasm creating a gradient, which provides the necessary energy for the 
transport processes. For detailed reviews of nucleocytoplasmic transport, see 
also (Cook, et al., 2007) (Terry, Shows, & Wente, 2007).  
Cargos imported into the nucleus are recognized by their karyopherins by the 
nuclear localization signal (NLS) for import and the nuclear export signal (NES) 
for export. A monopartite NLS consist of a cluster of 3 to 5 positively charged 
amino acids such as the SV40 T antigen NLS whereas in case of a bipartite 
NLS a smaller lysine/arginine cluster is separated from the monopartite-like 
cluster by a linker of 10 to 12 residues. 
Studying virus nuclear import has proven to be difficult. Although some progress 
has been made the last decade, the lack of suitable live probes for DNA/RNA is 
still a major hurdle. While DNA virus nuclear import is often visualized using 
semiquantitative Fluorescent in situ hybridization (FISH) a live assay for 
poliovirus was recently developed where the viral genome was labeled by the 
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RNA binding dye Syto82 (Brandenburg, et al., 2007). To date, unfortunately, 
there is no such technique available for DNA viruses including adenovirus. 
Attempts undertaken in our lab by either inserting a series of 40 lac operator 
sequences in a recombinant Ad5 capable of binding fluorescently tagged lac 
repressor or labeling of viral DNA by the DNA intercalating dye TOTO-3 failed 
(unpublished). 
Since all DNA viruses make use of the host cells, nuclear import machinery 
analysis of the corresponding interactions shed some light on the mechanisms 
of viral import. Information on the role of NLSs for nuclear import of DNA-tumor 
viruses can be found in the review DNA-tumor virus entry – from plasma 
membrane to the nucleus embedded in this thesis. Adenovirus disruption at the 
NPC, nuclear import of adenovirus DNA associated proteins and their role in 
DNA import are also described. 
 
4.3 Adenovirus replication 
Once the viral genome has been imported into the nucleus a well timed series 
of events is initiated which is roughly divided into an early and a late phase. The 
later phase starts upon onset of viral DNA replication and subsequent late gene 
expression. In the early phase mRNA is transcribed from seven different 
locations in the viral genome, designated early regions 1A (E1A), E1B, E2A, 
E2B, E3, E4 and a late region 1 (L1). Translated proteins interact with viral and 
host cell proteins in order to optimize synthesis of new virions. The first protein 
to be expressed is E1A (Nevins, Ginsberg, Blanchard, Wilson, & Darnell, 1979). 
It induces the host to enter the S phase of the cell cycle and also stimulates 
expression from the other early transcription units. Viral proteins E1B-55K and 
E4orf6 inhibit p53 function and thereby prevent apoptosis of the cell (Cathomen 
& Weitzman, 2000). Proteins transcribed from the E3 region mainly provide 
protection from the immune system (Lichtenstein, Toth, Doronin, Tollefson, & 
Wold, 2004). Finally, terminal protein (pTP), DNA binding protein (DBP) and the 
viral polymerase are transcribed from the E2 region preparing the cell for 
replication of viral DNA. DNA replication is initiated at either terminus of the 
double-stranded viral genome. At each replication fork only one of the two 
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parental strands is replicated, producing a daughter duplex and a displaced 
single-strand DNA (Dery, et al., 1985). Viral DNA replication occurs at discrete 
intranuclear locations which are often visualized by staining of DBP as the 
displaced single-stranded DNA is bound by this protein. Focal viral inclusions 
with the shape of rings, crescents or spheres are thereby observed which were 
named ssDNA accumulation sites (Puvion-Dutilleul, Pedron, & Cajean-Feroldi, 
1984). While early in replication these sites are active for both replication and 
transcription, these activities become compartmentalized as replication 
proceeds. ssDNA continues to be accumulated at the DBP positive sites while 
dsDNA is released to the surrounding nucleoplasm, where it is used as 
template for transcription (Pombo, Ferreira, Bridge, & Carmo-Fonseca, 1994). 
Interestingly we were able to locate pV and GFP-pV expressed from Ad2 and 
Ad2-GFP-pV to ssDNA accumulation sites at early times and adjacent to them 
at late time points of infection. This suggests a role for pV in transcription, 
replication or assembly of new particles (unpublished). In this context it is 
worthwhile to note that it was speculated that only the single-stranded DNA is 
used for encapsidation. A premature chromatinization of viral dsDNA by pV and 
pVII would therefore not be beneficial as chromatinized viral genome is not a 
optimal template for transcription and replication (Johnson, et al., 2004; Korn & 
Horwitz, 1986). Indeed, expression of pV, which harbors NLSs targeting the 
protein to the nucleus and nucleolus (Matthews, 2001), was found to 
redistribute nucleolin/C23 and nucleophosmin/B23 from the nucleus to the 
cytoplasm (Matthews, 2001). B23 in turn interacts with pV and pre-pVII und 
suppresses the formation of aggregates between DNA and the core proteins 
(Samad, Okuwaki, Haruki, & Nagata, 2007) (Okuwaki, Matsumoto, Tsujimoto, & 
Nagata, 2001) (Okuwaki, Iwamatsu, Tsujimoto, & Nagata, 2001). This data 
suggest that spatial and temporal separation of viral components might be 
important for correct transcription, replication and assembly of new viral 
particles. 
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4.4 Cell lysis and egress 
At the end of the viral replication cycle, newly synthesized viral particles have to 
be released from the infected cell in order to spread and infect new cells. A 
major challenge, therefore is tricking the immune system as viruses in the 
extracellular space are readily recognized and cleared by components of the 
immune system. Two principle routes are known. Some viruses have chosen to 
avoid a direct exposure to immunocompetent factors by spreading through cell-
cell contacts. Neurotropic viruses such as herpesvirus and rhabdovirus were 
found to spread along neuronal networks and are transmitted via neurological 
synapses. Retroviruses use so called virological synapses, which closely 
resemble immunological synapses, for their cell-to-cell spread (Mothes, Sherer, 
Jin, & Zhong, 2010). If viruses do not make use of cell-assisted spreading they 
have to meet several requirements in order to be successful. Large numbers 
must be released that are sufficiently stable to reach distant areas by diffusion. 
Once particles reach the target cell, strong binding to receptors is necessary for 
efficient infection. There are several indications that adenoviruses support such 
a cell-free transmission mechanism. The adenovirus protease, for example, was 
found to cleave the cellular cytokeratin K18 thereby disrupting the intermediate 
filament system, which is thought to make infected cells more susceptible to 
lysis by mild mechanical forces (P. H. Chen, Ornelles, & Shenk, 1993). 
However, cleavage of cytokeratin K 18 alone is not sufficient to destabilize the 
cellular integrity, since the synthesis of new keratin readily repairs the 
intermediate filaments. Only at late stages of infection when translation of 
cellular proteins is inhibited does the lack of filament repair lead to a sufficient 
breakdown of the cytokeratin network, which facilitates release of newly 
synthesized infectious virus particles (Zhang & Schneider, 1994). Besides 
cytokeratin, actin and microtubules have also been identified as substrates for 
the viral protease suggesting that disruption of the cellular filament system is 
important for cell lysis (Mangel, et al., 2003). 
The second mechanism involves the virally encoded E3 11.6 kDa adenovirus 
death protein (ADP) (Tollefson, Scaria, et al., 1996). ADP is an integral 
membrane protein shown to localize to the endoplasmatic reticulum where it is 
synthesized, the Golgi apparatus where it is glycosylated (Scaria, Tollefson, 
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Saha, & Wold, 1992) and the nuclear membrane. While only small amounts of 
this protein are synthesized at early times of infection under the control of the 
E3 promotor, expression of ADP is greatly amplified at late stages of infection 
through transcription from the viral major late promoter (MLP) (Tollefson, 
Scaria, Saha, & Wold, 1992). At this time ADP accumulates at the nuclear 
membrane and the Golgi apparatus. Interestingly in EM studies with a mutant 
adenovirus lacking the gene for ADP, infected cells showed an extremely 
swollen nucleus with apparently intact nuclear envelope at late time points of 
infection and no cytosolic virus, whereas the nuclear envelope could not be  
readily defined in wt infected cells at the same time point (Tollefson, Ryerse, 
Scaria, Hermiston, & Wold, 1996). The authors therefore suggested that ADP 
might function in the disruption of the cell nucleus. 
Interestingly, adenovirus particles were found in the cytoplasm of infected Hela 
cells at late stages of infection, while the nuclear membrane was seemingly 
intact (Puvion-Dutilleul, Besse, Pichard, & Cajean-Feroldi, 1998). In addition 
infected cells were shown to be able to transmit penton to neighboring cells 
probably through a cell contact-assisted mechanism as no free penton could be 
detected in the extracellular medium (Trotman, Achermann, Keller, Straub, & 
Greber, 2003). This could indicate that viral components or even whole particles 
might be transmitted to adjacent cells in the absence of lysis. Since Ad2-GFP-
pV is able to complete a full replication cycle, this virus can be used for live 
imaging of virus adenovirus egress, and thus as a tool to unravel mechanisms 
of progeny virus release from adenovirus-infected cells. 
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Abstract 
DNA-tumor viruses comprise enveloped and nonenveloped agents that cause 
malignancies in a large variety of cell types and tissues by inferfering with cell 
cycle control and immortalization.  Those DNA-tumor viruses that replicate in 
the nucleus use cellular mechanisms to transport their genome and newly 
synthesized viral proteins into the nucleus.  This requires cytoplasmic transport 
and nuclear import of their genome.  Agents that employ this strategy include 
adenoviruses, hepadnaviruses, herpesviruses, papillomaviruses, and 
polyomaviruses, but not poxviruses which replicate in the cytoplasm.  Here, we 
discuss how DNA-tumor viruses enter cells, take advantage of cytoplasmic 
transport, and import their DNA genome through the nuclear pore complex into 
the nucleus.  Remarkably, nuclear import of incoming genomes does not 
necessarily follow the same pathways used by the structural proteins of the 
viruses during the replication and assembly phases of the viral life cycle.  
Understanding the mechanisms of DNA nuclear import can identify new 
pathways of cell regulation and anti-viral therapies.   
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1. Introduction 
 
Medical and epidemiologic records indicate that 12–20% of the human cancer 
incidences worldwide are associated with viral infections (Parkin, 2006).  These 
infections are mostly due to DNA-tumor viruses, the flavivirus hepatitis C virus 
(HCV), and retroviruses, such as the human T lymphotropic virus type 1 (HTLV-
1), a slow transforming RNA retrovirus associated with adult T-cell leukemia 
(Javier & Butel, 2008; McLaughlin-Drubin & Munger, 2008; Pagano, et al., 2004; 
zur Hausen, 2002).  A variety of viruses induce tumors in animals and a few of 
them have been recognized by the International Agency for Research in Cancer 
(IARC) as human carcinogens (Carbone & Barbanti-Brodano, 2006).  DNA-
tumor viruses are a diverse group of agents grouped into twenty-two families of 
double-stranded DNA-viruses infecting vertebrates and invertebrates but not 
plants (Tab. 1) (International Committee on Taxonomy of Viruses, 
http://www.ictvonline.org/index.asp).  Their capsid sizes range from 30 nm in 
the case of Hepatits B virus (HBV) up to 150 nm for Epstein Barr virus (EBV).  
Their genomes are linear, for example adenovirus, or circular such as SV40.  
They can be non-enveloped, such as adenoviridae, papillomaviridae, 
polyomaviridae, or enveloped, such as herpesviruses and hepadnaviruses.  
 
Human Adenovirus type 12 (Ad12) was the first human virus recognized to be 
oncogenic when it was found to cause malignant tumors after inoculation into 
newborn hamsters (Trentin, Yabe, & Taylor, 1962) (Tab. 1).  Later, it was shown 
that Ad12 integrates its DNA into the host chromosomes (Dörfler, 1968).  Up to 
now, no epidemiologic evidence has been reported of adenovirus-associated 
malignancies in humans, although a recent study detected Ad-DNA in pediatric 
brain tumors (Kosulin, et al., 2007).   
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Herpesviruses are classified into three subfamlies, alpha-, beta- and gamma-
herpesviruses (Knipe & Cliffe, 2008), some of which have been associated with 
human cancers of epithelia and lymphatic cells (Cesarman & Mesri, 2007; 
Molho-Pessach & Lotem, 2007) (Tab. 1).  The chicken alpha-herpesvirus 
Marek‟s disease virus causes T cell tumors, neurological disease and immune 
suppression in its natural host (Osterrieder, Kamil, Schumacher, Tischer, & 
Trapp, 2006).  The beta-herpesvirus human cytomegalovirus (HCMV) is 
associated with glioblastoma (for a recent discussion, see G. Miller, 2009) but 
has so far not been observed to transform normal cells into cancerous cells.  
The gamma-herpesvirus Epstein Barr virus (EBV) was the first virus shown to 
induce human tumors, nasopharyngeal carcinoma (Epstein, Henle, Achong, & 
Barr, 1965). 
 
Papillomaviruses are the causative agents of skin warts, laryngeal papillomas 
and cervical carcinoma, and occur in skin cancers and head and neck 
sarcomas (Hebner & Laimins, 2006) (Tab. 1).  Sexually transmitted human 
HPVs infect the genital tract, and are classified as „low risk‟ or „high risk‟ based 
on their capability to cause cervical carcinoma.  Among the high risk papilloma 
viruses, HPV16 is a major cause of cervical cancer (J. N. Roberts, et al., 2007) 
and infects basal keratinocytes of mucosal epithelia that undergo differentiation.  
 
Members of the polyomavirus family have tumorigenic potential which was 
initially shown for SV40 (Girardi, Sweet, Slotnick, & Hilleman, 1962) (Tab. 1).  
SV40 causes oncogenic transformation in nonpermissive rodent hosts, although 
not in its natural host, the rhesus macaque.  Other members of the 
polyomaviruses have been implicated in the etiology of rare neuronal tumors 
(White, et al., 2005).  Most recently, an aggressive human skin cancer, Merkel 
cells carcinoma has been linked to a previously unknown polyomavirus, the 
Merkel cell polyomavirus (MCPyV) (Feng, Shuda, Chang, & Moore, 2008).  In 
addition, hepadnaviruses that replicate through an RNA intermediate have been 
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associated with hepatocellular carcinoma (Pungpapong, Kim, & Poterucha, 
2007) (Tab. 1).   
 
Here we discuss the mechanims of nuclear transport and import of viral 
genomes during the early phases of DNA-tumor virus infections.  Nuclear import 
of viral structural proteins and transforming proteins has been extensively 
reviewed in the recent past (Alvisi, Rawlinson, Ghildyal, Ripalti, & Jans, 2008; 
Fontoura, Faria, & Nussenzveig, 2005; Greber & Fassati, 2003; Pouton, 
Wagstaff, Roth, Moseley, & Jans, 2007).  For nucleocytoplasmic transport of 
RNA from DNA-tumor viruses we refer to recent reviews on adenoviruses 
(Dobner & Kzhyshkowska, 2001; Fontoura, et al., 2005), herpesviruses 
(Mettenleiter, Klupp, & Granzow, 2006; Sandri-Goldin, 2001; Sommer & Heise, 
2008), papillomaviruses and polyomaviruses (Jiang, Abend, Johnson, & 
Imperiale, 2008) and hepadnaviruses (Lopez-Bueno, Villarreal, & Almendral, 
2006).  
 
 
2. DNA-tumor virus entry into cells 
 
Virus entry into cells is a stepwise process which has been studied in some 
detail in cultured cells (see e.g., Greber & Fassati, 2003; Marsh & Helenius, 
2006; Sieczkarski & Whittaker, 2005).  For a schematic view of a generic entry 
pathway, see Fig. 1.  In certain primary cells or explant cultures, they have been 
more difficult to study due to strong innate host anti-virus responses, and the 
limited availability and batch-to-batch variations of these cells.  Nonetheless, 
there are a number of entry steps that are universally required for infection of 
diverse cell types with human or prototypic DNA-tumor viruses, including virus 
attachment to a receptor at the cell surface (for recent reviews, see Dugan, 
Eash, & Atwood, 2006; Glebe & Urban, 2007; Greber & Gastaldelli, 2007; 
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Heldwein & Krummenacher, 2008; Pedersen & Hollsberg, 2006; Stanley, Pett, 
& Coleman, 2007; Young, Herbert, Barlow, Holers, & Hannan, 2008), and 
lateral movements of the virus-receptor complex to specialized sites on the 
plasma membrane (reviewed in Sattentau, 2008; Sherer & Mothes, 2008).  
These lateral movements can lead the virus particles, for example, to tight and 
adherens junctions, where additional receptors are localized, such as CAR for 
adenoviruses, or nectins for herpesviruses (Greber & Gastaldelli, 2007).   
 
The lateral junctions not only maintain cell adhesion but also regulate epithelial 
and endothelial cell proliferation.  This is reflected in the observation that 
deregulated cell adhesion is a hallmark of invasive tumors.  Recently it has 
been suggested that a ubiquitin ligase of KSHV targets vascular endothelial 
cadherin for ubiquitin-mediated degradation (Mansouri, Rose, Moses, & Fruh, 
2008).  Cadherin degradation leads to rearrangements of the actin cytoskeleton 
and disregulated transendothelial barriers, which could open the gate for 
additional viruses and increase tumorigenicity.  These features are reminescent 
of the HBV protein HBx which promotes hepatocellular carcinoma by enhancing 
the degradation of the extracellular matrix (Lara-Pezzi, et al., 2002) and 
downregulating cadherin (J. O. Lee, et al., 2005).   
 
The surface-bound DNA-tumor viruses are in many cases taken up by 
endocytic processes or direct penetration through the plasma membrane 
(Akula, et al., 2003; Amstutz, et al., 2008; Damm & Pelkmans, 2006; Dugan, et 
al., 2006; Funk, Mhamdi, Hohenberg, Will, & Sirma, 2006; Gastaldelli, et al., 
2008; Lin, et al., 1997; Meier & Greber, 2003; Querbes, O'Hara, Williams, & 
Atwood, 2006; Rappocciolo, et al., 2008; Spoden, et al., 2008), or they may 
fuse their envelope with the limiting endosomal membrane (Cooper, Paran, & 
Shaul, 2003; Heldwein & Krummenacher, 2008).  Endocytozed nonenveloped 
viruses can penetrate the limiting endosomal membrane (Greber, 2002; Greber, 
Singh, & Helenius, 1994; Sieczkarski & Whittaker, 2005), or a membrane of the 
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endoplasmic reticulum (Burckhardt & Greber, 2008; Schelhaas, et al., 2007).  
For example, papillomaviruses are taken up by endocytosis, and released from 
endosomes upon proteolytic cleavage of the minor capsid protein L2 by cellular 
furin proteases (Richards, Lowy, Schiller, & Day, 2006; Selinka, Giroglou, & 
Sapp, 2002).  L2 remains associated with the viral DNA and ends up in the 
nucleus near promyelocytic leukemia protein bodies (Day, Baker, Lowy, & 
Schiller, 2004).   
 
 
3. Bidirectional cytoplasmic transport of incoming virus 
particles provides a mechanism to reach the nucleus 
 
Cytoplasmic transport of DNA-tumor viruses or prototypic DNA-tumor viruses 
has been studied in some detail, most prominently with HSV1 (Mabit, et al., 
2002; Sodeik, Ebersold, & Helenius, 1997) and Ad2/5 (Kelkar, Pfister, Crystal, & 
Leopold, 2004; J. G. Smith, Cassany, Gerace, Ralston, & Nemerow, 2008; 
Suomalainen, Nakano, Boucke, Keller, & Greber, 2001; Suomalainen, et al., 
1999).  These viruses take advantage of the microtubule-based motor protein 
complex dynein/dynactin to the minus ends of microtubules near the nucleus 
(for reviews, see Greber & Way, 2006; Leopold & Pfister, 2006; Radtke, 
Dohner, & Sodeik, 2006).  EBV likely follows the same route on microtubules to 
the nucleus as HSV1 because its capsid protein BFRF3, a homologue of the 
HSV capsid protein UL35, associates with dynein light chains similar to HSV1 
(Douglas, et al., 2004).  Bidirectional transport towards and away from the 
nucleus allows fine-tuning and precise delivery of capsids to avoid unproductive 
situations, such as accumulations at the microtubule organzing centers (Greber 
& Way, 2006).  For DNA-tumor viruses it may ensure nuclear targeting in cells 
with divergent orientations of microtubules, such as polarized epithelial cells 
where microtubule minus ends are near the apical membrane, or basal cells 
where minus ends are near the nucleus.   
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3.1. Viral determination of the transport direction or no transport bias? 
There are several possibilities how viruses might achieve their delivery to the 
nuclear membrane.  One is that they themselves define a transport preference 
by exposing proteins on the capsid that preferentially associate with a plus end 
or a minus end directed microtubule motor (Greber, 2005).  For example, the 
gamma-herpesvirus murine herpesvirus 4 which lacks the ORF75c tegument 
protein failed to be transported to the nucleus of murine cells although it was 
delivered into the cytosol (Gaspar, Gill, Losing, May, & Stevenson, 2008).  
Incoming HSV1 capsids preferentially recruit the dynein/dynactin motor complex 
as opposed to a plus end-directed motor, whereas newly assembled capsids 
recruit a periphery directed motor (Luxton, et al., 2005; Nagel, et al., 2008).   
 
An important question is the nature of the viral binding partner for motor 
proteins. Limited proteolysis of incoming HSV capsid or tegument proteins is 
part of a stepwise uncoating programme to make virions competent for 
engagement with cytoplasmic motors, such as the minor capsid protein VP26 or 
the tegument protein UL36 (VP1/2) (Wolfstein, et al., 2006).  For incoming 
viruses, it was suggested that proteasomal degradation but not ubiquitin is 
required for HSV localization to the nucleus (Delboy, Roller, & Nicola, 2008).  
Alternatively, cytoplasmic processing of incoming capsids might make them 
competent for docking to the nuclear pore complex (NPC) as observed shortly 
after infection (Mabit, et al., 2002).  This suggests that nuclear accumulation 
occurs by retention, not requiring a transport bias.  In support of this, incoming 
Ad2/5 particles were found to be enriched at the nucleus in certain cell types 
without a detectable transport bias to the nucleus (Suomalainen, et al., 1999).   
 
3.2. Regulated transport 
Other aspects of cytoplasmic virus transport are subject to regulation by cell 
signalling.  It has been observed, for example, that signalling through protein 
kinase A and p38/MAPK enhanced the nuclear delivery of incoming Ad2/5 by 
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stimulating minus end–directed transport (Suomalainen, et al., 2001).  Likewise, 
the activation of Rac1 during Ad2/5 entry, which stabilizes peripheral 
microtubules (Gundersen, 2002) increased the loading of Ad2/5 to microtubules 
(Warren & Cassimeris, 2007).  This is consistent with the observation that 
microtubule stabilizing compounds at very low concentrations enhanced nuclear 
targeting of Ad2/5 (Giannakakou, et al., 2002), and incoming Ad2/5 stabilized 
microtubules (Warren, Rutkowski, & Cassimeris, 2006).   
 
Similar results have also been reported for KSHV, which activates Rho 
GTPases (Naranatt, Krishnan, Smith, & Chandran, 2005).  Activation of RhoA 
and Rac GTPase alters the dynamics by increasing the acetylation of 
microtubules thereby enhancing the dynein motor dependent transport of KSHV 
to the nucleus.  Interestingly, both Ad2/5 and KSHV use RGD peptides in one of 
their virion proteins to bind integrins for upstream signalling and endocytic 
uptake (Akula, Pramod, Wang, & Chandran, 2002; Meier & Greber, 2003; 
Stewart & Nemerow, 2007).  Integrin activation by the incoming viruses may 
lead to activation of Rho GTPases and PI3K activation (Raghu, et al., 2007), 
and local stabilization of microtubules, and thereby enhance the loading of 
viruses to the tracks.  It is possible that similar mechanisms are used by EBV, 
which encodes BFRF3, a homologue of the HSV UL35 (VP26) capsid protein 
which associates with dynein light chains (Douglas, et al., 2004).  The upstream 
signalling events for EBV are however not known, despite the notion that EBV 
enters B-cells through an endocytic pathway and fuses with the endosomal 
membrane at low pH (N. Miller & Hutt-Fletcher, 1992; Nemerow & Cooper, 
1984).  
 
Although the mechanisms of motor loading to the cytosolic virus particles are 
not known, components of the dynein motor in complex with the dynactin 
subunit have been observed on a number of cytoplasmic DNA-tumor viruses, 
including adenoviruses, herpesviruses, and papillomaviruses (Dohner, et al., 
 
36 
2002; Florin, et al., 2006; Leopold, et al., 2000; Schroer, 2004; J. G. Smith, et 
al., 2008; Suomalainen, et al., 1999).  Interestingly, interference with the 
dynein/dynactin motor not only reduced viral transport towards the nucleus, but 
also decreased the transport rate to the periphery in some instances.  This 
suggests that dynactin and components of the dynein motor complex enable 
high activities of both dynein and kinesin motors on DNA-tumor viruses.  This 
interpretation is supported by trafficking studies of cellular cargoes where 
dynactin interference inhibited bidirectional (Gross, Welte, Block, & Wieschaus, 
2002), and overexpression of p50/dynamitin reduced both dynein- and kinesin 
II-mediated transport of melanosomes in Xenopus laevis (Deacon, et al., 2003).  
Possibly, yet unknown proteins coordinate the activities of minus and plus end 
directed motors on the viral cargo, as suggested for lipid droplets in drosophila 
(Shubeita, et al., 2008), or bidirectional transport is simply a consequence of the 
properties of the motors, as suggested for the transport of peroxisomes (Ally, 
Larson, Barlan, Rice, & Gelfand, 2008).   
 
4. From microtubules to the nucleus 
 
Incoming DNA-tumor viruses can reach the nuclear envelope by several 
mechanisms.  One is that the viruses must pass through the microtubule-
organizing center (MTOC) (pathway A, Fig. 1), or that they detach from the 
microtubules proximal to the nucleus (pathway B, Fig. 1).  Detachment could, 
for example, occur by virus modification at the MTOC, or by an activity gradient 
of a nuclear factor leading to motor detachment from the tracks or the virus.  For 
Ad2/5 it has been shown that treating cells with inhibitors or siRNAs against the 
nuclear export factor CRM1 reduced the targeting of incoming Ad2/5 to the 
nucleus but did not affect viral transport on microtubules (Strunze, Trotman, 
Boucke, & Greber, 2005), and this requires the capsid protein hexon as 
suggested by antibody interference (J. G. Smith, et al., 2008).  CRM1 or a 
nuclear protein exported by CRM1 to the cytoplasm could hence provide a cue 
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for virus detachment from microtubules.  Alternatively, CRM1, which binds 
Nup214/CAN could be involved in maintaining a functional binding site for the 
virus on the NPC.   
 
A second possibility to localize viruses to the nucleus is by stochastic 
detachment from microtubule tracks and cytoplasmic diffusion of the free 
particles until a binding site at the nuclear envelope, for example the NPC is 
reached.  This mechanism would be expected to be less rapid and less efficient 
than regulated detachment.   
 
A third, intermediate strategy is to detach the incoming DNA-tumor viruses from 
microtubules directly at the NPC thereby bypassing a diffusion step through the 
cytoplasm.  This model is attractive because the most distal NPC protein 
RanBP2 (NUP358) has a binding site for microtubules (Joseph & Dasso, 2008), 
and could thereby connect cytoplasmic transport with nuclear import.  In this 
model viruses could either traffic all the way to the minus ends of microtubules 
near the centrosome, and revert transport direction towards the periphery to 
approach the nuclear envelope, or they could directly reach the nucleus by 
microtubules that lead from the periphery to the centrosome in close proximity 
to the nuclear envelope.   
 
A fourth possibility to access the nucleoplasm has been suggested for 
polyomaviruses.  These viruses are targeted to the endoplasmic reticulum and 
nuclear envelope lumen, from where they could penetrate the inner nuclear 
membrane (Magnuson, et al., 2005; Schelhaas, et al., 2007).  To what extent 
this unconventional pathway into the nucleus is used is, however, unknown.  
Infectious incoming SV40 particles have been found in the cytosol on the other 
hand (reviewed in Greber & Kasamatsu, 1996; Whittaker, Kann, & Helenius, 
2000) which implies that these viruses can use a pathway from the cytosol to 
the NPC into the nucleus for infection.   
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5. The nuclear pore complex - gate keeper of 
nucleocytoplasmic exchange 
 
DNA-tumor viruses infect nondividing cells and effectively utilize and manipulate 
the NPC.  NPCs are large macromolecular complexes, which control all known 
nucleocytoplasmic exchange of nondividing cells (reviewed in D'Angelo & 
Hetzer, 2008; Terry, Shows, & Wente, 2007).  There are multiple pathways for a 
large variety of cargoes through the NPC.  The general transport mechanism 
involves affinity gating on natively unfolded phenylalanine-glycine (FxFG and 
GLFG) rich nucleoporins (NUPs, Frey & Gorlich, 2007; Lim, et al., 2007; Patel, 
Belmont, Sante, & Rexach, 2007).  The affinity of transport receptors to the 
natively unfolded proteins provides selectivity for passage of the receptor-cargo 
complex through the NPC.  Stability and hence directionality of the receptor-
cargo complex is controlled by the small GTP binding protein Ran (Gorlich & 
Kutay, 1999).   
 
Within the NPC, the cytoplasmic filament protein Nup214/CAN and its 
associated protein Nup88 are involved in nuclear export of preribosomal 
complexes (Bernad, Engelsma, Sanderson, Pickersgill, & Fornerod, 2006), and 
NES bearing proteins (Hutten & Kehlenbach, 2006).  The cytoplasmic filament 
protein RanBP2/Nup358 provides a docking platform for export complexes that 
are being disassembled, and for binding of cargo-free export receptors before 
they return to the nucleus (Engelsma, Bernad, Calafat, & Fornerod, 2004).  It is 
also involved in import of NLS containing proteins, and its absence can be 
compensated by overexpression of import receptors (Hutten, Flotho, Melchior, 
& Kehlenbach, 2008).  In single round import reactions, neither RanBP2 nor 
Nup214/CAN are required for import of model proteins (Walther, et al., 2002).  
This supports the notion that NPC proteins, and in particular the FG-repeat 
proteins have a high degree of redundancy (Strawn, Shen, Shulga, Goldfarb, & 
Wente, 2004).   
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Finally, an important aspect of NPC function for DNA-tumor virus infections is 
that the pore diameter can be gated.  Kinetic studies have shown that within 
time frames typical for the entry phase of most viruses, the permeability 
diameter of the pore is in the range of 40 nm (Pante & Kann, 2002).  Although 
this is still too small for the passage of adenovirus, herpesvirus, or papovavirus 
(polyoma and papilloma) capsids, it is large enough for the passage of 
hepadnaviruses and also parvoviruses.   
 
 
6. Adenovirus docks and disassembles at the NPC, and 
releases the viral chromatin into the nucleus 
 
6.1. Adenovirus disruption 
In vitro and in vivo studies have shown that Ad2/5 bind to NPCs independently 
of cytosolic factors including NLS-containing proteins or nuclear import or export 
receptors (Trotman, Mosberger, Fornerod, Stidwill, & Greber, 2001; Wisnivesky, 
Leopold, & Crystal, 1999).  The major viral capsid protein hexon binds to the 
NPC protein Nup214/CAN located at the base of the cytoplasmic filaments.  
This is reminescent of the Stat1 transcription factor binding to FG-nucleoporins 
Nup153 and Nup214 (Marg, et al., 2004).  Unlike Stat1, only 5% of the incoming 
hexon is found to be imported into the nucleus (Greber, Willetts, Webster, & 
Helenius, 1993).  This is equivalent to the amount of one facette of the 
icosahedral capsid, and indicates that hexon itself does not have a functional 
NLS.  Accordingly, newly synthesized hexon protein enters the nucleus for viral 
capsid assembly only by chaperone-mediated folding (Hong, et al., 2005) and 
binding to the nucleophilic protein VI (D.A. Matthews & Russell, 1994; Wodrich, 
et al., 2003).  Noteably, the large majority of incoming protein VI remains within 
endosomes (Greber, Webster, Weber, & Helenius, 1996) where it supports 
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virus escape to the cytosol (Gastaldelli, et al., 2008; Wiethoff, Wodrich, Gerace, 
& Nemerow, 2005).  The NPC-docked virions bind the highly mobile nuclear 
histone H1 (Misteli, Gunjan, Hock, Bustin, & Brown, 2000), either via the acidic 
clusters of hexon facing towards the outside of the virion (Rux & Burnett, 2000), 
or the viral DNA (Fig. 2).  This together with the H1-import factors importin 
(karyopherin) β and importin 7, and additional factors contributes to capsid 
disruption and uncoating of the DNA-nucleoprotein complex for import (Saphire, 
Guan, Schirmer, Nemerow, & Gerace, 2000; Trotman, et al., 2001).   
 
6.2. Nuclear import of adenovirus DNA associated proteins 
The viral chromatin enters the nucleus, yet the composition of the core, which is 
translocated through the NPC is not well defined.  The covalent interaction of 
the preterminal protein (pTP) with the 5‟ ends of the viral genome predicts that 
the pTP is imported together with the DNA (Zhao & Padmanabhan, 1988) (Fig. 
2).  It is also likely that pVII and possibly histone H1 accompany the DNA 
through the NPC (Trotman, et al., 2001; Xue, Johnson, Ornelles, Lieberman, & 
Engel, 2005).  In contrast, the composition of the core in the virus is well known.  
It is made up of four viral proteins, protein V (pV, 368 amino acids, 157 copies 
per genome (van Oostrum & Burnett, 1985)), pVII (174 amino acids, about 800 
copies per genome, (Sung, Lischwe, Richards, & Hosokawa, 1977)), mu (19 
amino acids, Hosokawa & Sung, 1976)) and two copies of the terminal protein 
(671 amino acids) covalently attached to the 5' ends of the linear viral DNA 
(Berk, 2007).   
 
pV, pVII and mu are positively charged and condense the viral DNA.  The most 
abundant core protein pVII is tightly bound to the DNA in a manner similar to the 
core histones of eucaryotic chromatin (Johnson, et al., 2004), and remains 
associated with the viral DNA throughout the early phase of the viral life cycle 
(Chatterjee, Vayda, & Flint, 1986; Xue, et al., 2005).  It is thought to attenuate 
viral gene expression, and is associated with the chromatin-modifying 
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complexes SET and INHAT.  The precursor of pVII has basic NLS sequences 
that target the protein to the nucleus by interacting with importin alpha/beta 
(Hindley, Lawrence, & Matthews, 2007; T. W. Lee, Blair, & Matthews, 2003).  It 
has also been shown that pVII isolated from recombinant E. coli is imported into 
the nucleus of digitonin permeabilized cells by binding to the import factor 
transportin which recognizes M9-type sequences (Hindley, et al., 2007).  
Whether pVII contains an M9-like sequence is unknown.  In vitro assays further 
suggested that nuclear import of the viral DNA required transportin, as it could 
be competed for by excess of soluble M9-GST fusion proteins (Hindley, et al., 
2007).  Surprisingly, an excess of pVII was not able to compete for DNA-import 
which suggests that pVII is not sufficient.  If transportin is involved in nuclear 
import of the incoming viral DNA and infection remains unknown.  It is also 
unknown if and how the terminal protein is involved in import of the viral DNA 
(Zhao & Padmanabhan, 1988).   
 
Regardless, the incoming viral DNA-protein complex is remodeled in the 
nucleus, which involves several host factors of the chromatin remodeling 
complex, template-activating factor-I (TAF-I), TAF-II, TAF-III and the acidic 
protein pp32 (Haruki, Okuwaki, Miyagishi, Taira, & Nagata, 2006; Spector, 
2007).  TAF-I forms a ternary complex with pVII (Haruki, Gyurcsik, Okuwaki, & 
Nagata, 2003; Xue, et al., 2005), and this is required for rapid onset of early 
viral gene transcription as suggested by siRNA knock-down experiments 
(Haruki, et al., 2006).  Later in the infection cycle, nucleophosmin/B23 interacts 
with newly synthesized precursor of pVII and suppresses aggregation of viral 
DNA with core proteins in the nucleus, and thereby supports viral assembly 
(Samad, Okuwaki, Haruki, & Nagata, 2007).   
 
Unlike pVII and terminal protein, the other core protein pV is less tightly bound 
to the DNA, and may be released before or during DNA import into the nucleus, 
as suggested by chromatin immunoprecipitations (Spector, Johnson, Baird, & 
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Engel, 2003).  It is not known if pV enters the nucleus on its own or in complex 
with other factors (D. A. Matthews & Russell, 1998b), or if it stays in the 
cytoplasm in association with the mitochondrial protein p32 implicated in ARF-
mediated apoptosis (Itahana & Zhang, 2008; D. A. Matthews & Russell, 1998a).  
Remarkably, a pV knock-out virus is viable in the presence of compensatory 
mutations in the mu protein (Ugai, Borovjagin, Le, Wang, & Curiel, 2007).  This 
suggests that pV has no unique functions in the replication cycle of 
mastadenoviruses, at least in cultured cells, which is further supported by the 
observation that pV does not occur in atadenoviruses, aviadenoviruses and 
siadenoviruses.   
 
 
7. Herpesviruses dock to the NPC and release their 
DNA into the nucleus 
 
7.1. Herpes simplex virus type 1 docking to the NPC 
Similar to adenoviruses, herpesviruses uncoat their DNA at the NPC (see Fig. 
2).  This strategy precludes that the naked viral chromatin travels through the 
cytoplasm, which could trigger DNA-sensing innate immune responses 
including the TBK-IRF pathway or inflammasome (Barchet, Wimmenauer, 
Schlee, & Hartmann, 2008; Muruve, et al., 2008).  In vitro experiments showed 
that HSV-1 capsids purified from extracellular virions by detergent and high salt 
treatments bound to NPCs of rat liver nuclear envelopes depending on soluble 
importin β, Ran-GTP and other factors (Ojala, Sodeik, Ebersold, Kutay, & 
Helenius, 2000).  Experiments with the hamster mutant cell line tsBN2 
(Dickmanns, et al., 1996) at the restrictive temperature confirmed that the Ran 
guanine nucleotide exchange factor RCC1 (regulator of chromosome 
condensation 1) was required for genome delivery to the nucleus or gene 
expression (Strang & Stow, 2007).   
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Although the components of the viral capsid recognized by importin beta are not 
known, it has been shown trypsin-treated capsids, which lost the inner tegument 
proteins including UL47 (VP13/14), UL48 (VP16) and UL49 (VP22) poorly 
bound to the isolated nuclei.  While the UL48 (VP16) transcription factor 
associated with UL49 (VP22) and supported virus assembly (Hafezi, Bernard, 
Cook, & Elliott, 2005), the knock out of UL49 (VP22) had no effects on the 
expression levels of the immediate early viral protein ICP0 (Elliott, Hafezi, 
Whiteley, & Bernard, 2005), indicating that UL49 (VP22) has no important role 
for nuclear import of HSV1 DNA.  Interestingly, the 32 kDa tegument protein 
UL14 has been implicated in enhancing nuclear import of UL48 (VP16), and it 
enhanced nuclear targeting of incoming HSV1 (Yamauchi, et al., 2008).  In the 
nucleus, it forms a regulatory complex with HCF1 and the POU-domain 
transcription factor Oct1, and thereby activates transcription of immediate early 
viral genes (Wysocka & Herr, 2003).  It is possible that UL14 is involved in 
cytoplasmic transport or docking of incoming virions to the NPC, and thereby 
facilitates the uncoating of the viral DNA for nuclear import.   
 
7.2. Herpes simplex type 1 mutants dissect uncoating and nuclear import 
The recent developments of viral mutants have allowed progress in 
understanding viral mechanisms of capsid disassembly.  Experiments with the 
classical HSV1 temperature sensitive mutant tsB7 and a similar pseudorabies 
virus mutant indicated that viral DNA is released at the NPC (Batterson, 
Furlong, & Roizman, 1983; Feldman, Blankenship, & Ben-Porat, 1981).  At the 
non-permissive temperature tsB7 capsids containing DNA accumulated at the 
NPC, whereas upon temperature shift, DNA was released.  This was consistant 
with early electron microscopy studies showing that empty capsids of incoming 
viruses accumulated at the nuclear membrane and persisted for several hours 
(Miyamoto & Morgan, 1971; Morgan, Rose, & Mednis, 1968).  Mutational 
mapping of tsB7 showed that the UL36 gene encoding the VP1/2 tegument 
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protein was involved in releasing the DNA from the capsid (Zhou, Chen, 
Jakana, Rixon, & Chiu, 1999).  UL36 (VP1/2) is conserved in beta- and gamma- 
herpesviruses (reviewed in Mettenleiter, 2004).  UL36 (VP1/2) together with 
UL37 and UL25 is one of the innermost capsid associated tegument proteins 
that remain associated with the incoming capsids until docking at the NPC.  
UL36 deletion mutants failed to spread the infection to uninfected nuclei in 
experimentally induced syncitia indicating that UL36 was required for capsid 
transport to, or DNA import into the nucleus (A. P. Roberts, et al., 2009).  
Interestingly, proteolytic cleavage of VP1/2 was required for DNA import into the 
nucleus but not for capsid docking to the NPC (Jovasevic, Liang, & Roizman, 
2008).   
 
While UL37 was not required for delivery of HSV1 DNA into the nucleus (A. P. 
Roberts, et al., 2009) – although it was involved in pseudorabiesvirus transport 
to the nucleus (Krautwald, Fuchs, Klupp, & Mettenleiter, 2009), another inner 
tegument protein UL25 was specifically implicated in DNA uncoating, as 
indicated by the temperature sensitive HSV1 ts1249 mutant which had an 
uncoating defect at the restrictive temperature but was transported to the 
nucleus (Preston, Murray, Preston, McDougall, & Stow, 2008).  Interestingly, 
the EBV may use similar mechanisms since its protein BVRF1 is a homologue 
of UL25 (Johannsen, et al., 2004) which remains capsid associated and 
localizes to microtubules as well as to nuclear membrane with incoming capsids 
(Kaelin, Dezelee, Masse, Bras, & Flamand, 2000).  Since UL25 is also required 
for DNA packaging and associates with the portal complex at a single capsid 
vertex (Cockrell, Sanchez, Erazo, & Homa, 2009), it is possible that the DNA is 
extruded through the portal structure of the capsid (Cardone, et al., 2007; 
Chang, Schmid, Rixon, & Chiu, 2007; Newcomb, Booy, & Brown, 2007; 
Newcomb, et al., 2001).  The portal is part of a ring structure made up by the 
UL6 protein, and has a 5 nm pore through which the viral DNA is packaged into 
the procapsid during replication of both herpesviruses and double-stranded 
DNA bacteriophages (Lander, et al., 2006).  UL6 is conserved among other 
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alpha- herpesviruses, such as varizella zoster virus (VZV), which causes 
varicella (chickenpox, primary infection) and zoster (shingles, a secondary 
infection upon reactivation of VZV from latency).  Future measurements of 
herpesvirus DNA uncoating on isolated nuclear envelopes in combination with 
specific orientations of single virus particles may unveil if the portal needs to be 
oriented towards the NPC for DNA release into the nucleus or if the orientation 
of the particles can be random.  All this provides strong evidence that the inner 
tegument proteins UL25 and UL36 (VP1/2) and the portal are parts of capsid-
associated complexes that interact with the NPC, and trigger the release of viral 
DNA from the capsid.   
 
In the herpesvirus capsid, the DNA is tightly packed in a paracristalline array 
and thought to be protein-free, similar to bacteriophage DNA (Oh & Fraser, 
2008).  Studies of DNA ejection from bacteriophages had argued that DNA 
release can be attenuated by surrounding osmotic pressure implying that the 
process is independent of ATP consuming enzymes, such as motor proteins 
(Evilevitch, Lavelle, Knobler, Raspaud, & Gelbart, 2003).  Recent studies have 
extended this concept showing that DNA condensation by osmotic stress and 
DNA binding proteins enhances the ejection process from the phages 
(Jeembaeva, Castelnovo, Larsson, & Evilevitch, 2008).  For HSV1, atomic force 
microscopy experimentation suggested that the incoming genome is 
translocated through the NPC as a condensed rod-like structure with a diameter 
of 35-40 nm and a length of 130-160 nm (Shahin, et al., 2006).  It is thus 
possible that the herpesvirus DNA picks up DNA condensing proteins, such as 
cellular histones after its release from the capsids.  Histones would not only 
condense and neutralize negative charges on the DNA backbone, they would 
also be a template for import factors, such as importin beta- and importin 7 
(Jakel, et al., 1999), and thereby increase the probability for DNA passage 
through the NPC, as suggested for adenovirus DNA (Trotman, et al., 2001).  
That histones could be involved in herpesvirus infection is also supported by the 
finding that incoming viral DNA was complexed with histones as early as 1 h 
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post infection, although it is not known how and where histones associate with 
the incoming DNA (Kent, et al., 2004).  Whether tegument proteins with 
functional NLSs, such as UL36 (VP1/2) (Abaitua & O'Hare, 2008) mediate 
nuclear import of the DNA is not known.   
 
 
8. Nuclear import of papillomaviruses and 
polyomaviruses 
 
Human papillomaviruses (HPV) uptake is a slow process and not well defined, 
although it seems to be acid dependent (Day, Lowy, & Schiller, 2003; Selinka, 
et al., 2002; J. L. Smith, Campos, & Ozbun, 2007; Spoden, et al., 2008).  Some 
HPVs bind to heparansulfate-proteoglycans (Giroglou, Florin, Schafer, Streeck, 
& Sapp, 2001) and possibly secondary receptor(s), such as alpha-6 integrin, 
laminin or tetraspanin proteins (Culp, Budgeon, Marinkovich, Meneguzzi, & 
Christensen, 2006; Evander, et al., 1997).  Factors and signals that lead to 
nuclear import of nonstructural and structural HPV proteins are listed in Tab. 2.  
It is unknown, however, how the viruses reach the cytosol, and the genomes 
imported into the nucleus.  
 
Similar to papillomaviruses, the polyomaviruses SV40, JC virus and BK virus 
access the nucleus after endocytic uptake (see Fig. 2) (Eash, Querbes, & 
Atwood, 2004; Pelkmans, Kartenbeck, & Helenius, 2001; Pho, Ashok, & 
Atwood, 2000).  SV40 has a double-stranded closed circular DNA of 5000 base 
pairs, three structural proteins VP1, VP2, and VP3, and four core histones, 
H2A, H2B, H3 and H4 (Imperiale & Major, 2007).  VP1 forms 72 pentameric 
capsomers (Yan, Stehle, Liddington, Zhao, & Harrison, 1996), incorporating the 
minor proteins, VP2 and VP3 that are thought to contact the minichromosome 
and the VP1 pentamer (Clever, Dean, & Kasamatsu, 1993).  It is thought that 
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polyomaviruses undergo limited conformational changes at the plasma 
membrane, in endosomes or the endoplasmic reticulum (ER).  In the case of 
SV40, the reducing environment and the protein folding machinery of the ER 
may lead to the release of DNA-containing subviral particles into the cytosol 
(Schelhaas, et al., 2007).  This may also lead to the exposure of the NLS in the 
amino-terminus of the capsid protein VP1 (reviewed in Greber & Kasamatsu, 
1996; Kasamatsu & Nakanishi, 1998).   
 
Experiments with microinjected SV40 favor the notion that infectious viral DNA 
passes through the cytosol (Clever, Yamada, & Kasamatsu, 1991).  SV40 
subviral particles were found to be imported into the nucleus, as concluded from 
the observation that the injection of neutralizing antibodies against the VP1 
amino-terminus or against VP3 into infected cells blocked infection (Nakanishi, 
Clever, Yamada, Li, & Kasamatsu, 1996) (Fig. 2).  These subviral particles are 
thought to contain the core histones, yet the histone-complexed 
minichromosomes were poorly targeted to the nucleus (Nakanishi, et al., 1996).  
This indicates a role for the VP1,2,3 proteins in cytoplasmic transport or NPC 
binding.   
 
Interestingly, VP1,2,3 can each be independently imported into the nucleus 
(Ishii, et al., 1996).  VP1 has a bipartite amino-terminal NLS whereas VP2 and 
VP3 have a classical SV40 T-antigen-like signal in the carboxy-terminus (Ishii, 
Nakanishi, Yamada, Macalalad, & Kasamatsu, 1994).  Recently, cytosolic virus 
was found to bind importin α and β (Nakanishi, Li, Qu, Jafri, & Kasamatsu, 
2007).  Only a small fraction of the incoming DNA was, however, recovered in 
immune complexes with VP1 and the minor capsid protein VP3.  The DNA was 
sensitive to DNase, unlike the DNA of intact purified SV40 particles.  This 
suggests that SV40 entry into the cytosol is slow, rather inefficient, and coupled 
to partial DNA uncoating.   
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A similar process of NLS exposure and importin binding may operate for JC 
virus entry, which may reflect a similar use of NLS sequences for nuclear import 
of newly synthesized proteins (Shishido-Hara, Ichinose, Higuchi, Hara, & Yasui, 
2004).  Unlike SV40, JC virions were apparently imported into the nucleus in a 
more intact form than the SV40 subviral particles, as suggested by analyses of 
particles loaded with free fluorescent dye molecules (Qu, et al., 2004).  
 
 
9. Nuclear import of hepadnaviruses 
 
HBV is an enveloped DNA-virus with an icosahedral capsid of 180 or 240 core 
proteins (Crowther, et al., 1994).  HBV infects primary human hepatocytes and 
a few cell lines at low efficiency, which makes it difficult to study the infectious 
entry of this virus.  Lipofection has been used to deliver HBV capsids into the 
cytoplasm (Rabe, Glebe, & Kann, 2006).  In these experiments capsids were 
transported by microtubule dependent motors to the nuclear membrane where 
they bound to NPCs, and they released their genome into the nucleus.  These 
results were similar to studies with duck hepatitis virus (dHBV) (Funk, et al., 
2006; Funk, Mhamdi, Lin, Will, & Sirma, 2004; Stoeckl, et al., 2006).  dHBV core 
proteins have an internal NLS as the carboxy-terminus of the HBV core (Mabit, 
Breiner, Knaust, Zachmann-Brand, & Schaller, 2001).  A dHBV knock-out 
mutant lacking the core NLS was not found at the NPC suggesting that this NLS 
was directly or indirectly required for capsid localization to the NPC.  
Biochemical studies suggested that attachment of HBV capsids to the NPC and 
transport through the NPC involved importins and the NLS in the carboxy-
terminus of the HBV core protein (Kann, Sodeik, Vlachou, Gerlich, & Helenius, 
1999; Steven, et al., 2005) (Fig. 2).  In native capsids, this NLS is not exposed 
at the surface, which implies that conformational changes of the capsid during 
entry are required for importin binding, capsid uncoating and DNA import into 
the nucleus (Kann, Schmitz, & Rabe, 2007).  An alternative nuclear import 
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model for HBV suggested that the capsids could very transiently interact with 
the NPC in an importin-independent manner (Lill, et al., 2006).  These results 
suggested that binding of HBV initially occurs on one of the cytoplasmic 
filaments, off-centered from the central axis of the NPC towards the edges by 
about 45 nm.  How uncoating of the viral DNA occurs is unknown. 
 
 
10. Conclusions and outlook 
 
Nuclear import of DNA-tumor virus genomes depends on cell type and virus 
specific steps, such as binding to receptors, uptake and signaling into cells.  
Subsequent events, including rupture of endomembranes, cytoplasmic 
transport, uncoating and nuclear import of the genome involve virus family-
specific mechanisms, and can be studied with prototypic DNA-tumor viruses 
and the tumor viruses.  In the past years, signals and host factors for nuclear 
import have been identified for a considerable number of DNA-tumor virus 
capsid proteins.  These studies have so far not resulted in novel anti-viral 
treatments, possibly due to a strong similarity of viral protein import with host 
protein import into the nucleus.  Ongoing analyses of viral genome uncoating 
and nuclear import may, in contrast, identify exquisite host factors for viral DNA 
import.  If such factors are dispensible for normal cell functions in cells that are 
infected by DNA-tumor viruses, they constitute a new class of targets for anti-
viral compounds.  Mechanistic cell biological analyses combined with 
interference experiments in cells and animal models will be necessary to 
elucidate the complex interplay between the tumor viruses and the host. 
 
 
 
50 
Acknowledgements 
 
Work in the Greber laboratory was supported by the Swiss National Science 
Foundation, the Cancer League of the Canton of Zurich and Oncoswiss.  
 
 
 
 
51 
Figures and Tables 
 
Fig. 1: Prototypic entry pathway of a DNA-tumor virus 
An intact virus particle (red) attaches to a primary and secondary receptor(s), 
which can elicit signalling into the cell.  Viral transport on the cell surface is 
followed by confinement and endocytosis (or direct penetration of the plasma 
membrane in some cases), which coincides with initiation of a stepwise viral 
uncoating programme (or membrane fusion).  Virus is taken into primary 
vesicles and transported to intracellular compartments where penetration to the 
cytosol occurs.  Bidirectional microtubule-dependent transport moves viruses to 
the microtubule-organizing center (MTOC) (A), or along the nuclear envelope 
(B), from where viruses reach the nuclear pore complex (NPC) by unknown 
mechanisms.  They bind to the NPC, uncoat their DNA and release it into the 
nucleus.  
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Fig. 2: Disassembly and nuclear import strategies of DNA-tumor viruses 
Adenoviruses, herpesviruses, polyomaviruses and hepadnaviruses import cores 
with linear or circular genomic DNA and viral proteins into the nucleus of post-
mitotic cells.  A) Schematic representation of four prototypic nuclear import 
mechanisms for viral cores containing genome and viral proteins.  Adenoviruses 
employ a capsid disruption strategy at the nuclear pore complex to release the 
core from the capsid.  Herpesviruses use a capsid unplugging mechanism, and 
polyomaviruses and hepadnaviruses a mechanism which delivers capsids or 
subcapsid particles into the nucleus.  The table of panel B) lists the NLS-
containing viral core proteins and the host factors (importins) recognizing these 
NLSs.  
 
 
 
53 
Table 1 
 
 
 
 
 
 
 
 
 
 
 
 
54 
Table 2 
 
 
 
 
 
55 
References 
 
 
Abaitua, F., & O'Hare, P. (2008). Identification of a highly conserved, functional nuclear localization signal within the N-
terminal region of herpes simplex virus type 1 VP1-2 tegument protein. J Virol, 82(11), 5234-5244. 
Akula, S. M., Naranatt, P. P., Walia, N. S., Wang, F. Z., Fegley, B., & Chandran, B. (2003). Kaposi's sarcoma-
associated herpesvirus (human herpesvirus 8) infection of human fibroblast cells occurs through endocytosis. 
J Virol, 77(14), 7978-7990. 
Akula, S. M., Pramod, N. P., Wang, F. Z., & Chandran, B. (2002). Integrin alpha3beta1 (CD 49c/29) is a cellular receptor 
for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells. Cell, 108(3), 407-419. 
Ally, S., Larson, A. G., Barlan, K., Rice, S., & Gelfand, V. (2008). Mechanical Cross-Talk between Kinesin-1 and 
Cytoplasmic Dynein In Vivo. Mol Cell Biol, 19 (suppl), abstract no 1547. 
Alvisi, G., Rawlinson, S. M., Ghildyal, R., Ripalti, A., & Jans, D. A. (2008). Regulated nucleocytoplasmic trafficking of 
viral gene products: a therapeutic target? Biochim Biophys Acta, 1784(1), 213-227. 
Amstutz, B., Gastaldelli, M., Kälin, S., Imelli, N., Boucke, K., Wandeler, E., et al. (2008). Subversion of CtBP1 controlled 
macropinocytosis by human Adenovirus serotype 3. EMBO J., 27(7), 956-966. 
Barchet, W., Wimmenauer, V., Schlee, M., & Hartmann, G. (2008). Accessing the therapeutic potential of 
immunostimulatory nucleic acids. Curr Opin Immunol, 20(4), 389-395. 
Batterson, W., Furlong, D., & Roizman, B. (1983). Molecular genetics of Herpes simplex virus.  VIII.  Further 
characterization of a temperature-sensitive mutant defective in release of viral DNA and in other stages of the 
viral reproductive cycle. J. Virol., 45, 397-407. 
Berk, A. J. (2007). Adenoviridae: the viruses and their replication. In D. M. Knipe & P. M. Howley (Eds.), Fields Virology 
(5 ed., Vol. 2, pp. 2355-2436). Philadelphia, PA, USA: Lippincott Williams & Wilkins. 
Bernad, R., Engelsma, D., Sanderson, H., Pickersgill, H., & Fornerod, M. (2006). Nup214-Nup88 nucleoporin 
subcomplex is required for CRM1-mediated 60 S preribosomal nuclear export. J Biol Chem, 281(28), 19378-
19386. 
Burckhardt, C. J., & Greber, U. F. (2008). Redox rescues virus from ER trap. Nat Cell Biol, 10(1), 9-11. 
Carbone, M., & Barbanti-Brodano, M. G. (2006). Viral carcinogenesis. In A. E. C. e. al. (Ed.), Oncology, an evidence-
based approach (pp. 214-232). New York: Springer. 
Cardone, G., Winkler, D. C., Trus, B. L., Cheng, N., Heuser, J. E., Newcomb, W. W., et al. (2007). Visualization of the 
herpes simplex virus portal in situ by cryo-electron tomography. Virology, 361(2), 426-434. 
Cesarman, E., & Mesri, E. A. (2007). Kaposi sarcoma-associated herpesvirus and other viruses in human 
lymphomagenesis. Curr Top Microbiol Immunol, 312, 263-287. 
Chang, J. T., Schmid, M. F., Rixon, F. J., & Chiu, W. (2007). Electron cryotomography reveals the portal in the 
herpesvirus capsid. J Virol, 81(4), 2065-2068. 
Chatterjee, P. K., Vayda, M. E., & Flint, S. J. (1986). Adenoviral protein VII packages intracellular viral DNA throughout 
the early phase of infection. Embo Journal, 5(7), 1633-1644. 
Clever, J., Dean, D. A., & Kasamatsu, H. (1993). Identification of a DNA binding domain in simian virus 40 capsid 
proteins Vp2 and Vp3. J. Biol. Chem., 268(28), 20877-20883. 
Clever, J., Yamada, M., & Kasamatsu, H. (1991). Import of simian virus 40 virions through nuclear pore complexes. 
Proc. Natl. Acad. Sci. U.S.A., 88(16), 7333-7337. 
Cockrell, S. K., Sanchez, M. E., Erazo, A., & Homa, F. L. (2009). Role of the UL25 protein in herpes simplex virus DNA 
encapsidation. J Virol, 83(1), 47-57. 
Cooper, A., Paran, N., & Shaul, Y. (2003). The earliest steps in hepatitis B virus infection. Biochim Biophys Acta, 
1614(1), 89-96. 
Crowther, R. A., Kiselev, N. A., Bottcher, B., Berriman, J. A., Borisova, G. P., Ose, V., et al. (1994). Three-dimensional 
structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell, 77(6), 943-950. 
Culp, T. D., Budgeon, L. R., Marinkovich, M. P., Meneguzzi, G., & Christensen, N. D. (2006). Keratinocyte-secreted 
laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring 
them to adjacent cells. J Virol, 80(18), 8940-8950. 
D'Angelo, M. A., & Hetzer, M. W. (2008). Structure, dynamics and function of nuclear pore complexes. Trends Cell Biol, 
18(10), 456-466. 
Damm, E. M., & Pelkmans, L. (2006). Systems biology of virus entry in mammalian cells. Cell Microbiol, 8(8), 1219-
1227. 
Day, P. M., Baker, C. C., Lowy, D. R., & Schiller, J. T. (2004). Establishment of papillomavirus infection is enhanced by 
promyelocytic leukemia protein (PML) expression. Proc Natl Acad Sci U S A, 101(39), 14252-14257. 
Day, P. M., Lowy, D. R., & Schiller, J. T. (2003). Papillomaviruses infect cells via a clathrin-dependent pathway. 
Virology, 307(1), 1-11. 
Deacon, S. W., Serpinskaya, A. S., Vaughan, P. S., Lopez Fanarraga, M., Vernos, I., Vaughan, K. T., et al. (2003). 
Dynactin is required for bidirectional organelle transport. J Cell Biol, 160(3), 297-301. 
Delboy, M. G., Roller, D. G., & Nicola, A. V. (2008). Cellular proteasome activity facilitates herpes simplex virus entry at 
a postpenetration step. J Virol, 82(7), 3381-3390. 
Dickmanns, A., Bischoff, F. R., Marshallsay, C., Luhrmann, R., Ponstingl, H., & Fanning, E. (1996). The thermolability of 
nuclear protein import in tsBN2 cells is suppressed by microinjected Ran-GTP or Ran-GDP, but not by 
RanQ69L or RanT24N. J Cell Sci, 109 ( Pt 6), 1449-1457. 
Dobner, T., & Kzhyshkowska, J. (2001). Nuclear export of adenovirus RNA. Curr Top Microbiol Immunol, 259, 25-54. 
Dohner, K., Wolfstein, A., Prank, U., Echeverri, C., Dujardin, D., Vallee, R., et al. (2002). Function of dynein and 
dynactin in herpes simplex virus capsid transport. Molecular Biology of the Cell, 13(8), 2795-2809. 
Dörfler, W. (1968). The fate of the DNA of adenovirus type 12 in baby hamster kidney cells. 60, 636-643. 
Douglas, M. W., Diefenbach, R. J., Homa, F. L., Miranda-Saksena, M., Rixon, F. J., Vittone, V., et al. (2004). Herpes 
simplex virus type 1 capsid protein VP26 interacts with dynein light chains RP3 and Tctex1 and plays a role in 
retrograde cellular transport. J Biol Chem, 279(27), 28522-28530. 
Dugan, A. S., Eash, S., & Atwood, W. J. (2006). Update on BK virus entry and intracellular trafficking. Transpl Infect Dis, 
8(2), 62-67. 
 
56 
Eash, S., Querbes, W., & Atwood, W. J. (2004). Infection of vero cells by BK virus is dependent on caveolae. J Virol, 
78(21), 11583-11590. 
Elliott, G., Hafezi, W., Whiteley, A., & Bernard, E. (2005). Deletion of the herpes simplex virus VP22-encoding gene 
(UL49) alters the expression, localization, and virion incorporation of ICP0. J Virol, 79(15), 9735-9745. 
Engelsma, D., Bernad, R., Calafat, J., & Fornerod, M. (2004). Supraphysiological nuclear export signals bind CRM1 
independently of RanGTP and arrest at Nup358. Embo J, 23(18), 3643-3652. 
Epstein, M. A., Henle, G., Achong, B. G., & Barr, Y. M. (1965). Morphological and Biological Studies on a Virus in 
Cultured Lymphoblasts from Burkitt's Lymphoma. J Exp Med, 121, 761-770. 
Evander, M., Frazer, I. H., Payne, E., Qi, Y. M., Hengst, K., & McMillan, N. A. (1997). Identification of the alpha6 integrin 
as a candidate receptor for papillomaviruses. J Virol, 71(3), 2449-2456. 
Evilevitch, A., Lavelle, L., Knobler, C. M., Raspaud, E., & Gelbart, W. M. (2003). Osmotic pressure inhibition of DNA 
ejection from phage. Proc Natl Acad Sci U S A, 100(16), 9292-9295. 
Feldman, L., Blankenship, M. L., & Ben-Porat, T. (1981). Isolation and characterization of a temperature-sensitive 
uncoating mutant of pseudorabies virus. J Gen Virol, 54(Pt 2), 333-342. 
Feng, H., Shuda, M., Chang, Y., & Moore, P. S. (2008). Clonal integration of a polyomavirus in human Merkel cell 
carcinoma. Science, 319(5866), 1096-1100. 
Florin, L., Becker, K. A., Lambert, C., Nowak, T., Sapp, C., Strand, D., et al. (2006). Identification of a dynein interacting 
domain in the papillomavirus minor capsid protein l2. J Virol, 80(13), 6691-6696. 
Fontoura, B. M., Faria, P. A., & Nussenzveig, D. R. (2005). Viral interactions with the nuclear transport machinery: 
discovering and disrupting pathways. IUBMB Life, 57(2), 65-72. 
Frey, S., & Gorlich, D. (2007). A saturated FG-repeat hydrogel can reproduce the permeability properties of nuclear 
pore complexes. Cell, 130(3), 512-523. 
Funk, A., Mhamdi, M., Hohenberg, H., Will, H., & Sirma, H. (2006). pH-independent entry and sequential endosomal 
sorting are major determinants of hepadnaviral infection in primary hepatocytes. Hepatology, 44(3), 685-693. 
Funk, A., Mhamdi, M., Lin, L., Will, H., & Sirma, H. (2004). Itinerary of hepatitis B viruses: delineation of restriction points 
critical for infectious entry. J Virol, 78(15), 8289-8300. 
Gaspar, M., Gill, M. B., Losing, J. B., May, J. S., & Stevenson, P. G. (2008). Multiple functions for ORF75c in murid 
herpesvirus-4 infection. PLoS ONE, 3(7), e2781. 
Gastaldelli, M., Imelli, N., Boucke, K., Amstutz, B., Meier, O., & Greber, U. F. (2008). Infectious Adenovirus Type 2 
Transport Through Early but not Late Endosomes. Traffic, 9(12), 2265-2278. 
Giannakakou, P., Nakano, M., Nicolaou, K. C., O'Brate, A., Yu, J., Blagosklonny, M. V., et al. (2002). Enhanced 
microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamics. 
Proc Natl Acad Sci U S A, 99(16), 10855-10860. 
Girardi, A. J., Sweet, B. H., Slotnick, V. B., & Hilleman, M. R. (1962). Development of tumors in hamsters inoculated in 
the neonatal period with vacuolating virus, SV-40. Proc Soc Exp Biol Med, 109, 649-660. 
Giroglou, T., Florin, L., Schafer, F., Streeck, R. E., & Sapp, M. (2001). Human papillomavirus infection requires cell 
surface heparan sulfate. J Virol, 75(3), 1565-1570. 
Glebe, D., & Urban, S. (2007). Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol, 
13(1), 22-38. 
Gorlich, D., & Kutay, U. (1999). Transport between the cell nucleus and the cytoplasm. Annu Rev Cell Dev Biol, 15, 607-
660. 
Greber, U. F. (2002). Signalling in viral entry. Cell Mol Life Sci, 59, 608-626. 
Greber, U. F. (2005). Viral trafficking violations in axons - the herpes virus case. [review]. Proc. Natl. Acad. Sci. USA, 
102((16)), 5639-5640. 
Greber, U. F., & Fassati, A. (2003). Nuclear import of viral DNA genomes. Traffic, 4, 136-143. 
Greber, U. F., & Gastaldelli, M. (2007). Junctional gating:  the Achilles‟ heel of epithelial cells in pathogen infection. Cell 
Host and Microbe, 2, 143-146. 
Greber, U. F., & Kasamatsu, H. (1996). Nuclear targeting of adenovirus and simian virus SV40. Trends Cell Biol., 6, 
189-195. 
Greber, U. F., Singh, I., & Helenius, A. (1994). Mechanisms of virus uncoating. Trends Microbiol., 2, 52-56. 
Greber, U. F., & Way, M. (2006). A super highway to virus infection. [review]. Cell, 124(4), 741-754. 
Greber, U. F., Webster, P., Weber, J., & Helenius, A. (1996). The role of the adenovirus protease in virus entry into 
cells. EMBO J., 15, 1766-1777. 
Greber, U. F., Willetts, M., Webster, P., & Helenius, A. (1993). Stepwise dismantling of adenovirus 2 during entry into 
cells. Cell, 75, 477-486. 
Gross, S. P., Welte, M. A., Block, S. M., & Wieschaus, E. F. (2002). Coordination of opposite-polarity microtubule 
motors. J Cell Biol, 156(4), 715-724. 
Gundersen, G. G. (2002). Microtubule capture: IQGAP and CLIP-170 expand the repertoire. Curr Biol, 12(19), R645-
647. 
Hafezi, W., Bernard, E., Cook, R., & Elliott, G. (2005). Herpes simplex virus tegument protein VP22 contains an internal 
VP16 interaction domain and a C-terminal domain that are both required for VP22 assembly into the virus 
particle. J Virol, 79(20), 13082-13093. 
Haruki, H., Gyurcsik, B., Okuwaki, M., & Nagata, K. (2003). Ternary complex formation between DNA-adenovirus core 
protein VII and TAF-Ibeta/SET, an acidic molecular chaperone. FEBS Lett, 555(3), 521-527. 
Haruki, H., Okuwaki, M., Miyagishi, M., Taira, K., & Nagata, K. (2006). Involvement of template-activating factor I/SET in 
transcription of adenovirus early genes as a positive-acting factor. J Virol, 80(2), 794-801. 
Hebner, C. M., & Laimins, L. A. (2006). Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. 
Rev Med Virol, 16(2), 83-97. 
Heldwein, E. E., & Krummenacher, C. (2008). Entry of herpesviruses into mammalian cells. Cell Mol Life Sci, 65(11), 
1653-1668. 
Hindley, C. E., Lawrence, F. J., & Matthews, D. A. (2007). A role for transportin in the nuclear import of adenovirus core 
proteins and DNA. Traffic, 8(10), 1313-1322. 
Hong, S. S., Szolajska, E., Schoehn, G., Franqueville, L., Myhre, S., Lindholm, L., et al. (2005). The 100K-chaperone 
protein from adenovirus serotype 2 (Subgroup C) assists in trimerization and nuclear localization of hexons 
from subgroups C and B adenoviruses. J Mol Biol, 352(1), 125-138. 
 
57 
Hosokawa, K., & Sung, M. T. (1976). Isolation and characterization of an extreme basic protein from adenovirus type 5. 
J. Virol., 17, 924-934. 
Hutten, S., Flotho, A., Melchior, F., & Kehlenbach, R. H. (2008). The Nup358-RanGAP Complex Is Required for Efficient 
Importin {alpha}/{beta}-dependent Nuclear Import. Mol Biol Cell, 19(5), 2300-2310. 
Hutten, S., & Kehlenbach, R. H. (2006). Nup214 is required for CRM1-dependent nuclear protein export in vivo. Mol Cell 
Biol, 26(18), 6772-6785. 
Imperiale, M., & Major, E. (2007). Polyomaviruses. In D. M. Knipe & P. M. Howley (Eds.), Fields Virology (5 ed., Vol. 2, 
pp. 2263-2298). Philadelphia, PA, USA: Lippincott Williams & Wilkins. 
Ishii, N., Minami, N., Chen, E. Y., Medina, A. L., Chico, M. M., & Kasamatsu, H. (1996). Analysis of a nuclear 
localization signal of simian virus 40 major capsid protein Vp1. J Virol, 70(2), 1317-1322. 
Ishii, N., Nakanishi, A., Yamada, M., Macalalad, M. H., & Kasamatsu, H. (1994). Functional complementation of nuclear 
targeting-defective mutants of simian virus 40 structural proteins. J. Virol., 68(12), 8209-8216. 
Itahana, K., & Zhang, Y. (2008). Mitochondrial p32 is a critical mediator of ARF-induced apoptosis. Cancer Cell, 13(6), 
542-553. 
Jakel, S., Albig, W., Kutay, U., Bischoff, F. R., Schwamborn, K., Doenecke, D., et al. (1999). The importin beta/importin 
7 heterodimer is a functional nuclear import receptor for histone H1. Embo J, 18(9), 2411-2423. 
Javier, R. T., & Butel, J. S. (2008). The history of tumor virology. Cancer Res, 68(19), 7693-7706. 
Jeembaeva, M., Castelnovo, M., Larsson, F., & Evilevitch, A. (2008). Osmotic pressure: resisting or promoting DNA 
ejection from phage? J Mol Biol, 381(2), 310-323. 
Jiang, M., Abend, J. R., Johnson, S. F., & Imperiale, M. J. (2008). The role of polyomaviruses in human disease. 
Virology. 
Johannsen, E., Luftig, M., Chase, M. R., Weicksel, S., Cahir-McFarland, E., Illanes, D., et al. (2004). Proteins of purified 
Epstein-Barr virus. Proc Natl Acad Sci U S A, 101(46), 16286-16291. 
Johnson, J. S., Osheim, Y. N., Xue, Y., Emanuel, M. R., Lewis, P. W., Bankovich, A., et al. (2004). Adenovirus protein 
VII condenses DNA, represses transcription, and associates with transcriptional activator E1A. J Virol, 78(12), 
6459-6468. 
Joseph, J., & Dasso, M. (2008). The nucleoporin Nup358 associates with and regulates interphase microtubules. FEBS 
Lett, 582(2), 190-196. 
Jovasevic, V., Liang, L., & Roizman, B. (2008). Proteolytic cleavage of VP1-2 is required for release of herpes simplex 
virus 1 DNA into the nucleus. J Virol, 82(7), 3311-3319. 
Kaelin, K., Dezelee, S., Masse, M. J., Bras, F., & Flamand, A. (2000). The UL25 protein of pseudorabies virus 
associates with capsids and localizes to the nucleus and to microtubules. J Virol, 74(1), 474-482. 
Kann, M., Schmitz, A., & Rabe, B. (2007). Intracellular transport of hepatitis B virus. World J Gastroenterol, 13(1), 39-47. 
Kann, M., Sodeik, B., Vlachou, A., Gerlich, W. H., & Helenius, A. (1999). Phosphorylation-dependent binding of hepatitis 
B virus core particles to the nuclear pore complex. J Cell Biol, 145(1), 45-55. 
Kasamatsu, H., & Nakanishi, A. (1998). How do animal DNA viruses get to the nucleus? Annu Rev Microbiol, 52, 627-
686. 
Kelkar, S. A., Pfister, K. K., Crystal, R. G., & Leopold, P. L. (2004). Cytoplasmic dynein mediates adenovirus binding to 
microtubules. J Virol, 78(18), 10122-10132. 
Kent, J. R., Zeng, P. Y., Atanasiu, D., Gardner, J., Fraser, N. W., & Berger, S. L. (2004). During lytic infection herpes 
simplex virus type 1 is associated with histones bearing modifications that correlate with active transcription. J 
Virol, 78(18), 10178-10186. 
Knipe, D. M., & Cliffe, A. (2008). Chromatin control of herpes simplex virus lytic and latent infection. Nat Rev Microbiol, 
6(3), 211-221. 
Kosulin, K., Haberler, C., Hainfellner, J. A., Amann, G., Lang, S., & Lion, T. (2007). Investigation of adenovirus 
occurrence in pediatric tumor entities. J Virol, 81(14), 7629-7635. 
Krautwald, M., Fuchs, W., Klupp, B. G., & Mettenleiter, T. C. (2009). Translocation of incoming pseudorabies virus 
capsids to the cell nucleus is delayed in the absence of tegument protein pUL37. J Virol. 
Lander, G. C., Tang, L., Casjens, S. R., Gilcrease, E. B., Prevelige, P., Poliakov, A., et al. (2006). The structure of an 
infectious P22 virion shows the signal for headful DNA packaging. Science, 312(5781), 1791-1795. 
Lara-Pezzi, E., Gomez-Gaviro, M. V., Galvez, B. G., Mira, E., Iniguez, M. A., Fresno, M., et al. (2002). The hepatitis B 
virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and 
cyclooxygenase-2 expression. J Clin Invest, 110(12), 1831-1838. 
Lee, J. O., Kwun, H. J., Jung, J. K., Choi, K. H., Min, D. S., & Jang, K. L. (2005). Hepatitis B virus X protein represses E-
cadherin expression via activation of DNA methyltransferase 1. Oncogene, 24(44), 6617-6625. 
Lee, T. W., Blair, G. E., & Matthews, D. A. (2003). Adenovirus core protein VII contains distinct sequences that mediate 
targeting to the nucleus and nucleolus, and colocalization with human chromosomes. J Gen Virol, 84(Pt 12), 
3423-3428. 
Leopold, P. L., Kreitzer, G., Miyazawa, N., Rempel, S., Pfister, K. K., Rodriguez-Boulan, E., et al. (2000). Dynein- and 
microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis. Hum Gene Ther, 
11(1), 151-165. 
Leopold, P. L., & Pfister, K. K. (2006). Viral strategies for intracellular trafficking: motors and microtubules. Traffic, 7(5), 
516-523. 
Lill, Y., Lill, M. A., Fahrenkrog, B., Schwarz-Herion, K., Paulillo, S., Aebi, U., et al. (2006). Single hepatitis-B virus core 
capsid binding to individual nuclear pore complexes in Hela cells. Biophys J, 91(8), 3123-3130. 
Lim, R. Y., Fahrenkrog, B., Koser, J., Schwarz-Herion, K., Deng, J., & Aebi, U. (2007). Nanomechanical basis of 
selective gating by the nuclear pore complex. Science, 318(5850), 640-643. 
Lin, C. T., Lin, C. R., Tan, G. K., Chen, W., Dee, A. N., & Chan, W. Y. (1997). The mechanism of Epstein-Barr virus 
infection in nasopharyngeal carcinoma cells. Am J Pathol, 150(5), 1745-1756. 
Lopez-Bueno, A., Villarreal, L. P., & Almendral, J. M. (2006). Parvovirus variation for disease: a difference with RNA 
viruses? Curr Top Microbiol Immunol, 299, 349-370. 
Luxton, G. W., Haverlock, S., Coller, K. E., Antinone, S. E., Pincetic, A., & Smith, G. A. (2005). Targeting of herpesvirus 
capsid transport in axons is coupled to association with specific sets of tegument proteins. Proc Natl Acad Sci 
U S A, 102(16), 5832-5837. 
Mabit, H., Breiner, K. M., Knaust, A., Zachmann-Brand, B., & Schaller, H. (2001). Signals for bidirectional 
nucleocytoplasmic transport in the duck hepatitis B virus capsid protein. J. Virol., 75(4), 1968-1977. 
 
58 
Mabit, H., Nakano, M. Y., Prank, U., Saam, B., Döhner, K., Sodeik, B., et al. (2002). Intact microtubules support 
Adenovirus and Herpes simplex virus infections. J. Virol., 76, 9962-9971. 
Magnuson, B., Rainey, E. K., Benjamin, T., Baryshev, M., Mkrtchian, S., & Tsai, B. (2005). ERp29 triggers a 
conformational change in polyomavirus to stimulate membrane binding. Mol Cell, 20(2), 289-300. 
Mansouri, M., Rose, P. P., Moses, A. V., & Fruh, K. (2008). Remodeling of endothelial adherens junctions by Kaposi's 
sarcoma-associated herpesvirus. J Virol, 82(19), 9615-9628. 
Marg, A., Shan, Y., Meyer, T., Meissner, T., Brandenburg, M., & Vinkemeier, U. (2004). Nucleocytoplasmic shuttling by 
nucleoporins Nup153 and Nup214 and CRM1-dependent nuclear export control the subcellular distribution of 
latent Stat1. J Cell Biol, 165(6), 823-833. 
Marsh, M., & Helenius, A. (2006). Virus entry: open sesame. Cell, 124(4), 729-740. 
Matthews, D. A., & Russell, W. C. (1994). Adenovirus protein-protein interactions: hexon and protein VI. J. Gen. Virol., 
75, 3365-3374. 
Matthews, D. A., & Russell, W. C. (1998a). Adenovirus core protein V interacts with p32--a protein which is associated 
with both the mitochondria and the nucleus. J Gen Virol, 79(Pt 7), 1677-1685. 
Matthews, D. A., & Russell, W. C. (1998b). Adenovirus Core Protein V Is Delivered By the Invading Virus to the Nucleus 
Of the Infected Cell and Later In Infection Is Associated With Nucleoli. Journal of General Virology, 79(Part 7), 
1671-1675. 
McLaughlin-Drubin, M. E., & Munger, K. (2008). Viruses associated with human cancer. Biochim Biophys Acta, 1782(3), 
127-150. 
Meier, O., & Greber, U. F. (2003). Adenovirus endocytosis. J. Gene Med., 5, 451–462. 
Mettenleiter, T. C. (2004). Budding events in herpesvirus morphogenesis. Virus Res, 106(2), 167-180. 
Mettenleiter, T. C., Klupp, B. G., & Granzow, H. (2006). Herpesvirus assembly: a tale of two membranes. Curr Opin 
Microbiol, 9(4), 423-429. 
Miller, G. (2009). Brain cancer. A viral link to glioblastoma? Science, 323(5910), 30-31. 
Miller, N., & Hutt-Fletcher, L. M. (1992). Epstein-Barr virus enters B cells and epithelial cells by different routes. 66, 
3409-3414. 
Misteli, T., Gunjan, A., Hock, R., Bustin, M., & Brown, D. T. (2000). Dynamic binding of histone H1 to chromatin in living 
cells. Nature, 408(6814), 877-881. 
Miyamoto, K., & Morgan, C. (1971). Structure and development of viruses as observed in the electron microscope. XI. 
Entry and uncoating of herpes simplex virus. J Virol, 8(6), 910-918. 
Molho-Pessach, V., & Lotem, M. (2007). Viral carcinogenesis in skin cancer. Curr Probl Dermatol, 35, 39-51. 
Morgan, C., Rose, H. M., & Mednis, B. (1968). Electron Microscopy of Herpes simplex virus.  I.  Entry. J. Virol., 2, 507-
516. 
Muruve, D. A., Petrilli, V., Zaiss, A. K., White, L. R., Clark, S. A., Ross, P. J., et al. (2008). The inflammasome 
recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature, 452(7183), 
103-107. 
Nagel, C. H., Dohner, K., Fathollahy, M., Strive, T., Borst, E. M., Messerle, M., et al. (2008). Nuclear egress and 
envelopment of herpes simplex virus capsids analyzed with dual-color fluorescence HSV1(17+). J Virol, 82(6), 
3109-3124. 
Nakanishi, A., Clever, J., Yamada, M., Li, P. P., & Kasamatsu, H. (1996). Association With Capsid Proteins Promotes 
Nuclear Targeting Of Simian Virus 40 Dna. Proceedings of the National Academy of Sciences of the United 
States of America, 93(1), 96-100. 
Nakanishi, A., Li, P. P., Qu, Q., Jafri, Q. H., & Kasamatsu, H. (2007). Molecular dissection of nuclear entry-competent 
SV40 during infection. Virus Res, 124(1-2), 226-230. 
Naranatt, P. P., Krishnan, H. H., Smith, M. S., & Chandran, B. (2005). Kaposi's sarcoma-associated herpesvirus 
modulates microtubule dynamics via RhoA-GTP-diaphanous 2 signaling and utilizes the dynein motors to 
deliver its DNA to the nucleus. J Virol, 79(2), 1191-1206. 
Nemerow, G. R., & Cooper, N. R. (1984). Early events in the infection of human B lymphocytes by Epstein-Barr virus: 
the internalization process. Virology, 132(1), 186-198. 
Newcomb, W. W., Booy, F. P., & Brown, J. C. (2007). Uncoating the herpes simplex virus genome. J Mol Biol, 370(4), 
633-642. 
Newcomb, W. W., Juhas, R. M., Thomsen, D. R., Homa, F. L., Burch, A. D., Weller, S. K., et al. (2001). The UL6 gene 
product forms the portal for entry of DNA into the herpes simplex virus capsid. J Virol, 75(22), 10923-10932. 
Oh, J., & Fraser, N. W. (2008). Temporal association of the herpes simplex virus genome with histone proteins during a 
lytic infection. J Virol, 82(7), 3530-3537. 
Ojala, P. M., Sodeik, B., Ebersold, M. W., Kutay, U., & Helenius, A. (2000). Herpes simplex virus type 1 entry into host 
cells: reconstitution of capsid binding and uncoating at the nuclear pore complex in vitro. Mol Cell Biol, 20(13), 
4922-4931. 
Osterrieder, N., Kamil, J. P., Schumacher, D., Tischer, B. K., & Trapp, S. (2006). Marek's disease virus: from miasma to 
model. Nat Rev Microbiol, 4(4), 283-294. 
Pagano, J. S., Blaser, M., Buendia, M. A., Damania, B., Khalili, K., Raab-Traub, N., et al. (2004). Infectious agents and 
cancer: criteria for a causal relation. Semin Cancer Biol, 14(6), 453-471. 
Pante, N., & Kann, M. (2002). Nuclear pore complex is able to transport macromolecules with diameters of about 39 nm. 
Molecular Biology of the Cell, 13(2), 425-434. 
Parkin, D. M. (2006). The global health burden of infection-associated cancers in the year 2002. Int J Cancer, 118(12), 
3030-3044. 
Patel, S. S., Belmont, B. J., Sante, J. M., & Rexach, M. F. (2007). Natively unfolded nucleoporins gate protein diffusion 
across the nuclear pore complex. Cell, 129(1), 83-96. 
Pedersen, S. M., & Hollsberg, P. (2006). Complexities in human herpesvirus-6A and -6B binding to host cells. Virology, 
356(1-2), 1-3. 
Pelkmans, L., Kartenbeck, J., & Helenius, A. (2001). Caveolar endocytosis of simian virus 40 reveals a new two-step 
vesicular-transport pathway to the ER. Nat Cell Biol, 3(5), 473-483. 
Pho, M. T., Ashok, A., & Atwood, W. J. (2000). JC virus enters human glial cells by clathrin-dependent receptor-
mediated endocytosis. Journal of Virology, 74(5), 2288-2292. 
Pouton, C. W., Wagstaff, K. M., Roth, D. M., Moseley, G. W., & Jans, D. A. (2007). Targeted delivery to the nucleus. 
Adv Drug Deliv Rev, 59(8), 698-717. 
 
59 
Preston, V. G., Murray, J., Preston, C. M., McDougall, I. M., & Stow, N. D. (2008). The UL25 gene product of herpes 
simplex virus type 1 is involved in uncoating of the viral genome. J Virol, 82(13), 6654-6666. 
Pungpapong, S., Kim, W. R., & Poterucha, J. J. (2007). Natural history of hepatitis B virus infection: an update for 
clinicians. Mayo Clin Proc, 82(8), 967-975. 
Qu, Q., Sawa, H., Suzuki, T., Semba, S., Henmi, C., Okada, Y., et al. (2004). Nuclear entry mechanism of the human 
polyomavirus JC virus-like particle: role of importins and the nuclear pore complex. J Biol Chem, 279(26), 
27735-27742. 
Querbes, W., O'Hara, B. A., Williams, G., & Atwood, W. J. (2006). Invasion of host cells by JC virus identifies a novel 
role for caveolae in endosomal sorting of noncaveolar ligands. J Virol, 80(19), 9402-9413. 
Rabe, B., Glebe, D., & Kann, M. (2006). Lipid-mediated introduction of hepatitis B virus capsids into nonsusceptible cells 
allows highly efficient replication and facilitates the study of early infection events. J Virol, 80(11), 5465-5473. 
Radtke, K., Dohner, K., & Sodeik, B. (2006). Viral interactions with the cytoskeleton: a hitchhiker's guide to the cell. Cell 
Microbiol, 8(3), 387-400. 
Raghu, H., Sharma-Walia, N., Veettil, M. V., Sadagopan, S., Caballero, A., Sivakumar, R., et al. (2007). Lipid rafts of 
primary endothelial cells are essential for Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-
induced phosphatidylinositol 3-kinase and RhoA-GTPases critical for microtubule dynamics and nuclear 
delivery of viral DNA but dispensable for binding and entry. J Virol, 81(15), 7941-7959. 
Rappocciolo, G., Hensler, H. R., Jais, M., Reinhart, T. A., Pegu, A., Jenkins, F. J., et al. (2008). Human herpesvirus 8 
infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN. J Virol, 82(10), 4793-
4806. 
Richards, R. M., Lowy, D. R., Schiller, J. T., & Day, P. M. (2006). Cleavage of the papillomavirus minor capsid protein, 
L2, at a furin consensus site is necessary for infection. Proc Natl Acad Sci U S A, 103(5), 1522-1527. 
Roberts, A. P., Abaitua, F., O'Hare, P., McNab, D., Rixon, F. J., & Pasdeloup, D. (2009). Differing roles of inner 
tegument proteins pUL36 and pUL37 during entry of herpes simplex virus type 1. J Virol, 83(1), 105-116. 
Roberts, J. N., Buck, C. B., Thompson, C. D., Kines, R., Bernardo, M., Choyke, P. L., et al. (2007). Genital transmission 
of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med, 13(7), 857-
861. 
Rux, J. J., & Burnett, R. M. (2000). Type-specific epitope locations revealed by X-ray crystallographic study of 
adenovirus type 5 hexon. Mol Ther, 1(1), 18-30. 
Samad, M. A., Okuwaki, M., Haruki, H., & Nagata, K. (2007). Physical and functional interaction between a nucleolar 
protein nucleophosmin/B23 and adenovirus basic core proteins. FEBS Lett, 581(17), 3283-3288. 
Sandri-Goldin, R. M. (2001). Nuclear export of herpes virus RNA. Curr Top Microbiol Immunol, 259, 2-23. 
Saphire, A. C. S., Guan, T. L., Schirmer, E. C., Nemerow, G. R., & Gerace, L. (2000). Nuclear import of adenovirus DNA 
in vitro involves the nuclear protein import pathway and hsc70. J. Biol. Chem., 275(6), 4298-4304. 
Sattentau, Q. (2008). Avoiding the void: cell-to-cell spread of human viruses. Nat Rev Microbiol, 6(11), 815-826. 
Schelhaas, M., Malmstrom, J., Pelkmans, L., Haugstetter, J., Ellgaard, L., Grunewald, K., et al. (2007). Simian Virus 40 
depends on ER protein folding and quality control factors for entry into host cells. Cell, 131(3), 516-529. 
Schroer, T. A. (2004). Dynactin. Annu Rev Cell Dev Biol, 20, 759-779. 
Selinka, H. C., Giroglou, T., & Sapp, M. (2002). Analysis of the infectious entry pathway of human papillomavirus type 
33 pseudovirions. Virology, 299(2), 279-287. 
Shahin, V., Hafezi, W., Oberleithner, H., Ludwig, Y., Windoffer, B., Schillers, H., et al. (2006). The genome of HSV-1 
translocates through the nuclear pore as a condensed rod-like structure. J Cell Sci, 119(Pt 1), 23-30. 
Sherer, N. M., & Mothes, W. (2008). Cytonemes and tunneling nanotubules in cell-cell communication and viral 
pathogenesis. Trends Cell Biol, 18(9), 414-420. 
Shishido-Hara, Y., Ichinose, S., Higuchi, K., Hara, Y., & Yasui, K. (2004). Major and minor capsid proteins of human 
polyomavirus JC cooperatively accumulate to nuclear domain 10 for assembly into virions. J Virol, 78(18), 
9890-9903. 
Shubeita, G. T., Tran, S. L., Xu, J., Vershinin, M., Cermelli, S., Cotton, S. L., et al. (2008). Consequences of motor copy 
number on the intracellular transport of kinesin-1-driven lipid droplets. Cell, 135(6), 1098-1107. 
Sieczkarski, S. B., & Whittaker, G. R. (2005). Viral entry. Curr Top Microbiol Immunol, 285, 1-23. 
Smith, J. G., Cassany, A., Gerace, L., Ralston, R., & Nemerow, G. R. (2008). A Neutralizing Antibody Blocks 
Adenovirus Infection by Arresting Microtubule-Dependent Cytoplasmic Transport. J Virol. 
Smith, J. L., Campos, S. K., & Ozbun, M. A. (2007). Human papillomavirus type 31 uses a caveolin 1- and dynamin 2-
mediated entry pathway for infection of human keratinocytes. J Virol, 81(18), 9922-9931. 
Sodeik, B., Ebersold, M. W., & Helenius, A. (1997). Microtubule-mediated transport of incoming Herpes Simplex Virus 1 
capsids to the nucleus. J. Cell Biol., 136(5), 1007-1021. 
Sommer, G., & Heise, T. (2008). Posttranscriptional control of HBV gene expression. Front Biosci, 13, 5533-5547. 
Spector, D. J. (2007). Default assembly of early adenovirus chromatin. Virology, 359(1), 116-125. 
Spector, D. J., Johnson, J. S., Baird, N. L., & Engel, D. A. (2003). Adenovirus type 5 DNA-protein complexes from 
formaldehyde cross-linked cells early after infection. Virology, 312(1), 204-212. 
Spoden, G., Freitag, K., Husmann, M., Boller, K., Sapp, M., Lambert, C., et al. (2008). Clathrin- and caveolin-
independent entry of human papillomavirus type 16--involvement of tetraspanin-enriched microdomains 
(TEMs). PLoS ONE, 3(10), e3313. 
Stanley, M. A., Pett, M. R., & Coleman, N. (2007). HPV: from infection to cancer. Biochem Soc Trans, 35(Pt 6), 1456-
1460. 
Steven, A. C., Conway, J. F., Cheng, N., Watts, N. R., Belnap, D. M., Harris, A., et al. (2005). Structure, assembly, and 
antigenicity of hepatitis B virus capsid proteins. Adv Virus Res, 64, 125-164. 
Stewart, P. L., & Nemerow, G. R. (2007). Cell integrins: commonly used receptors for diverse viral pathogens. Trends 
Microbiol, 15(11), 500-507. 
Stoeckl, L., Funk, A., Kopitzki, A., Brandenburg, B., Oess, S., Will, H., et al. (2006). Identification of a structural motif 
crucial for infectivity of hepatitis B viruses. Proc Natl Acad Sci U S A, 103(17), 6730-6734. 
Strang, B. L., & Stow, N. D. (2007). Blocks to herpes simplex virus type 1 replication in a cell line, tsBN2, encoding a 
temperature-sensitive RCC1 protein. J Gen Virol, 88(Pt 2), 376-383. 
Strawn, L. A., Shen, T., Shulga, N., Goldfarb, D. S., & Wente, S. R. (2004). Minimal nuclear pore complexes define FG 
repeat domains essential for transport. Nat Cell Biol, 6(3), 197-206. 
 
60 
Strunze, S., Trotman, L. C., Boucke, K., & Greber, U. F. (2005). Nuclear targeting of adenovirus type 2 requires CRM1-
mediated nuclear export. Mol Biol Cell, 16(6), 2999-3009. 
Sung, M. T., Lischwe, M. A., Richards, J. C., & Hosokawa, K. (1977). Adenovirus chromatin. I. Isolation and 
characterization of the major core protein VII and precursor pro-VII. J. Biol. Chem., 252, 4981-4987. 
Suomalainen, M., Nakano, M. Y., Boucke, K., Keller, S., & Greber, U. F. (2001). Adenovirus-activated PKA and 
p38/MAPK pathways boost microtubule-mediated nuclear targeting of virus. Embo J, 20(6), 1310-1319. 
Suomalainen, M., Nakano, M. Y., Boucke, K., Keller, S., Stidwill, R. P., & Greber, U. F. (1999). Microtubule-dependent 
minus and plus end-directed motilities are competing processes for nuclear targeting of adenovirus. J. Cell 
Biol., 144, 657-672. 
Terry, L. J., Shows, E. B., & Wente, S. R. (2007). Crossing the nuclear envelope: hierarchical regulation of 
nucleocytoplasmic transport. Science, 318(5855), 1412-1416. 
Trentin, J. J., Yabe, Y., & Taylor, G. (1962). The quest for human cancer viruses. Science, 137, 835-841. 
Trotman, L. C., Mosberger, N., Fornerod, M., Stidwill, R. P., & Greber, U. F. (2001). Import of adenovirus DNA involves 
the nuclear pore complex receptor CAN/Nup214 and histone H1. Nature Cell Biology, 3, 1092-1100. 
Ugai, H., Borovjagin, A. V., Le, L. P., Wang, M., & Curiel, D. T. (2007). Thermostability/infectivity defect caused by 
deletion of the core protein V gene in human adenovirus type 5 is rescued by thermo-selectable mutations in 
the core protein X precursor. J Mol Biol, 366(4), 1142-1160. 
van Oostrum, J., & Burnett, R. M. (1985). Molecular composition of the adenovirus type 2 virion. J. Virol., 56, 439-448. 
Walther, T. C., Pickersgill, H. S., Cordes, V. C., Goldberg, M. W., Allen, T. D., Mattaj, I. W., et al. (2002). The 
cytoplasmic filaments of the nuclear pore complex are dispensable for selective nuclear protein import. J Cell 
Biol, 158(1), 63-77. 
Warren, J. C., & Cassimeris, L. (2007). The contributions of microtubule stability and dynamic instability to adenovirus 
nuclear localization efficiency. Cell Motil Cytoskeleton, 64(9), 675-689. 
Warren, J. C., Rutkowski, A., & Cassimeris, L. (2006). Infection with replication-deficient adenovirus induces changes in 
the dynamic instability of host cell microtubules. Mol Biol Cell, 17(8), 3557-3568. 
White, M. K., Gordon, J., Reiss, K., Del Valle, L., Croul, S., Giordano, A., et al. (2005). Human polyomaviruses and brain 
tumors. Brain Res Brain Res Rev, 50(1), 69-85. 
Whittaker, G. R., Kann, M., & Helenius, A. (2000). Viral entry into the nucleus. Annu Rev Cell Dev Biol, 16, 627-651. 
Wiethoff, C. M., Wodrich, H., Gerace, L., & Nemerow, G. R. (2005). Adenovirus Protein VI Mediates Membrane 
Disruption following Capsid Disassembly. J Virol, 79(4), 1992-2000. 
Wisnivesky, J. P., Leopold, P. L., & Crystal, R. G. (1999). Specific binding of the adenovirus capsid to the nuclear 
envelope. Hum Gene Ther, 10(13), 2187-2195. 
Wodrich, H., Guan, T., Cingolani, G., Von Seggern, D., Nemerow, G., & Gerace, L. (2003). Switch from capsid protein 
import to adenovirus assembly by cleavage of nuclear transport signals. Embo J, 22(23), 6245-6255. 
Wolfstein, A., Nagel, C. H., Radtke, K., Dohner, K., Allan, V. J., & Sodeik, B. (2006). The inner tegument promotes 
herpes simplex virus capsid motility along microtubules in vitro. Traffic, 7(2), 227-237. 
Wysocka, J., & Herr, W. (2003). The herpes simplex virus VP16-induced complex: the makings of a regulatory switch. 
Trends Biochem Sci, 28(6), 294-304. 
Xue, Y., Johnson, J. S., Ornelles, D. A., Lieberman, J., & Engel, D. A. (2005). Adenovirus Protein VII Functions 
throughout Early Phase and Interacts with Cellular Proteins SET and pp32. J Virol, 79(4), 2474-2483. 
Yamauchi, Y., Kiriyama, K., Kubota, N., Kimura, H., Usukura, J., & Nishiyama, Y. (2008). The UL14 tegument protein of 
herpes simplex virus type 1 is required for efficient nuclear transport of the alpha transinducing factor VP16 
and viral capsids. J Virol, 82(3), 1094-1106. 
Yan, Y., Stehle, T., Liddington, R. C., Zhao, H., & Harrison, S. C. (1996). Structure determination of simian virus 40 and 
murine polyomavirus by a combination of 30-fold and 5-fold electron-density averaging. Structure, 4(2), 157-
164. 
Young, K. A., Herbert, A. P., Barlow, P. N., Holers, V. M., & Hannan, J. P. (2008). Molecular basis of the interaction 
between complement receptor type 2 (CR2/CD21) and Epstein-Barr virus glycoprotein gp350. J Virol, 82(22), 
11217-11227. 
Zhao, L.-J., & Padmanabhan, R. (1988). Nuclear transport of adenovirus DNA polymerase is facilitated by interaction 
with preterminal protein. Cell, 55, 1005-1015. 
Zhou, Z. H., Chen, D. H., Jakana, J., Rixon, F. J., & Chiu, W. (1999). Visualization of tegument-capsid interactions and 
DNA in intact herpes simplex virus type 1 virions. Journal of Virology, 73(4), 3210-3218. 
zur Hausen, H. (2002). Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer, 2(5), 
342-350. 
 
 
 61 
RESULTS 
 
 
Manuscript: 
 
 
Fluorescent DNA-core dynamics in entry and egress 
reveals nonisotropic hatching of viruses from infected 
cell nuclei 
Daniel Puntener, Martin F. Engelke, Nicola Imelli,  
Zsolt Ruzsics, Karin Boucke, Corinne Wilhelm and  
Urs F. Greber.  
Manuscript submitted to PLoS Pathogens. 
 
 
 
 
 
 
 
 
Contributions: 
Martin F. Engelke: Particle recognition routine 
Nicola Imelli:  Figure S2 
Karin Boucke: Figure 3B, 4A, 4E 
Corinne Wilhelm: Figure 2E, 2F, S4 
Zsolt Ruzsics: Recombineering 
Urs F. Greber: Manuscript 
 62 
Fluorescent DNA-core dynamics in entry and egress 
reveals nonisotropic hatching of viruses from infected 
cell nuclei 
 
Daniel Puntener1, Martin F. Engelke1, Nicola Imelli1, Zsolt Ruzsics2, Karin 
Boucke1, Corinne Wilhelm1 and Urs F. Greber1, 3 
 
1 Institute of Molecular Life Sciences, University of Zurich, Winterthurerstrasse 
190, CH-8057 Zurich, Switzerland 
2 Max von Pettenkofer Institute, Department of Virology, Gene Center, Ludwig-
Maximilians-University, 81377 Munich, Germany 
 
3 corresponding author: 
E-mail: urs.greber@imls.uzh.ch, Telephone: +41 44 635 48 41, Fax: +41 44 635 
68 22 
 
running head: Cell entry and egress of a DNA-core tagged virus 
 
Abstract:  156 words 
Total text:   46396 characters (wo spaces) 
Figure:  7 Table:  0 
 63 
Abstract 
 
DNA-viruses and retroviruses maintain and replicate their genomes in host cell 
nuclei using histone-based nucleosomes, similar to chromatin.  Human 
adenoviruses (HAdVs, short Ad) replicate and assemble in the nucleus.  They 
organise a linear double-strand DNA genome into a condensed core with about 
180 nucleosomes by the viral protein VII (pVII), the small pX, and by pV 
attaching the DNA to the capsid.  Using reverse genetics we replaced the 
genomic pV locus of Ad2 by GFP-pV.  Purified Ad2-GFP-pV virions 
incorporated GFP-pV, had normal internalization and endosomal escape 
kinetics, and produced viral particles.  Live cell imaging and electron 
microscopy revealed the release of both clusters and solitary Ad2-GFP-pV 
virions from the nucleus, indicating that egress of adenovirus from lytically 
infected cells is nonisotropic. Incoming Ad2-GPF-pV virions released GFP-pV in 
two steps, during entry into the cytosol, and at the nuclear membrane, 
suggesting nonhomogenous occurance of GFP-pV in virions.  These results 
have implications for virus-cell transmission and disease mechanisms.   
 
 
Keywords: 
Histone H2B, lytic egress, stepwise disassembly, fluorescent virus, 
fluorescence microscopy 
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Introduction 
 
Eucaryotic cells package their DNA with histones and associated proteins into 
nucleosomes, which are invariant in structure and composition and wrap 146 bp 
of DNA around a core of histones H2A, H2B, H3 and H4 (Luger & Richmond, 
1998).  The nucleosome cores are interconnected with the linker histone H1, 
which unlike the core histones has a short residence time of several minutes on 
chromatin (Janicki & Spector, 2003; Talbert & Henikoff, 2010).  Similar to host 
chromatin, DNA viruses and RNA retroviruses replicate by employing cellular 
histones, or they encode their own DNA-binding and organizing proteins 
(Lieberman, 2008; Paulus, Nitzsche, & Nevels, 2010; Puntener & Greber, 
2009).  They assemble and maintain their genomes in different chromatin states 
by packaging the nucleic acids into proteinaceous capsids and sometimes lipid 
envelopes, and thereby traffic their genome within and transmit it between cells 
(Burckhardt & Greber, 2009; Mothes, Sherer, Jin, & Zhong, 2010).  DNA of the 
oncogenic human adenovirus type 12 (HAdV12, short Ad12) was found to be 
integrated into host DNA and packaged around nucleosomes of transformed 
hamster cells, and was epigenetically silenced by DNA methylation and histone 
H3 and H4 hypo-acetylation in phenotypically reverted cells highlighting the high 
degree of viral genome plasticity in the nucleus (Hochstein, Muiznieks, Mangel, 
Brondke, & Doerfler, 2007).   
 
Intracellular viral genome dynamics is essential for infection.  Viruses that 
replicate in the nucleus are thought to release their genomes in isotropically, 
that is in continuous processes as individual assemblies of nucleic acids and 
proteins.  Herpesviruses, for example, package their DNA-genome into an 
icosahedral capsid in the nucleoplasm and release it by a budding process 
across the inner and outer nuclear membranes (reviewed in Mettenleiter, Klupp, 
& Granzow, 2009).  Retroviruses, such as immunodeficiency virus, negative 
sense RNA-viruses, such as influenza virus, or autonomous parvoviruses use 
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the nuclear export machineries of the cell to transport their replicated genomes 
from the nucleus to the cytoplasm as continuous processes (Boulo, Akarsu, 
Ruigrok, & Baudin, 2007; Cullen, 2003; Engelsma, et al., 2008).  
 
Adenoviruses replicate and assemble particles in the nucleus, and they are well 
known to lyse cultured and primary cells (Berk, 2007).  Adenoviruses encode 
their own histone-like proteins to condense a linear double-strand DNA genome 
of about 36 kbp into a proteinaceous DNA-core.  Although it is unknown how 
the viral DNA is precisely organised in the virion, isolated cores of species C 
human adenovirus serotypes 2 or 5 (HAdV2/5, short Ad2/5) contain five viral 
proteins, the basic proteins V, VII and X (pV, pVII, pX), the terminal protein 
covalently attached to the 5‟ ends of the DNA, and a small number of protein 
IVa2 and L3/p23 protease, which are involved in DNA encapsidation and 
transcriptional regulation, or virion processing (reviewed in Berk, 2007; Russell, 
2009).  Proteins V, VII and X are tightly interconnected as indicated by chemical 
cross-linking experiments (Chatterjee, Vayda, & Flint, 1985).  Digestion of virion 
cores with staphylococcal nuclease combined with electron microscopy (EM) 
analyses and stoichiometric calculations suggested a model where the viral 
DNA is organised into approximately 180 nucleosome-like units by three 
subunits of dimeric pVII interspersed with one copy of pV (Black & Center, 
1979; Chatterjee, Vayda, & Flint, 1986b; Corden, Engelking, & Pearson, 1976; 
Mirza & Weber, 1982; Sung, Cao, Coleman, & Budelier, 1983; Vayda, Rogers, 
& Flint, 1983).  This model predicts 1080 copies of pVII and 180 copies of pV, 
which is 10-20% higher than the experimentally determined amounts of pVII 
and pV in isolated virion DNA (Lehmberg, et al., 1999; van Oostrum & Burnett, 
1985), suggesting that there are stretches in the viral genome lacking pVII and 
pV.  pV not only binds the viral DNA in a sequence independent manner, it also 
bridges the DNA-core and the capsid by interacting with pVI on the inner side of 
the major capsid protein hexon (Chatterjee, et al., 1985; Lindert, Silvestry, 
Mullen, Nemerow, & Stewart, 2009; Matthews & Russell, 1998; Perez-Berna, et 
al., 2009; Saban, Silvestry, Nemerow, & Stewart, 2006).  Interestingly, a pV-
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deleted Ad5 gave rise to low levels of viral particles, suggesting that pV was 
involved in the assembly of infectious virions (Ugai, Borovjagin, Le, Wang, & 
Curiel, 2007).  Mutations in the gene encoding the precursor of pX could 
compensate for the lack of pV suggesting redundancy for core organisation by 
molecular adaptation.  This is also supported by the notion that pV is specific for 
Mastadenoviruses, which exclusively infect mammals 
(http://www.vmri.hu/~harrach/ADENOSEQ.HTM).    
 
Viral infection starts with entry, which delivers subviral particles to the cytosol.  
Invariably, the condensed viral genomes have to be uncoated for infection to 
proceed (Greber, Singh, & Helenius, 1994).  The uncoating process of Ad2/5 
starts at the plasma membrane, when virion fibers bind their primary receptor, 
the coxsackievirus Ad receptor CAR, and alpha v integrin coreceptors bind to 
penton base, which anchors fiber to the capsid (Bergelson, et al., 1997; 
Burckhardt & Greber, 2009; Meier & Greber, 2003; Wickham, Mathias, 
Cheresh, & Nemerow, 1993).  Ad2/5 release their fibers prior to or during 
endocytosis (Greber, Willetts, Webster, & Helenius, 1993; Nakano, Boucke, 
Suomalainen, Stidwill, & Greber, 2000).  An early step of Ad2/5 uncoating is 
sensitive to defensins, which bind virions and preclude viral escape from 
endosomes to the cytosol (Nguyen, Nemerow, & Smith, 2010), phenotypically 
mimicking the fate of the uncoating and escape-defective Ad2 mutant Ad2-ts1 
(Gastaldelli, et al., 2008; Imelli, Ruzsics, Puntener, Gastaldelli, & Greber, 2009).  
The cytosolic Ad2/5 capsids traffic on microtubules to the nuclear pore complex 
(NPC), where they bind to the CAN/Nup214 receptor, and release their genome 
into the nucleus (Greber & Way, 2006).  This process is sensitive to the 
macrolide antibiotic leptomycin B (LMB), which inhibits nuclear protein export 
and prevents the attachment of incoming virions to the nuclear pore complex 
(Strunze, Trotman, Boucke, & Greber, 2005).  The precise composition of the 
imported DNA is unknown (reviewed in Puntener & Greber, 2009).  It is known, 
however, that pVII remains with the incoming viral genome in the nucleus during 
the early infection phase (Walkiewicz, Morral, & Engel, 2009; Xue, Johnson, 
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Ornelles, Lieberman, & Engel, 2005).  pVII together with pV then assembles 
newly synthesised viral DNA into core structures that are packaged into virions 
and released upon nuclear disintegration (reviewed in Berk, 2007).  
 
 
Results 
 
Genetic construction and reconstitution of Ad2-GFP-pV 
We generated recombinant Ad2 genomic DNA with an N-terminally eGFP-
tagged core protein V (GFP-pV) using exposon mutagenesis of Ad2_BAC53 
(Fig. 1A, B).  The resulting bacterial artificial chromosome (BAC) DNA had the 
expected in silico predicted restriction fragments and correct sequence between 
GFP and pV (Fig. 1C, not shown).  Linearised BAC_Ad2-GFP-pV DNA was 
transfected into HER-911 cells, and infectious particles were serially expanded 
in A549 cells through about 5 passages, and purified by double CsCl density 
gradient as described (Greber, et al., 1993).  XhoI restriction enzyme digests of 
DNA from these particles yielded the expected fragments (Fig. 1B).  This 
suggested that Ad2-GFP-pV was stable for at least 5 passages.  At passages 
higher than 10, loss of GFP-pV expression by Ad2-GFP-pV was, however, 
observed and this coincided with genetic alterations in the pV locus (not 
shown). 
 
Ad2-GFP-pV particles contain GFP-pV and are infectious 
We next analysed the protein composition of CsCl-gradient purified Ad2-GFP-
pV.  SDS-PAGE and Coomassie blue analyses indicated that Ad2-GFP-pV had 
a protein band of about 75 kDa, which was absent in Ad2, and lacked a 
prominent band at about 48 kDa (Fig. 2A).  Both of these bands were 
immunostained by an anti-pV antibody in Western blots, but only the 75 kDa 
band of Ad2-GFP-pV also reacted with an anti-GFP antibody (Fig. 2B).  This 
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corresponded well with the calculated mass for this fusion protein, which is 
70.409 kDa (Fig. 2C).  The other major structural proteins of Ad2-GFP-pV and 
Ad2 were normal in SDS-PAGE (Fig. 2A).  The relative abundance of the viral 
structural proteins was estimated by densitometry using Coomassie blue 
stained protein II (hexon, pI = 5.1) as an internal reference and bovine serum 
albumin (BSA, pI = 5.8, http://expasy.org/tools/) as a calibration standard (Fig. 
2C, D).  Each virion contains 720 copies of hexon, as indicated by structural 
and metabolic labeling analyses (Stewart, Fuller, & Burnett, 1993; van Oostrum 
& Burnett, 1985).  The copy numbers of pVII and pV had been estimated by 
biochemical assays or reversed phase high performance liquid chromatography 
to be 833 +/- 33 or 633 +/- 59 for pVII, and 157 +/- 1 or 170 +/- 15 for pV, 
respectively (Lehmberg, et al., 1999; van Oostrum & Burnett, 1985).  Our 
Coomassie blue analyses found 63 +/-5 copies of pIII (penton base, pI = 5.3, 
expected copy number 60), and 316 +/- 92 copies of pVI (pI = 9.6, expected 
copy number 360) per virion, which agrees well with the expected values.  The 
basic proteins pV (pI = 10.3) and pVII (pI = 12.3, expected copy number 833) 
were overestimated by a factor of 1.5 and 3.3, respectively, compared to 
metabolic labeling (van Oostrum & Burnett, 1985).  This was expected from the 
fact that Coomassie blue attaches better to highly positively charged proteins 
than to neutral proteins (Tal, Silberstein, & Nusser, 1985).  Coomassie blue 
analyses indicated 38 +/- 6 copies of GFP-pV (pI = 9.5) per virion, which is 
about 25% of the pV levels in Ad2.  Importantly, both GFP-pV and Ad2 pV 
segregated with the viral DNA core in pyridine-disrupted virions fractionated in 
sucrose density gradients, although we noticed some proteolysis in both of the 
pelleted core fractions (Fig. 2E, F).   
 
Since pV links the viral DNA to the inside wall of the capsid (Matthews & 
Russell, 1998), we measured the thermostability of Ad2-GFP-V particles by 
spectrofluorometric measurements of the binding of the DNA-interchalating dye 
TOTO-3 to isolated virions (Fig. 2G).  TOTO-3 binding to both Ad2-GFP-pV and 
Ad2 was constant in the range of 25° to 47°C, and sharply increased from 47 to 
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51°C where it reached a plateau at about 60°C.  However, about 10-15% of the 
Ad2-GFP-pV particles bound the dye, indictive of defective particles, which 
could in part explain that 15-20% of the Ad2-GFP-pV particles bound to cells 
but did not endocytose (see Fig. 4A).  
 
Ad2-GFP-pV enters cells but is attenuated at particle production 
To track the incoming GFP-pV, we isolated Ad2-GFP-pV particles and labeled 
the capsids with the fluorophore Atto647 according to previously established 
protocols (Suomalainen, et al., 1999).  The Atto647 dye was found to be 
specifically incorporated into the major capid protein hexon, as indicated by 
fluorography of SDS-PAGE fractionated virions (Fig. 3A).  Purified Ad2-GFP-pV 
virions labeled with red Atto fluorophores retained their full infectivity compared 
to the non-labeled virions (not shown).  Both, Atto-647-Ad2-GFP-pV and Ad2 
were monodisperse as shown by negative-stain EM (Fig. 3B).  Dual color 
fluorescence microscopy indicated that most of the Atto-647-Ad2-GFP-pV 
particles were positive for both colors (Fig. 3C, arrows) with Gaussian 
distributions for both colors, indicating the presence of a single species of dual-
colored particles (Fig. 3D).  Importantly, non-labeled Ad2 or Ad2-GFP-pV gave 
no signals in the red and green, or red channels, respectively, indicating 
specificity of detection (Fig. S1A, B).   
 
Entry of Ad2-GFP-pV particles into HeLa-ATCC cells was analysed by 
transmission EM.  Viral particle counts at the plasma membrane, endosomes 
and the cytosol indicated that Ad2-GFP-pV endocytosis occurred with similar 
kinetics as wild type Ad2, although 15-20% of the Ad2-GFP-pV particles were 
not endocytosis-competent (Fig. 4A).  At 90 min pi, about 50% of the Ad2-GFP-
pV particles were in the cytosol, 30% in endosomes and 20% at the plasma 
membrane.  Endosomal escape of Ad2-GFP-pV was confirmed by fluid phase 
marker dextran-FITC (10 kDa) uptake showing that Ad2-GFP-pV infection not 
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only triggered dextran uptake but also release to the cytosol and the 
nucleoplasm, similar to Ad2 (Suppl. Fig. 1, Meier, et al., 2002).  
 
Ad2-GFP-pV was delayed at expressing the immediate early transactivator E1A 
compared to Ad2 (Fig. 4B).  This was more pronounced at 12 h than 20 h pi or 
at low moi than high moi, suggesting that Ad2-GFP-pV could compensate the 
defect with time and increased particle numbers, consistent with the notion that 
Ad2-GFP-pV had a lower infectious particle to particle ratio than Ad2.  In lung 
epithelial A549 cells, Ad2-GFP-pV gave 10 to 100-fold lower yields of cell-
associated infectious viruses compared to Ad2, although the amounts of cell-
free infectious units were similar to Ad2 at 72 h pi (Fig. 4C), again suggesting 
that Ad2-GFP-pV compensates a growth defect with time.  These results were 
confirmed by measurements of tissue culture infectious dose 50 (TCID50) and 
fluorescent focus forming units (fffu) (Fig. 4D).   We speculate that Ad2-GFP-pV 
is slightly impaired at particle assembly, and perhaps at a step between 
endosomal escape and expression of the immediate early transactivator E1A.  
Despite the lower overall yields, Ad2-GFP-pV clusters of several hundred 
particles and also single Ad2-GFP-pV were readily detected by transmission 
EM in the nucleus and the cytoplasm 37 h pi, similar to Ad2 (Fig. 4E).  In 
addition, these infected cells had crystalline inclusions both in the nuclei and 
cytoplasm, identical with Ad5 protein inclusions (Franqueville, et al., 2008).  In 
addition, both newly synthesised GFP-pV and pV were found in similar 
subnuclear structures, devoid of the viral DNA binding protein (DBP) (Fig. S3A), 
as indicated by a pV specific antibody (Fig. S3B, C).   
 
Lytic egress of Ad2-GFP-pV from infected cells 
We employed live cell fluorescence microscopy to analyze the subcellular 
localization of GFP-pV.  Projected z-stacks from HeLa cells infected with Ad2-
GFP-pV at moi 0.2 confirmed that newly synthesised GFP-pV accumulated in 
histone H2B-mCherry positive nuclei and nucleoli 30 h pi (Fig. 5A, B, and Suppl. 
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Mov. 1 and 2).  The cells stably expressed H2B-mCherry and grew normally, 
similar to H2B-GFP cells (not shown, Kanda, Sullivan, & Wahl, 1998).  At 30 to 
39 h pi, the localization of GFP-pV changed, initially by the increase of a diffuse 
GFP-pV signal in the cytosol, and then by GFP-pV clusters that were expelled 
from the nuclei (Fig. 5A, B, Suppl. Mov. 1 and 2).  These clusters often 
contained H2B-cherry, and some H2B-cherry remained in the nuclei, suggesting 
that release of GFP-pV was not necessarily accompanied by complete nuclear 
disintegration (Fig. 5A).  EM-analyses of infected HeLa cells at 35 h pi revealed 
clustered Ad2-GFP-pV particles in the cytoplasm (Fig. 4E), suggesting that the 
cytoplasmic GFP-pV patches were composed of newly synthesized viral 
particles.  We found no evidence for H2B-mCherry in purified Ad2 by Western 
blots (Fig. S4).  In addition to partial nuclear disintegration, we also found 
completely disintegrated H2B-mCherry nuclei disappearing from the infected 
cells along with the GFP-pV structures (Fig. 5B).  This represented lysis of the 
nuclear membrane and the plasma membrane.  Quantitative analyses from 8 
different movies recorded between 30 and 45 h pi indicated that 5.5% of the 
Ad2-GFP-pV infected nuclei either partially or completely disintegrated (Fig. 
5C).   This amount of cell lysis was in agreement with the 50-fold higher levels 
of cell-associated Ad2-GFP-pV compared to extracellular viruses 48 h pi (see 
Fig. 4D).  Together the data show that adenovirus induced cell lysis is 
nonisotropic, and releases large clusters of several hundred virions to the 
cytoplasm and extracellular medium.   
 
GFP-pV dissociates from Ad2-GFP-pV particles during entry 
We next analyzed entry of Ad2-GFP-pV and the major core protein pVII into 
cells by confocal microscopy in live and fixed cells.  Spinning disc confocal 
microscopy indicated progressive attachment of dual-color Atto565-labeled 
Ad2-GFP-pV to the periphery of HER-911 cells (Fig. S5, and Suppl. Mov. 3).  
The number and average intensity of solitary Atto647-labeled capsid puncta 
remained approximately constant from 0 min (cold-binding of virions) until 240 
min pi indicating that incoming virions were neither degraded in nor released 
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from the cells, consistent with earlier findings (Fig. 6A, B, Greber, Webster, 
Weber, & Helenius, 1996; Trotman, Mosberger, Fornerod, Stidwill, & Greber, 
2001).   
 
 
In contrast, the GFP-pV fluorescence of Atto647-labeled virion capsids rapidly 
dropped to about 35% of the original value at 30 min pi, and to almost 
background levels at 90 min pi (Fig. 6B, C).   Individual GFP-pV puncta distinct 
from capsids were occasionally found at 30 min pi but not at 0 min pi, 
suggesting that GFP-pV separated from capsids during cell-binding, 
endocytosis or escape from endosomes.  The cytoplasmic GFP-pV puncta were 
not stained with an anti-pVII antibody (Fig. 6A), although this antibody detected 
a small percentage of cell-bound Ad2-GFP-pV at 0 min pi (Fig. 6D), suggesting 
that these surface-bound capsids, but not the intracellular GFP-pV puncta 
contained viral DNA.  We speculate that the pVII-positive particles at 0 min pi 
(Fig. 6A) belong to the 10-15% DNA-dye positive Ad2-GFP-pV particles 
detected in the virus inoculum (Fig. 2G).  The pVII-positive particles were faintly 
positive for GFP-pV at 0 min but not 30 min pi, suggesting that GFP-pV 
disappeared from the broken particles (Fig. 6E).   
 
In addition, we noticed that the average pVII fluorescence on the Atto647-
capsids steadily decreased from 0 to 240 min pi, and the number of pVII-
positive Atto647-capsids increased to about 11% at 90 min and decreased 
again after 150 min pi (Fig. 6D).  Many of the strongly pVII-positive particles at 
the late time points were in the nuclear area, together with a significant number 
of pVII puncta lacking Atto-647 (Fig. 6A).  Since incoming pVII but not capsids 
are delivered into the nucleus 1 to 3 h pi (Greber, et al., 1997; Strunze, et al., 
2005; Xue, et al., 2005), and pVII is released from the viral DNA in the nucleus 
by ongoing transcription (Chen, Morral, & Engel, 2007), our data suggest that 
the nuclear pVII puncta represent infectious incoming genomes, in agreement 
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with recent analyses (Walkiewicz, et al., 2009).  Remarkably, we did not find 
GFP-pV on pVII-positive puncta in the nucleus, suggesting that it dissociated 
prior to or during nuclear import of the viral genomes (Le, et al., 2006). 
 
A fraction of GFP-pV dissociates from the incoming virus particles 
depending on leptomycin B 
Single particle analyses indicated that GFP-pV dissociated from incoming Ad2-
Atto647 in two steps, a rapid phase from 0 to 30 min and a slower phase 30 to 
90 min pi (Fig. 6).  The timing of the slower phase coincides with virus transport 
on microtubules to the nucleus (Suomalainen, et al., 1999).  To address the 
nature of the second dissociation phase of GFP-pV from Ad2, we treated HER-
911 cells with the nuclear export inhibitor LMB.  LMB confines the incoming 
Ad2/5 particles to the cytosol or blocks them at the microtubule-organizing 
center depending on the cell type, and prevents Ad2/5 attachment to the 
nuclear pore complex, and nuclear import of pVII (Strunze, et al., 2005).  
Ratiometric analyses of GFP-pV / Atto647 fluorescence in image stacks 
recorded by automated fluorescence microscopy at constant illumination and 
with chromatic aberrations corrections (see Fig. S6) indicated that the ratio of 
GFP-pV to Atto647 was 0.105 at 30 min pi, and dropped to 0.085 at 150 min pi, 
close to background levels (Fig. 7A, B).  At 0 min pi it was approximately 0.2 
(see also Fig 5C).  These numbers closely matched the ratios of GFP-pV to 
Atto647 determined by single slice confocal microscopy (see Fig. 6C, insert). 
 
The data suggest that the second step of GFP-pV loss occurs at the nuclear 
pore complex.  Although the GFP-pV / Atto647 ratio at 30 min pi was slightly 
increased in LMB-treated cells, the drug did not inhibit the first phase of GFP-pV 
release (not shown).  The detection of double positive Atto647-Ad2-GFP-pV 
particles in the cytosol and at the POM121-mCherry-labeled nuclear pore 
complexes corroborated this notion (Fig. S7,  Dultz, et al., 2008).  These results 
imply that the early detachment of GFP-pV occurred before or shortly after virus 
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penetration into the cytosol, while the second step occurred at the nuclear 
membrane, suggesting that GFP-pV is not organized homogeneously in the 
viral particle.   
 
 
Discussion 
 
Imaging of subcellular localizations of viral DNA, RNA, proteins or particles at 
high resolution has greatly advanced concepts in molecular virology and cell 
biology.  It has been significantly enhanced by labeling of viruses with chemical 
fluorophores or fluorescent proteins (reviewed in, Brandenburg & Zhuang, 2007; 
Burckhardt & Greber, 2009; Greber & Way, 2006).   For adenoviruses, GFP had 
been fused to the capsid-stabilizing protein pIX (240 copies per virion, San 
Martin & Burnett, 2003), and purified virions were observed at the plasma 
membrane and the cytoplasm (Meulenbroek, Sargent, Lunde, Jasmin, & Parks, 
2004).  In addition, an adenovirus encoding pV-GFP, pre-pVII-GFP and a dual 
color Ad5 with pIX-RFP and pV-GFP were also reported (Le, et al., 2006; Ugai, 
et al., 2010).  The utility of these viruses was, however, limited.  Both pre-pVII-
GFP and pV-GFP were expressed from an artificial promoter in the deleted E3 
region of the genome, while endogenous pre-pVII and pV were also expressed, 
which resulted in low incorporation of pV-GFP in virus particles (Ugai, et al., 
2010).  In addition, the pV-GFP expressing Ad5 contained significant amounts 
of disrupted virions (Le, et al., 2006).  The pIX-RFP / pV-GFP labeled virions on 
the other hand were heterogeneous with respect to green and red fluorescence, 
and it remained unknown how these viruses enter or exit cells.   
 
Using a combination of live cell and quantitative fluorescence imaging of a 
DNA-core protein in the context of a complete viral genome, we visualize for the 
first time the dynamics of viral release from the nucleus at late times of the 
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adenoviral live cycle.  Unexpectedly, we find that infected cells release clusters 
of Ad2-GFP-pV virions from the nuclei, indicating that lytic virus release is 
nonisotropic.  This feature is reminiscent of a reverse process of Ostwald 
ripening observed in inorganic systems and macromolecule crystals, such as 
tabacco mosaic virus, where the minimization of total interfacial energy drives 
crystal growth from precipitate clusters of various sizes  (Malkin & McPherson, 
1993; Voorhees, 1992).  Virus clusters from crystal-like assemblies in the cell 
nucleus are new feature for cell-free spreading of viruses, and extend the 
concept of viral spreading through aqueous medium.  We suggest that 
extracellular virus clusters can not only adhere to noninfected cells by 
cumulative low affinity interactions, but these cells are then subject to high 
multiplicity infection, which proceeds faster than low multiplicity infections, since 
single viruses do not activate quiescent cells as efficiently as a cohort of viruses 
does.  In addition, viruses within such clusters might be protected from stress or 
cellular inactivation.  
 
Remarkably, before virus clusters were found to be released, a homogenous 
GFP-pV signal increased in the cytoplasm, suggesting that the nuclear 
membrane is leaky for small molecules, such as GFP-pV.  The subsequent 
release of Ad2/5 from the nucleus likely involves the adenovirus death protein 
(ADP, 11.6 kD protein) (Wold, Tollefson, & Hermiston, 1995), and lamin 
proteolysis (Chiou & White, 1998).  We speculate that a driving force in the 
nucleus expells virus clusters by osmotic pressure from protein and nucleic acid 
polymers that are built up during viral replication.   
 
Interestingly, the virus clusters frequently remained associated with the 
cytoplasm, before they were displaced to the medium, which suggests 
disruption of the plasma membrane.  The latter may be a consequence of 
nuclear disruption, which releases the viral protease L3/p23 to the cytosol, and 
thereby could enhance degradation of the cytoskeleton.  L3/p23 cleaves 
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cytokeratin K18, microtubules and actin, and makes the infected cell more 
susceptible to mechanical stress (reviewed in, Greber, 1998; Mangel, Baniecki, 
& McGrath, 2003).  Precisely how the plasma membrane is disrupted and the 
newly synthesized virus clusters are released from the cell can now be 
analysed with the cell-lytic Ad2-GFP-pV.  We anticipate, however, that the virus 
clusters can be controlled in size and shape by cellular or viral factors, and that 
isotropic release of single viruses from cell-tethered clusters will give rise to 
infection along the conventional single particle entry pathway.  
 
Our detailed entry studies of Ad2-GFP-pV revealed two new steps of virus 
uncoating.  First, we showed that a large fraction of GFP-pV is lost from the 
particles at 30 min pi, when the majority of endocytosis-competent Ad2-GFP-pV 
has arrived in the cytosol.  We suggest that this early loss of GFP-pV coincides 
with structural changes of the capsid, such as the loss of fibers and pentons, or 
capsid-stabilizing proteins IIIa and VIII (Fabry, et al., 2005; Greber, et al., 1993; 
Nakano, et al., 2000; Saban, et al., 2006).  These disassembly steps occur in 
most of the entry-competent virions (Greber, et al., 1993), and are manifested 
also by the exposure of pVI epitopes on viral particles early in infection 
(Wodrich, et al., 2010).  Biochemical experiments and crosslinking studies have 
suggested that pV attaches the viral DNA to the capsid possibly via pVI 
(Chatterjee, et al., 1985; Matthews & Russell, 1998).  pVI has recently been 
assigned to hexon cavities inside the capsid (Perez-Berna, et al., 2009; 
Silvestry, et al., 2009), but it remains unknown, precisely how the 360 copies of 
pVI are arranged within the capsid.  Intriguingly, unassigned structures around 
the 5-fold symmetry of the vertices projecting towards the DNA-core have been 
detected in cryo-EM studies, and these structures have been tentatively 
assigned to pVI (Fabry, et al., 2005; Stewart, et al., 1993).  Since dimers of pVI 
bind pV in biochemical assays, it is possible that pV acts as a DNA-organizer 
near the vertices.  pV could be released when penton base or fibers detach 
from the capsid, either together or separately from pVI and penton base.   
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The second novel step for adenovirus uncoating identified here was that about 
30% of GFP-pV dissociates from the cytoplasmic particles and this was 
inhibited by LMB.  LMB blocks the attachment of incoming Ad2/5 to the nuclear 
pore complex and inhibits capsid disintegration (Strunze, et al., 2005), 
consistent with a key role of the nuclear pore complex in the final step of capsid 
disassembly (Trotman, et al., 2001).  This suggests that, in addition to linking 
the viral DNA to the capsid, pV functions in core assembly and organisation, in 
close contact with the virion DNA, as supported by UV-crosslinking and 
fractionation studies (Brown, Westphal, Burlingham, Winterhoff, & Doerfler, 
1975; Chatterjee, Vayda, & Flint, 1986c; Everitt, Sundquist, Pettersson, & 
Philipson, 1973).   
 
Remarkably, the pVII-positive DNA-cores inside the nucleus do not contain 
GFP-pV or wild type pV (Hindley, Lawrence, & Matthews, 2007; Le, et al., 
2006).  The absence of pV or GFP-pV on these cores has been underlined by 
earlier studies, showing that the viral DNA and pVII alone can be a template for 
replication and transcription without pV (Chatterjee, Vayda, & Flint, 1986a; 
Haruki, Okuwaki, Miyagishi, Taira, & Nagata, 2006; Xue, et al., 2005).  Possibly, 
post-translational modifications of the viral core proteins pV and pVII, including 
ADP-ribosylation, phosphorylation or acetylation facilitate a relaxation of the 
core, and thereby aid the detachment of DNA from the capsid (Dery, et al., 
1986; Fedor & Daniell, 1980; Weber & Khittoo, 1983).  In summary, Ad2-GFP-
pV provides evidence for a role of virus clusters in aqueous transmission of 
virus infections, and may in the future give insights into viral spreading 
dynamics in organisms in disease and therapy. 
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Experimental procedures 
 
Construction of Ad2-GFP-pV  
Ad2_BAC53 is derived from Ad2 reference strain "adenoid 6" (Imelli, et al., 
2009).  The Ad2-GFP-pV insertion mutant was obtained using exposon 
mutagenesis as described (Ruzsics, et al., 2006).  Briefly, in the first step a 
mini-Tn cassette (transprimer-1) was amplified from pGPS1.1 and inserted by 
ET recombination into BAC53 containing the full length wild type genome of 
Ad2 (Imelli, et al., 2009).  Synthetic oligonucleotide primers for insertion of 
Transprimer-1 contained at their 5‟ end homologies to position 16491-16538 
(upstream) and 16539-16586 (downstream) relative to the adenoviral genome.  
The priming sequences for the transprimer-1 cassette of pGPS1.1 were as 
published (Ruzsics, et al., 2006).  Successful insertion of transprimer-1 was 
examined by restriction analysis and partial sequencing of the insertion sites.  
To replace the transprimer-1 element with eGFP coding sequences 
recombinant BAC-DNA was amplified from two independent clones and 
transprimer-1 sequences were excised in vitro using TnsABC* (New England 
Biolabs) in the presence of the acceptor plasmid pST76T.  The insertion 
fragment containing the ORF of eGFP was obtained as follows.  The eGFP 
gene including a small linker portion was PCR amplified from pEGFP-C1 
(Clontech). Priming regions were designed such that the fragment contained 
position 613-1380 of the plasmid.  The 5‟ extensions contain the recognition site 
for SapI, one random base plus 3 bases identical to the upstream or 
downstream region of the insertion site.  Primer sequences were as follows: 
upstream primer (5‟-GTC AGC TCT TCC GCT ATG GTG AGC AAG GGC 
GAG-3‟), downstream primer (5‟-CAA GGC TCT TCT CAT GGT ACC GTC 
GAC TGC AGA ATT C-3‟).  The SapI excised insertion fragment was ligated 
into the TnsABC* linearised BAC and the recombinants were recovered by 
transformation into competent bacteria.  Successful replacement was confirmed 
by restriction analysis and partial sequencing of the insertion sites.  Four 
independent colonies were chosen and amplified for reconstitution of virus by 
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calcium phosphate transfection of 80% confluent HER-911 cells in a 10 cm cell 
culture dish with 10 µg SnaBI linearised BAC DNA.  48 h post-transfection cells 
were split 1 to 4, and viruses harvested from cells and supernatant at onset of 
cytopathic effects (passage 1, p1), serially passaged in four 10 cm dishes of 
A549 cells (p2), and then in twenty 10 cm dishes (p3), followed by virus 
purification from cells.  The supernatants were used for further amplification 
rounds until p7.  Viruses from passages lower than 8 had normal DNA patterns 
of restriction enzyme digests.  
 
Supplemental data describe the details of cell culture, transfections, antibodies, 
Western blots and protein determinations, virus purifications and quantifications, 
one step growth curves, preparation of pyridine cores, thermostability assays.  
Similarly, single particle fluorescence analyses, live-cell microscopy, kinetics of 
GFP-pV release from Atto-647-Ad2 and EM analyses are described in 
supplemental data.  
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Figure Legends 
 
Fig. 1: Construction of Ad2-GFP-pV 
A. Schematic overview of the pV and pVII loci of Ad2 (left) and Ad2-GFP-pV 
(right) with boxed open reading frames for pVII and pV, and nucleotide numbers 
of the starting and terminating nucleotides. 
B. XhoI restriction enzyme analysis of genomic DNA isolated from purified Ad2 
and Ad2 GFP-pV with an in silico predicted restriction pattern (right) and 
molecular weight markers (M) in kbp.  
C. DNA sequence analysis and derived amino acid sequence at the GFP-pV 
junction from Ad2-GFP-pV virion DNA with nucleotide numbers. 
 
Fig. 2: Biochemical characterization of Ad2-GFP-pV 
A. 12% SDS-PAGE stained with Coomassie brilliant blue, including protein 
marker (M) with relative mass in kDa.  Roman numbers denote viral structural 
proteins.   
B. Anti-pV (left panel) or anti-GFP (right panel) stained Western blot of purified 
Ad2 and Ad2-GFP-pV, including recombinant GFP with a nuclear export 
sequence (NES). 
C. Estimation of copy numbers of viral structural proteins by densitometric 
analysis of Coomassie blue stained SDS-PAGE.  The table shows calculated 
molecular weight (MW in Dalton) values for indicated proteins, the isoelectric 
point (pI), the copy numbers based on the virus structure (Zubieta, Schoehn, 
Chroboczek, & Cusack, 2005), the copy numbers estimated by metabolic 
labeling (van Oostrum & Burnett, 1985), the measured optical density (OD), the 
amount of protein based on the BSA standard curve (panel D, linear regression 
value R2 0.9924) and the estimated copy numbers.   
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E, F. Sucrose density gradient-fractionated pyridine-extracted Ad2 or Ad2-GFP-
pV, including a pellet (loaded as pellet plus fractions fr 13+14), molecular weight 
markers (M) and input sample.  Gels were stained with Coomassie blue (left), or 
Western blotted against pV (right).  Note that both intact and partially degraded 
pV and GFP-pV fractionate with the core protein pVII.  
G. Purified Ad2 (open bars) and Ad2-GFP-pV (black bars) were heated in the 
presence of the DNA-intercalating dye TOTO-3 and fluorescence of the DNA-
bound dye analyzed by the Tecan SAFIRE II microplate reader at 642 ± 8 nm 
excitation and 660 ± 9 nm emission.  One from three typical independent 
experiments is shown. 
 
Fig. 3: Capsid labeled Ad2-GFP-pV particles contain GFP-pV 
A. Fluorogram of Atto647-Ad2-GFP-pV separated by 12% SDS-PAGE and 
excited by by 633 nm light.  Positions of pII (hexon), pIII and pVI are indicated.   
B. Transmission-EM analysis of negatively stained Ad2 (left) and Ad2-GFP-pV 
show monodispersed intact particles. 
C. Fluorescence analysis of Atto647-Ad2-GFP-pV at 96-well clear bottom 
imaging plates by ImageXpress Micro microscope using 600-640 nm (Atto647 
channel, top left) and 450-480 nm excitation (GFP channel, top right), including 
merged pseudo-colored images (lower left).  The particles scored by Matlab 
routine are shown in green and the size-threshold rejected background puncta 
in red.  Arrows indicate examples of double labeled particles, and arrow heads 
single labeled Atto647-particles. 
D. Frequency profiles of Ad2-GFP-pV fluorescence showing Atto647 (top), GFP 
(middle) and merged ratiometric colors (bottom), including background 
thresholds (blue lines). 
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Fig. 4: Growth of Ad2-GFP-pV 
A. Quantitative EM analysis of Ad2 and Ad2-GFP-pV entry into HeLa-ATCC 
cells, scoring virus particles at the plasma membrane (left), endosomes (middle) 
and the cytosol (right).  Green: Ad2-GFP-pV, light brown: Ad2.  Note that 15-
20% of the Ad2-GFP-pV particles are not internalized.  Data points show the 
means of indicated cells, including SEM. 
B. E1A expression analyses by immunofluorescence of Ad2 or Ad2-GFP-pV 
infected A549 cells using dilutions of 1 µg virus.  Each point represents the 
mean of three independent measurements including SEM.   
C. Multi-round growth curves of Ad2 and Ad2-GFP-pV in A549 cells infected 
with 5 fluorescent focus forming units (fffu) per cell and fffu titers of cell-
associated or supernatant virus shown at indicated time points as the mean of 
three experiments with corresponding SEM. 
D. End point titers of Ad2 and Ad2-GFP-pV measured as tissue culture 
infectious dose 50 (TCID50) units or fffu in HER-911 cells with SEM from four 
independent experiments.   
E. Transmission EM images of ultrathin 80 nm sections from epon embedded 
HER-911 cells 37 h pi.  The images show clustered and solitary Ad2 (left) or 
Ad2-GFP-pV particles (right) in the nucleus (n) and the cytoplasm (c), and also 
crystalline inclusions (incl) of viral proteins (Franqueville, et al., 2008).  Note that 
the virus particles have different shades of grey depending on whether they are 
partly (grey) or completely (dark) included in the section.  
 
Fig. 5: Live cell analyses of GFP-pV dynamics and lytic egress of Ad2-
GFP-pV from HeLa cells 
A. Live cell confocal fluorescence microscopy of H2B-mCherry cells infected 
with Ad2-GFP-pV at moi 0.2 reveals dispersion of GFP-pV clusters from the 
nucleus to the cytoplasm at 35 to 37 h pi (time stamps min:s).  Merged pseudo-
colored maximum projections for GFP-pV (green) and H2B-mCherry (red), 
including black/white images for each channel at  37 h pi.  The arrow indicates a 
 86 
GFP-pV expressing H2B-mCherry positive nucleus, and arrow heads show 
GFP-pV positive clusters in the cytoplasm.  
B. Lysis of Ad2-GFP-pV infected cell nuclei.  Arrows point to GFP-pV positive 
nuclei.  Note that both the GFP-pV and the H2B-mCherry signals of the two 
upper infected nuclei decreases close to the detection threshold.   
C. Cell lysis events were scored by the disappearance of both GFP-pV and 
H2B-mCherry signals, quantified from eight different movies 24 to 45 h pi.  
 
Fig. 6: Fluorescence microscopy of incoming Ad2-GFP-pV reveals 
progressive loss of GFP-pV from capsids before nuclear import of pVII. 
A. Maximum projections of entire stacks from confocal fluorescence microscopy 
images of Atto647-Ad2-GFP-pV infected HER-911 cells depict progressive 
dissociation of GFP-pV from capsids highlighted in the fourth row with enlarged 
areas of quadruple merged channels and stippled outlines of the nuclei (n) and 
the cytoplasm (c).  Yellow arrows indicate Atto647/GFP-pV double positive 
particles, red arrows Atto647-positive particles, green arrows GFP-pV particles 
and blue arrows Atto647/pVII double positive particles.  Note that the arrows at 
0 min pi denote Atto647 plus pV (yellow) and pVII (blue) signals outside of the 
cell.  The green fluorescent background of the cell, the GFP-pV signal was 
thresholded (see materials and methods), which reduced its apparent intensity.  
The yellow frame in the second column indicates the enlarged area from the 
forth column. 
B. Quantification of the total number of scored particles (light red) and the 
average Atto647 fluorescence per particle (dark red).  
C. Average GFP fluorescence per scored particle (green) and ratio of average 
GFP/Atto647 fluorescence.  The ratio of GFP/Atto647 average fluorescence is 
shown in the inset. 
D. Quantification of pVII positive Atto647-particles (blue), and average 
fluorescence intensity of pVII in Atto647-particles (magenta).  
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E. Average GFP-pV fluorescence of pVII-positive Atto647-particles. 
 
Fig. 7: LMB blocks the late dissociation of incoming GFP-pV from capsids 
A. HER-911 cells on 96-well plates were infected with Atto647-Ad2-GFP-pV and 
analysed by fluorescence imaging for GFP-pV, Atto647-fluorescence and the 
merged pseudocolored images, including the periphery of the nuclei (n) 
determined by DAPI staining and the cytoplasm (c) (white lines, and not 
shown).   
B. GFP-pV quantification of the scored Atto647-particles, including total 
numbers of analyzed viral particles, cells and numbers of experiments (exps), 
error bars with SEM and number of experiments (n), and P-values from two 
tailed T-tests.  
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Legends to supplemental figures 
 
Fig. S1: Imaging of single virus particles by spinning disc confocal 
fluorescence microscopy or MetaXpress automated microscopy 
A. Ad2, Ad2-GFP-V, Atto565-Ad2 or Atto565-Ad2-GFP-pV were attached to 
coverslips, mounted and recorded by spinning disc confocal fluorescence 
microscopy in beamsplitter mode and identical illumination settings.  Left 
column: fluorescence from the GFP channel, right column: fluorescence from 
the Atto565 channel.  Note the absence of crosstalk between the channels.  
B. Ad2, Atto647-Ad2, Ad2-GFP-pV or Atto647-Ad2-GFP-pV were bound to 
empty wells of a 96-well clear bottom plate and recorded with the MetaXpress-
Micro automated microscope.  Upper row shows GFP channel, lower row the 
Atto647 channel.  Note the absence of crosstalk between the channels. 
 
 
Fig. S2: Incoming Ad2-GFP-pV triggers fluid phase uptake similar to Ad2 
A. HeLa-ATCC cells were cold-bound with Ad2 or Ad2-GFP-pV (5 µg/ml), 
washed and incubated at 37°C for 15 min in the presence of the fluid phase 
marker dextran-FITC (0.5 mg/ml), fixed and total cell-associated fluorescence 
was measured by flow cytometry as described (Meier, et al., 2002).  Results are 
expressed as the ratio of fluorescence relative to noninfected cells.  Note that 
the fluorescence of Ad2-GFP-pV was negligible compared to dextran-FITC.   
B. Dextran release from endosomes in Ad2 or Ad2-GFP-pV infected cells (cold-
bound with 5 µg/ml virus and washed) was assessed by measuring the dextran 
fluorescence over the nuclear area of fixed cells.  Cells with significantly 
enhanced nuclear dextran were counted positive.  For Ad2, n = 143 cells, and 
for Ad2-GFP-pV n = 157 cells were analysed.  
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Fig. S3: Newly synthesized GFP-pV from Ad2-GFP-pV has a similar 
subcellular localization as pV from Ad2 
A. Hela-ATCC cells were infected or not infected with Ad2 or Ad2-GFP-pV at 
moi 2 for 20 h, fixed and stained for the viral DNA binding protein (DBP) and the 
nucleus (DAPI), or with an affinity-purified rabbit anti-pV antibody.  Note that 
GFP-pV and pV are both excluded from DBP positive areas.  
B. Purified Ad2 or Ad2-ts1 and cell lysates from Ad2 infected or not infected (not 
inf.) cells were fractionated by 12% SDS-PAGE, blotted and stained with affinity 
purified rabbit anti-pV antibody followed by goat anti-rabbit conjugated horse 
raddish peroxidase staining.  
C. Hela-ATCC cells were infected with Ad2-GFP-pV for 20 h, stained with anti-
pV antibody and Alexa594 goat anti-rabbit (rab594) or only with secondary 
Alexa 594 goat anti-rabbit antibody, and with DAPI.  Note the extensive overlap 
of the GFP-pV signal with the anti-pV antibody stain.  
 
 
Fig. S4: Ad2 isolated from H2B-mCherry expressing cells contains no 
detectable H2B-mCherry 
HeLa cells stably expressing H2B-mCherry or human epithelial A431 cells were 
infected with Ad2 at moi 2 for 3 days.  Virus was purified by CsCl gradient 
centrifugation, fractionated by 12% SDS-PAGE and stained with Coomassie 
blue (upper panel) or Western blotted and immunostained with an anti-mRFP 
antibody (Abcam, 1:1000, lower panel).  Relative molecular weights are in kDa.   
 
 
Fig. S5: Rapid cell binding of Atto565-Ad2-GFP-pV 
A. Attachment of dual color Atto565-Ad2-GFP-pV (0.2 µg/ml) to HER-911 cells 
was monitored by live cell spinning disc confocal microscopy with a beamsplitter 
focusing on the lower parts of the cells.  The left part of each picture shows the 
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GFP channel and the right part the Atto565 channel.  Time stamps are in min 
and s. 
B. The GFP image at 7 min 30 s was pseudo-colored in green and the Atto565 
image in red.  Processed images were merged, and the DIC image from the 
same time point are also shown.  Arrows indicate a couple of dual color puncta.  
 
 
Fig. S6: Schematic representation for the cell-based GFP-pV dissociation 
assay of incoming Ad2-GFP-pV 
A. Image processing procedure.  Image stacks from the GFP, Atto647 and 
DAPI channels were background subtracted, and based on the Atto647 channel 
also aberration corrected individually, merged using maximum intensity 
projection algorithm and analysed for GFP-pV and Atto647 colocalization.  
B. Illustration of the aberration correction procedure.  Multi fluorescent 
Tetraspec beads were bound to the bottom of a 96-well clear bottom plate and 
recorded with the MetaXpress Micro microscope in the GFP and Atto647 
channels.  The mismatch between the Atto647 channel and the GFP channel 
was corrected with a Matlab (MathWorks, Inc. Natick, MA,USA) routine post 
image acquisition, as shown with the GFP-pV/Atto647 merged original picture 
(upper left), and the shift-corrected image (upper right).  Red arrows originate 
from the fixpoint used in the correction routine and define the direction of the 
correction displacement.  The accuracy of the procedure is illustrated by the two 
lower images showing enlarged regions of the boxed areas in the two upper 
images.   
C. Particle identification procedure in representative images taken with the 
MetaXpress Micro microscope of background and aberration corrected 
maximum projections from the Atto647, GFP and DAPI channels 30 min pi in 
the absence of drugs.  The Matlab routine shown in the second panel identifies 
single particulate puncta in the Atto647 channel (green) and rejects 
nonhomogeneous signals (red) according to a size-threshold.  
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Fig. S7: Localisation of double positive Atto647-Ad2-GFP-pV near nuclear 
pore complexes 
POM121-mCherry transfected HER-911 cells were infected with Atto647-Ad2-
GFP-pV and live imaged with spinning disc confocal microscopy with focus near 
the bottom of the nucleus at 60 min pi.  The left panel shows images recoded in 
the Atto647, GFP and cherry channels.  A pseudo-colorized merged image is 
shown in the right panel where red represents Atto647 labeled Ad2, green GFP-
pV and blue POM121-mCherry.   
 
 
Movies S1 and S2: Live cell analyses of GFP-pV dynamics and lytic egress 
of Ad2-GFP-pV from HeLa cells 
Hela cells stably expressing H2B-mCherry were infected with Ad2-GFP-pV at 
moi 0.2 and recorded by live cell confocal fluorescence microscopy from 24 to 
45 h pi at 15 min per frame.  Merged pseudo-colored maximum projections are 
shown with GFP-pV in green, and H2B-mCherry in red.  
Movie S1: Dispersion of GFP-pV positive clusters from the nucleus into a 
confined cytoplasmic region around the nucleus (see cell in the center of the 
movie) 35:45 – 38:30 min pi.  Note that the clusters as well nuclear GFP-pV 
signal disappear almost completely while GFP-pV of neighbouring cells remains 
visible. 
Movie S2: Lysis of Ad2-GFP-pV infected cell nuclei.  Note that both the GFP-pV 
and the H2B-mCherry signals of the two upper infected nuclei decrease to 
background levels.   
 
Movie S3: Rapid cell binding of Atto565-Ad2-GFP-pV and dynamic 
colocalization of GFP-pV with Atto565 labeled capsids 
HER-911 cells were infected with Atto565-Ad2-GFP-pV and live imaged by 
spinning disc confocal fluorescence microscopy in beam splitter mode, allowing 
simultaneous recordings of GFP-pV and Atto565 signals. Total recording time 
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was 15 min at 12 frames per min.  Note that red and green signals were 
simultaneously detected in both channels at similar locations relative to the cell, 
indicating that at the time of cell binding, a large fraction of viral particles were 
double positive for Atto565 and GFP-pV. 
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Supplemental Experimental Procedures 
 
Cells, transfection and antibodies 
HeLa-ATCC and human lung carcinoma A549 cells were purchased from 
American Type Culture Collection, Rockville, MD. Ad5-E1 transfected human 
embryonic retinoblast 911 cells (Fallaux, et al., 1996) were obtained from Dr. S. 
Hemmi (University of Zurich, Switzerland).  HeLa cells stably expressing H2B-
mMCherry were obtained from Dr. Daniel Gerlich, ETH Zurich, prepared 
analogous to the HeLa clone stably expressing H2B-GFP (Kanda, Sullivan, & 
Wahl, 1998).  A431 human epithelial carcinoma cell lysate was purchased from 
BD Transduction Laboratories (Lexington, KY, USA).  Cells were grown as 
monolayers in Dulbecco‟s modified Eagle medium (DMEM) supplemented with 
10% fetal bovine serum (GIBCO-BRL) on alcian blue-coated glass coverslips 
(Suomalainen, et al., 1999) or cell culture dishes.  Plasmid POM121-mCherry 
(obtained from Dr. Daniel Gerlich, ETH Zurich) was transfected into 50% 
confluent cells using FuGENE 6 (Roche, Indianapolis, IN) according to the 
manufacture‟s protocol.  Mouse anti-GFP was purchased from Roche (Roche 
Diagnostics (Schweiz) AG, Rotkreuz, Switzerland). Rabbit anti-protein V serum 
was obtained from W.C. Russell (University of St Andrews, UK, Matthews & 
Russell, 1998) and rabbit anti-protein VII antibody from L. Gerace (The Scripps 
Research Institute, La Jolla, USA).  Guinea Pig anti-DBP (DNA Binding Protein) 
was from W. Deppert (University of Hamburg, Germany).  Purified rabbit anti-pV 
C-term antibody was manufactured by immunizing rabbits with the synthetic 
peptide RRVAREGGRTLVLPTAR, position 347-363 of Ad2 pV.  Serum was 
harvested and an enriched IgG fraction was affinity purified on immobilized 
peptide (Davids Biotechnologie, Regensburg, Germany).   
 
SDS-PAGE, Western blots, fluorography and protein quantification 
SDS-PAGE gels were run with a Hoefer minigel device according to the 
manufacturer‟s instructions, and stained with Coomassie Brilliant Blue.  Pictures 
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were recorded either directly with the Syngene G:BOX gel documentation 
system (BIOLABO Scientific Instruments SA, Chatel-St-Denis, Switzerland) 
under white-light conditions or scanned after drying on filter paper.  For Western 
Blots, SDS-PAGE gels were electro-transferred in semi-dry mode onto Millipore 
Immobilon-PSQ 0.2 µm PVDF transfer membranes (Milian SA, Geneve, 
Switzerland), and developed with the Amersham ECL Plus Western Blotting 
Detection kit (GE Healthcare Life Sciences, Glattbrugg, Switzerland).  
Chemiluminescence was recorded either with the Kodak Digital Science Image 
Station 440CF or by exposing the membranes onto Amersham Hyperfilm ECL 
films (GE Healthcare Life Sciences, Glattbrugg, Switzerland).  Fluorography of 
Atto647-Ad2-GFP-pV after 12% SDS-PAGE was recorded with the Amersham 
Typhoon 9400 gel scanner using the 633 nm Helium-Neon laser.   
 
Protein bands from Ad2 and Ad2-GFP-pV (5 µg each) on Coomassie-stained 
SDS-gel were quantified with the MacBiophotonics ImageJ open source 
software (Rasband, W.S., ImageJ, U.S. National Institutes of Health, Bethesda, 
Maryland, USA, http://rsb.info.nih.gov/ij/, 1997-2010).  Briefly, a region of 
interest (ROI) was drawn around the protein band of interest and the integrated 
density of the selection calculated.  A background ROI with the same 
dimensions near the band was chosen and the integrated density subtracted 
from the protein band ROI.  The protein amount was calculated relative to a 
BSA standard curve using the background subtracted total intensity of each 
bands.  The number of molecules was determined by dividing the protein 
amount by the theoretical molecular mass of the protein.  The copy number of 
an individual protein per virion was calculated relative to hexon (720 copies per 
virion).  Calculated copy numbers were the mean of three independent 
experiments including SEM.  Optical densities shown were derived from the 
same representative experiment.  Molecular weights given in Dalton and the pI 
values were calculated with the “Compute pI/Mw tool” 
(http://www.expasy.ch/tools/pi_tool.html) from the Swiss Institute of 
Bioinformatics ExPASy Proteomics Server.  Sequences used were from the 
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UniProtKB/Swiss-Prot database: P03277 (pII), P03276 (pIII), P03267 (pV), 
P03274 (pVI) and P68950 (pVII).  In case of precursor proteins the mature form 
of the corresponding proteins was used for calculation.  Values for copy 
numbers (structural) and copy numbers (35S metabolic labeling) were obtained 
from the literature (van Oostrum & Burnett, 1985).   
 
Amplification, purification and labeling of viruses  
Ad2 and Ad2-GFP-pV were grown, isolated and labeled with Atto647 and 
Atto565 dyes (Atto-tec, Germany) as described (Greber, Webster, Weber, & 
Helenius, 1996; Nakano & Greber, 2000).   
 
Virus quantification 
Virus titers were determined using either tissue culture infective dose 50 
(TCID50) or a modified fluorescent focus assay (FFA).  In both assays virus was 
titrated on HER 911 cells plated on 96-well plates.  In case of TCID50 infection 
was allowed to proceed for 6 days while in the FFA cells were fixed after 4 
days.  For the calculation of fluorescent focus forming units per ml (fffu/ml) cells 
were fixed, quenched, immunostained for expression of protein V and 
fluorescent focus units counted using a fluorescence microscope.  A fluorescent 
focus was defined as 3 or more adjacent cells expressing protein V or GFP-pV.  
FFA titers were calculated using the formula of Spaerman and Kaerber.  Protein 
concentrations of purified viruses were measured using the Micro BCATM 
Protein Assay Reagent Kit (Pierce, Thermo Fisher Scientific, Switzerland). 
 
E1A measurement 
50% confluent A549 cells in 96-well plates were infected with serial dilutions of 
1 µg Ad2 or Ad2-GFP-pV in growth medium for 12, 16 or 20 h.  Cells were fixed, 
immunostained with mouse anti-E1A (Harlow, Franza, & Schley, 1985) and goat 
anti-mouse Alexa 594 (1/500), DAPI stained and recorded with the ZEISS 
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Axiovert 40 CFL fluorescence microscope using suitable filters.  The ratio 
between E1A expressing cells and DAPI positive nuclei was calculated and 
plotted against the virus dilution. Around 150 cells were counted per time point.  
The experiment was repeated 3 times with standard error of the mean (SEM). 
 
One step growth curves 
About 70% confluent A549 cells in 35 mm cell culture dishes were inoculated 
with 5 fffu of either Ad2 or Ad2-GFP-pV in a volume of 1 ml RPMI 0.2% BSA at 
4°C on a shaker for 1 h.  Cells were washed twice with PBS and incubated in 2 
ml DMEM/10% FBS/NEA/PS (growth medium) at 37°C and 5% CO2 for 0, 3, 12, 
24, 48 or 72 h. Supernatant was collected in 2 ml tubes and frozen while cells 
were broken up in 1 ml medium by freeze-thaw 3 times, transferred to 2 ml 
tubes and supplemented with another ml of growth medium.  Supernatants and 
cell lysates were centrifuged and viral titers determined on A549 cells.   
 
Preparation of pyridine cores 
Double CsCl gradient-purified Ad2 and Ad2-GFP-pV virions were dialyzed 
against 5 mM Tris pH 8.1, and 50 µg of each virus supplemented with 16 µl 
pyridine to 8% (v/v), similar to a previously described protocol (Everitt, 
Sundquist, Pettersson, & Philipson, 1973).  Samples were incubated at 37°C for 
2 h, followed by centrifugation on a 10-30% sucrose gradient at 111000 x g, 4°C 
for 2 h.  14 160 µl fractions were collected, TCA precipitated and dissolved in 20 
µl sample buffer.  Fractions 1-4, 5-8, 9-12 were combined as well as fraction 13 
and 14 with the pellet (collectively the pellet fractions), and analyzed on a 
Coomassie stained 12% SDS-PAGE.  From the pellet fractions of Ad2, a 
Western blot was prepared and immunostained with affinity-purified anti-pV 
antibody (1/200), and for Ad2-GFP-pV with anti-GFP antibody (1/1000).  
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Thermostability assay 
Accessibility of viral DNA from double CsCl gradient purified Ad2 or Ad2-GFP-
pV for the DNA intercalating fluorescent dye TOTO-3 iodide (1 mM solution in 
DMSO, Invitrogen) with 642/660nm excitation/emission was measured after 
heat-shock treatment at different temperatures.  Specifically, samples 
containing 5 µg virus diluted in buffer containing 10 mM Tris pH 8.1, 150 mM 
NaCl, 1 mM MgCl and 1 µM TOTO-3 in a total volume of 50 µl were prepared in 
1.5 ml Eppendorf tubes on ice, heated at indicated temperatures in a heating 
block for 3 min and rapidly chilled on ice.  The samples were transferred to a 
96-well plate and fluorescence was measured at 642±8 nm excitation and 660 ± 
9 nm emission with the Tecan SAFIRE II microplate reader. 
 
Single particle fluorescence analysis of Atto647-Ad2-GFP-pV 
Atto647-Ad2-GFP-pV was adsorbed to the bottom of 96-well clear bottom plates 
at 20°C for 15 min, washed with PBS, and overlaid with 100 µl fresh PBS.  
Images were recorded with the automated ImageXpressMICRO fluorescence 
microscope (Molecular Devices) using settings for Atto647 and GFP.  Images 
were processed as described in supplemental methods.  Briefly, images were 
corrected for background and aberration and single virus particles were scored.  
Average fluorescence intensities within the selected particle areas in the 
Atto647 and GFP channels were measured. For determination of background 
threshold 10 random ROIs which contained no virus particles were chosen 
using MacBiophotonics ImageJ and the average fluorescence intensity in the 
Atto647 or GFP channels calculated.  The background thresholds are 
represented as blue lines in Fig. 5D.  Population statistics were performed with 
Microsoft Office Excel software.  The average intensity per particle (GFP and 
Atto647) and calculated ratios of average GFP/Atto647 intensities were plotted 
against the number of particles.  
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Live-cell microscopy 
Live-cell confocal laser scanning fluorescence microscopy was conducted with 
an inverted Leica SP5 microscope (Leica Microsystems, Switzerland) equipped 
with a 63x (oil immersion, NA 1.4) objective, a diode laser (405 nm excitation), 
an argon laser (458/476/488/496/514 nm excitation), a helium laser 
(561/594/633 nm excitation) and a humidified chamber at 37°C and 5% CO2.  
HeLa cells stably expressing H2B-mCherry were plated at 25% confluency onto 
35 mm glass bottom microwell dishes, and cells were allowed to adhere 
overnight, followed by infection with Ad2-GFP-pV (0.8 µg) for 24 h.  Image 
stacks were recorded every 15 minutes for 21.5 h and processed with ImageJ.  
From 8 movies cell lysis events were counted and plotted against total numbers 
of infected cells as judged by the expression of GFP-pV. 
 
Kinetics of GFP-pV release and pVII epitope exposure of Atto647-Ad2-
GFP-pV particles during infection 
HER-911 cells were seeded to 60% confluency onto alician blue coated 
coverslips in 24-well cell culture dishes overnight.  Growth medium was 
replaced by serum-free medium, and cells were starved overnight to reduce cell 
background.  Cells were infected with 0.1 µg/ml Atto647-Ad2-GFP-pV at 37°C 
5% CO2 for 10 min, washed briefly and supplemented with 0.5 ml serum free 
medium.  0 min samples were immediately fixed with 3% PFA-PBS for 15 
minutes, washed and quenched for 10 min with 25 mM NH4Cl in PBS and 
permeabilized with 0.5% Triton X-100 in PBS for 10 min.  Other samples were 
allowed to proceed for 30, 90, 150 or 240 min post-addition of virus.  Cells were 
blocked with 20% goat serum and stained against pVII with preadsorbed anti-
pVII/Alexa594 goat anti-rabbit and DAPI.  Images were recorded on the same 
day with an inverted Leica SP5 single-point confocal microscope (Leica 
Microsystems, Switzerland) equipped with a 63x (oil immersion, NA 1.4) 
objective.  Excitations were at 405 nm (DAPI), 488 nm (GFP), 594 nm (pVII) 
and 633 nm (Atto647).  Individual stacks were recorded with 0.21 µm intervals 
using 10x accumulation and 4x averaging.  Maximum projections were 
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generated with MacBiophotonics ImageJ.  A Matlab-based routine (for details 
see supplementary information) was used to score individual viral particles and 
measure average fluorescence intensities in the particle areas from the Atto647 
(capsid), GFP (GFP-pV) or Alexa594 (pVII) channels.  Threshold values for 
fluorescence intensities were obtained by subtracting the average intensity of 
the entire image calculated using MacBiophotonics ImageJ from individual 
average intensities of single virus particles.  Statistics were performed with 
Microsoft Office Excel.  The total numbers of scored particles and average 
fluorescence intensities in the Atto647 channel (capsid) were plotted against 
time.  Average GFP fluorescence intensities in scored (Atto647) particles were 
plotted against time as well as GFP/Atto647 average fluorescence ratios of 
single particles.  The population of particles with pVII intensities over threshold 
(Atto647 and pVII positive Ad2) was determined and the ratio of this population 
relative to the total amount of scored (Atto647) particles plotted against time.  
From the same population average pVII fluorescence intensities were 
calculated and plotted against time, or average GFP fluorescence were 
calculated and plotted against time.   
 
GFP-pV dissociation from Ad2 
HER-911 cells were platted on 96-well clear bottom plates to 30% confluency in 
75 µl DMEM/10% FBS/1% NEA/1% PS plus 25 µl Optimem and incubated for 3 
days at 37°C and 5% CO2.  For background controls medium was added to 
wells containing no cells.  Cells were supplemented with 10 µl LMB dissolved in 
DMEM/0.2% BSA/1% PS to a final concentration of 20 nM or were MOCK 
treated 1 h prior to infection.  LMB was present during the whole experiment.  
Atto647-labelled Ad2-GFP-pV (0.125 µg, centrifuged for 10 min at 10000 rpm in 
an Eppendorf 5415 R centrifuge at 4°C prior use) was added in 10 µl 
DMEM/0.2% BSA/1% PS for 15 min.  Medium was removed and fresh 
DMEM/0.2% BSA/1% PS was added.  30 or 150 min p.i. 25 µl 16% PFA in PBS 
was added for 10 min, cells were washed 2 times with PBS and quenched with 
25 mM NH4Cl in PBS for 10 minutes followed by another washing step and 
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treatment with 0.5% TX-100 in PBS containing 0.5 µg/ml DAPI for 10 min.  Cells 
were then washed extensively and 100 µl PBS-N3 was added prior to recording. 
 
Fluorescence was recorded with the automated ImageXpressMICRO fluorescence 
microscope (Molecular Devices) using a Nikon 40x air objective NA 0.95, 
Semrock BrightLine® filters (GFP-3035B-NTE-ZERO, Cy5-4040A-NTE-ZERO 
and DAPI-5060B-NTE-ZERO) and the Molecular Devices MetaXpress 2 
software.  9 individual regions per well were recorded as stacks comprised of 9 
sections with a z-distance of 1 µm and images were saved as 16 bit TIFFs.  
Illumination times were 6 seconds for GFP, 8 seconds for Atto647 and 5 ms for 
DAPI without binning.  Images were processed as described in supplementary 
information.  Briefly, images were corrected for background and aberration.  
Maximum projections were generated and single viral particles were scored in 
the Atto647 channel.  Average fluorescence intensities in selected particle 
areas in the GFP and Atto647 channels were determined and GFP/Atto647 
intensity ratios calculated for all scored particles individually.  Average 
GFP/Atto647 intensities were plotted against time, and statistics performed with 
Microsoft Office Excel, including SEM calculated with n = 9. 
 
Crosstalk control experiments 
Ad2, Ad2-GFP-pV, Atto565-Ad2 or Atto565-Ad2-GFP-pV were attached to 
coverslips, mounted with DAKO and recorded by spinning disc confocal 
fluorescence microscopy in beamsplitter mode (GFP and Atto565) using 
identical illumination settings.  Ad2, Atto647-Ad2, Ad2-GFP-pV or Atto647-Ad2-
GFP-pV were adsorbed to the bottom of 96-well clear bottom plates at 20°C for 
15 min.  Wells were washed with PBS, medium removed and 100 µl fresh PBS 
was added.  Virus particles were recorded with the MetaXpress-Micro 
automated microscope focusing on the bottom of the plate using identical 
illumination settings (GFP and Atto647) for all viruses.  
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Live cell SDCM microscopy 
For live cell spinning disc confocal microscopy (SDCM), images were recorded 
with an N.A. 1.35 UplanApo 100x objective on an Olympus IX81 inverted 
microscope (Olympus Schweiz) equipped with a temperature controlled 
incubator box (Life imaging services), a Yokogawa scanning head QLC100 
(VisiTech International) with a triple bandpass excitation filter (488 nm/565 
nm/647 nm) (Chroma) and an Innova 70C mixed gas laser (Coherent).  For 
simultaneous dual color imaging (GFP/Atto565) a Dualview MultiSpec-
MicroImager (Optical Insights, USA) was used.  Images were recorded onto a 
back-illuminated monochrome Cascade 512 EM-CCD camera (Photometrics) 
containing a 512x512 pixel chip.  Microscope and camera were controlled with 
the Metamorph software package (Molecular Devices). 
HER-911 cells were grown on cover slips, serum starved over night and 
maintained in DMEM with HEPES modification (SIGMA, D6171) containing 
0.2% BSA during acquisition.  Recording was started and Atto565-Ad2-GFP-pV 
was added to 0.2 µg/ml.   
 
Image processing, particle scoring and quantification of GFP-pV from the 
Ad2 particles 
Images were recorded with an automated ImageXpressMICRO fluorescence 
microscope (Molecular Devices) controlled by the Molecular Devices 
MetaXpress 2 software as described earlier. Image stacks comprising 9 serial 
sections separated by a z-distance of 1 µm were recorded in the DAPI, GFP, 
and Atto647 channels and saved as 16 bit TIFF stacks.  To correct for uneven 
illumination across the field of view, a well containing no cells was recorded 
using identical settings (background stack).  From each slice in the sample 
stack the pixel intensity of the corresponding slice in the background stack was 
subtracted.  
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Lense aberrations caused a shift of the virus position in the GFP channel 
relative to its position in the Atto647 channel.  This was corrected with a custom 
written Matlab script.  A factor for the radial and linear increasing position shift 
was determined manually.  The pixel intensity value associated with each 
element in the image matrix was distributed into elements of a new matrix 
relative to the calculated shift.  This resulted in a new image matrix where 
intensity values were shifted to the corrected image locations. 
 
A Matlab based algorithm was used for particle scoring.  In brief, Otsu's method 
(Otsu, 1979) was used for thresholding of maximum intensity projections 
generated from background and aberration corrected images acquired in the 
Atto647 channel.  A manually set area threshold was used to attribute 
contiguous pixel over the grey threshold to virus particles in an image mask.  
Particles that meet the area threshold were displayed in green whereas particle 
that did not fulfill the threshold criteria were depicted in red (Figure S6C).  This 
image mask was subsequently employed to measure average fluorescent 
intensities over the particle areas in both average intensity projections from 
GFP channel images and Atto565 channel images.  The following particle 
parameters were extracted and used for analysis: Particle size, average GFP 
fluorescence intensity, average Atto565 fluorescence intensity, and the ratio 
(GFP/Atto647) of the two aforementioned intensities.  Statistical analysis was 
performed with Microsoft Office Excel.  The source code of all Matlab routines is 
available from the authors upon request. 
 
Live cell SDCM of POM121-mCherry transfected HER-911 cells 
HER-911 cells were transfected with a POM121-mCherry expressing plasmid 
using FuGENE 6 (Roche) according to the manufacture‟s instructions.  Cells 
were serum starved overnight and warm infected with 0.2 µg/ml Atto647-Ad2-
GFP-pV for 15 min, medium removed and incubated for another 45 min at 37°C 
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5% CO2.  Cells were recorded with the spinning disc confocal microscope 
without beamsplitter.  
 
EM analyses 
HeLa cells grown on alician blue coated coverslips at 70% confluency were 
incubated with 10 µg each Ad2 or Ad2-GFP-pV on ice for 1h, washed and 
incubated In DMEM-BSA at 37°C for 0, 30, 60 or 90 min.  Cells were prepared 
for EM analyses as described and analyzed for subcellular localization of virus 
using ruthelium red as a plasma membrane marker post fixation (Gastaldelli, et 
al., 2008). 
 
Fluid phase endocytosis and flow cytometry 
Fluid phase uptake and dextran release assays were performed as described 
(Meier, et al., 2002).  Briefly, HeLa-ATCC cells were cold-bound with 10 µg/ml 
Ad2 or Ad2-GFP-pV, washed and incubated at 37°C for 15 min in the presence 
of 1 mg/ml dextran-FITC and another 5 min in the absence of dextran-FITC.  
Cells were washed, acid stripped in 0.1 M sodium acetate, 0.05 M NaCl pH 5.5 
and detached with trypsin.  10000 cells were analyzed by flow cytometry in an 
Epics XL cell sorter (Beckman Coulter, Miami, Fla).  Dextran release from 
endosomes was assessed by measuring the dextran fluorescence over the 
nuclear area.  Cells with significantly enhanced nuclear dextran stain were 
counted positive and plotted against total numbers of cells.  
 
Localization of GFP-pV and pV relative to DBP and characterization of the 
anti-pV antibody 
HeLa-ATCC cells were infected with Ad2 or Ad2-GFP-pV at moi 2 for 20 h or 
left non-infected.  They were fixed, quenched, Triton X-100 treated and blocked 
for 1 h with 20% goat serum in PBS.  DNA binding protein (DBP) was 
immunostained with a guinea pig anti-DBP antibody, pV with an affinity purified 
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rabbit anti-pV antibody and the cell nucleus with DAPI.  Purified Ad2 or Ad2-ts1 
and cell lysates from Ad2 infected cells (3, 18 and 30 h) or non-infected HeLa-
ATCC cells grown on cell culture dishes were fractionated by 12% SDS-PAGE, 
blotted and stained with affinity purified rabbit anti-pV antibody followed by goat 
anti-rabbit conjugated horse raddish peroxidase staining. 
 
Preparation of Ad2 from H2B-mCherry expressing HeLa cells 
Ad2 was grown on HeLa cells stably expressing H2B-mCherry and purified. 5 
µg of this virus was fractionated by 12% SDS-PAGE together with cell lysates 
from A431 human epithelial carcinoma cells (BD Transduction Laboratories, 
Lexington, KY, USA) and non-infected HeLa H2B-mCherry cells.  A Western 
blot was prepared and stained for H2B-mCherry with a cross-reactive (mCherry) 
rabbit anti-mRFP antibody diluted 1:1000 (purchased from Abcam, ab62341) 
followed by goat anti-rabbit conjugated horse raddish peroxidase staining. 
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CONCLUSIONS AND FINAL REMARKS 
 
Ever since humans were confronted with diseases, they aimed to counteract 
them. While resources to do so were rather limited in ancient times an 
increased understanding of the principles of life resulted in the development of 
effective treatments and therapies of current time. A big step forward in this 
direction was the description of the nature of DNA by James Watson and 
Francis Crick in 1953. This discovery preceded a revolution in biological 
sciences, which still continues today. The study of viruses and their interaction 
with the host cell contributed substantially to the increased understanding of 
basic biological mechanisms and revealed insights into key cellular events.  
The rationale of this thesis was to shed some light on two basic steps in the life 
cycle of adenovirus in the context of its chromatin. First, we analyzed 
disassembly of adenovirus particles on its way to the nucleus and second we 
visualized egress of viral particles from infected cells through lysis. Therefore, 
we constructed a recombinant Ad2 where pV was replaced by GFP-pV. The 
resulting Ad2-GFP-pV possessed a fluorescent DNA core, successfully 
accomplished the whole replication cycle and could therefore be used for live 
cell imaging experiments. This virus is unique in that it is the first core-labeled 
genomically intact adenovirus available without any deletions or mutations 
beside the replacement of pV by GFP-pV. 
Since the use of fluorescently-tagged viruses proved to be very successful in 
gaining new insights into adenovirus host interactions such as surface motions 
at the cell surface (Helmuth, Burckhardt, Koumoutsakos, Greber, & Sbalzarini, 
2007), cell entry (Nakano, Boucke, Suomalainen, Stidwill, & Greber, 2000) and 
transport along microtubules (Suomalainen, Nakano, Boucke, Keller, & Greber, 
2001; Suomalainen, et al., 1999), several fluorescent adenoviruses have been 
generated to date. One of the first available techniques was capsid labeling by 
chemical conjugation of synthetic fluorophores. More recently, GFP was fused 
to the minor capsid protein IX (Meulenbroek, Sargent, Lunde, Jasmin, & Parks, 
2004). However, these labeling methods allow only visualization of the outer 
capsid structure, but not the inner core. In addition, the GFP-pIX labeled virus is 
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deleted in the E1 and E3 region and therefore is not capable to fully replicate in 
normal cells.  The field of application of these viruses is therefore restricted to 
viral entry. As delivery of the viral genome into the nucleus as well as dynamics 
thereof is still not understood, many attempts were undertaken to generate 
recombinant viruses with fluorescently-tagged chromosomes. Glotzer et al. 
inserted tetO repeat sequences into the adenovirus genome, which was bound 
by the fusion protein tetR-GFP (Glotzer, Michou, Baker, Saltik, & Cotten, 2001). 
Although genome labeling could be demonstrated and exogenously provided 
tetR-GFP was incorporated into newly synthesized viral particles, usefulness 
proved to be limited as only around 20 copies of tetR-GFP were incorporated 
into the capsid and the signal therefore was very weak. In addition, this virus 
was devoid of regions E1 and E3 of the viral genome limiting use of the virus to 
cells that provide E1A in trans and to cell culture systems were no immune 
system is present. In addition, adenoviruses encoding pV-GFP or pre-pVII-GFP 
and a dual color Ad5 with pIX-RFP and pV-GFP were also reported (Le, et al., 
2006; Ugai, et al., 2010). But again, all of those viruses suffered from a missing 
E3 region and in case of both pre-pVII-GFP- and pV-GFP -expressing viruses 
the recombinant proteins were under the control of an artificial promoter while 
endogenous pre-pVII and pV were also expressed, which resulted in low 
incorporation of recombinant proteins in virus particles. The pIX-RFP / pV-GFP 
labeled virions on the other hand were heterogeneous with respect to green and 
red fluorescence, and their cellular trafficking was difficult to elucidate (Ugai, et 
al., 2010). 
How viral particles are released from infected cells at late stages of the 
replication cycle is poorly characterized. While there is an increasing amount of 
studies addressing this question in case of enveloped viruses such as 
herpesvirus (for a review see (Mettenleiter, 2002)), non-enveloped viruses such 
as adenoviruses are still lacking a detailed characterization. This can be 
explained in part by the lack of suitable tools to study this question. 
Using a combination of live cell and quantitative fluorescence imaging, we now 
were able for the first time to visualize the dynamics of cellular disintegration 
events at late times of the adenovirus life cycle. We observed the release of 
GFP-pV positive clusters from the nucleus, which frequently remained 
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associated with the cytoplasm at late stages of infection and, later, a 
displacement of the clusters into the medium. Therefore we proposed that virus- 
induced cell lysis occurs in two morphologically defined steps. First, the nucleus 
is disintegrated and thereby releases its contents into the cytoplasm -and 
second, viruses are released into the extracellular space upon lysis of the 
plasma membrane. In support of this model, we identified viral clusters in the 
nucleus and the cytoplasm by EM analysis at similar time points, which is in 
agreement with published data from Puvion-Dutilleul that identified pre-lytic 
single viral particles in the cytoplasm (Puvion-Dutilleul, Besse, Pichard, & 
Cajean-Feroldi, 1998). Adenovirus death protein (ADP) was also identified to 
play a role in viral lysis (Tollefson, Ryerse, Scaria, Hermiston, & Wold, 1996). 
Intriguingly, an ADP deletion mutant produced smaller plaques and showed an 
enlarged nucleus upon infection, indicating that this protein has a role in nuclear 
membrane disruption (Tollefson, Scaria, et al., 1996). This fits well with our data 
as we observed an “explosion-like” nuclear disruption, which could be the result 
of an enhanced pressure onto the nuclear membrane from continuous import of 
viral proteins and subsequent accumulation of viral particles. The second step 
in our model, lysis of the plasma membrane, could be the consequence of 
release of the viral protease L3/p23, which is known to cleave cytokeratin, actin 
and microtubules (Mangel, Baniecki, & McGrath, 2003). Interestingly, actin is 
used as cofactor by the protease and therefore activates this enzyme. As actin 
is present in large quantities in the cytoplasm it is tempting to assume that once 
L3/p23 is released from the nucleus it is readily activated which subsequently  
induces disintegration of the cytoskeleton which makes the infected cell more 
susceptible to mechanical stress (Chen, Ornelles, & Shenk, 1993). Precisely 
how the plasma membrane is disrupted and the newly synthesized virions are 
released from the cell is, however, unknown. This can now be addressed with 
the help of the cell-lytic Ad2-GFP-pV particles.  
In a second part, we analyzed viral chromatin during entry into cells. We could 
show that around 65% of GFP-pV was released within 30 minutes and the 
remaining 35% after 90 minutes pi. The release of the latter was inhibited upon 
treatment of cells with LMB. We therefore proposed that release of GFP-pV 
from Ad2-GFP-pV is a two step process. In a first rapid step, most of GFP-pV is 
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released from the viral particle while the remaining part is released upon capsid 
disassembly at the NPC. We speculate that the first step in GFP-pV release 
from the virions coincides with structural changes of the capsid, such as the 
loss of fibers and penton base proteins, or capsid-stabilizing proteins IIIa and 
VIII (Fabry, et al., 2005; Greber, Willetts, Webster, & Helenius, 1993; Nakano, 
et al., 2000). Interestingly, biochemical studies have suggested that pV attaches 
the viral DNA to the capsid via an interaction with pVI (Chatterjee, Vayda, & 
Flint, 1985; Matthews & Russell, 1998). In addition, thermal in vitro disassembly 
studies simulating disassembly in endosomes indicate that mature wild-type Ad 
virions release around 80% of penton base with around 25% of the hexons and 
around 80% of protein VI (Wiethoff, Wodrich, Gerace, & Nemerow, 2005) while 
65% of pVI was found to be degraded upon infection of KB cells with Ad2 for 40 
min in a degradation assay based on autoradiography (Greber, et al., 1993). In 
our own study, we observed, that 60-70% of GFP-pV signal is lost after 30 min 
endocytosis of Ad2-GFP-pV. This is in the range of the protein loss observed for 
pVI. We therefore speculate that GFP-pV is lost together with pVI. As a result, 
this could lead to a destabilization of the core preparing for the release of DNA 
into the nucleus. pV release might also support an early step in viral entry. 
However, the above mentioned data about pVI release are contradicting a 
model that suggests that pVI is associated with every capsomer (trimer of 
hexon) in the capsid (Silvestry, et al., 2009). As there are 240 capsomers 
present in each viral particle and around 360 copies of protein VI there are 120 
copies of pVI that are not assigned. In addition it is somehow hard to explain 
how such a large fraction (80%) of pVI is lost from the capsid even if 25% hexon 
is lost (Wiethoff, et al., 2005) The remaining capsomers 180 in number should 
bind 180 copies of pVI which is not released. This corresponds to 50% of all pVI 
present in the capid. The authors therefore suggest a homotopic interaction 
among pVI proteins which then would lead to a higher loss of protein VI. 
In summary, this thesis described the generation of a novel recombinant 
adenovirus with a fluorescently-tagged genome and characterization of it during 
specific stages of the adenovirus life cycle. 
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ABBREVIATIONS 
 
Ad   Human adenovirus 
Ad2-GFP-pV Adenovirus type 2 with pV replaced by GFP-pV 
ADP   Adenovirus death protein 
AIDS  Acquired immune deficiency syndrome 
ATCC  American Type Cell Culture Collection 
B23   Nucleophosmin 
BAC   Bacterial artificial chromosome 
BSA   Bovine serum albumin 
C23   Nucleolin 
CAR   Coxsackie B virus and adenovirus receptor 
CLSM  Confocal laser scanning microscopy 
CsCl   Cesium chloride 
DAPI  4‟-6‟-diamidino-2-phenylindole 
DBP   DNA binding protein 
dHBV  Duck hepatitis virus 
DIC   Differential interference contrast 
DMEM  Dulbeccos‟s modified Eagle medium 
DNA   Deoxyribonucleic acid 
dsDNA  Double-stranded deoxyribonucleic acid 
EBV   Epstein Barr virus 
eGFP  Enhanced green fluorescent protein 
EM   Electron microscopy 
ER   Endoplasmic reticulum 
FBS   Fetal bovine serum 
FFA   Fluorescent focus assay 
FFFU  Fluorescent focus forming unit 
FG   Amino acid abbreviation for phenylalanine-glycine 
FISH  Fluorescent in situ hybridization 
FITC   Fluorescein isothiocyanate 
GDP   Guanosine diphosphate 
GFP   Green fluorescent protein 
GON  Group-of-nine 
GTP   Guanosine triphosphate 
GTPase  Guanosine triphosphatase 
HAd   Human adenovirus 
HBV   Hepatitis B virus 
HeLa  Cancer cell line named after deceased patient Henrietta Lacks 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HHV   Human herpesvirus 
HIV   Human immunodeficiency virus 
HPV   Human papillomavirus 
HSV   Herpes simplex virus 
HTLV  Human T lymphotropic virus 
INHAT  Inhibitor of acetyltransferase 
INM   Inner nuclear membrane 
Kbp   Kilo base pairs 
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kDa   Kilo Dalton 
KSHV  Kaposi‟s sarcoma-associated herpesvirus 
LMB   Leptomycin B 
MAPK  Mitogen activated protein kinase 
MCPyV  Merkel cell polyomavirus 
MLP   Major late promotor 
MOI   Multiplicity of infection 
mRNA  Messenger ribonucleic acid 
MTOC  Microtubule organizing center 
NEA   Non-essential amino acid 
NES   Nuclear export signal 
NIH   National Institutes of Health 
NLS   Nuclear localization signal 
Nm   Nanometer 
NPC   Nuclear pore complex 
Nup   Nucleoporin   
ONM  Outer nuclear membrane 
PAGE  Polyacrylamide gel electrophoresis 
PBS   Phosphate buffered saline 
PFA   Paraformaldehyde 
PKA   Protein kinase A 
PM   Plasma membrane 
PS   Penicillin/Streptomycin 
Ran   Ras-related nuclear protein  
RanGAP  Ran GTPase-activating protein 
RanGEF  RanGDP/GTP exchange factor 
RFP   Red fluorescent protein 
RGD   Amino acid abbreviation for arginine-glycine-aspartate 
RNA   Ribonucleic acid 
ROI   Region of interest 
SDCM  Spinning disc confocal microscope 
SDS   Sodium dodecyl sulfate 
SEM   Standard error of the mean 
ssDNA  Single-stranded deoxyribonucleic acid 
SV40  Simian virus 40 
TAF   Template activating factor 
TCA   Trichloroacetic acid 
TCID50  Tissue culture infective dose 50 
TEM   Transmission electron microscopy 
VZV   Varizella zoster virus 
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